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Abstract 
The objective of this study was to evaluate the congruence between HIV testing 
policies and everyday testing practices in a small urban centre in Newfoundland and 
Labrador (NL). Social justice principles were used to explore the challenges associated 
with anonymous testing in a small urban centre and how current service delivery 
practices may be affecting "at-risk" populations and other test seekers who require a 
higher degree of confidentiality. Framed within a constructivist epistemology, qualitative 
description was used to determine data collection and analysis strategies. The findings are 
presented within an expanded social determinants of health framework, which 
emphasizes health inequalities as a driver of poor health outcomes. Data were collected 
from four testing sites using individual interviews and a document review of policy-
related documents·. A reflexive journal was logged throughout data collection and used 
for verification during analysis, which included thematizing, diagramming and coding. 
The applicable legislation was the Communicable Diseases Act, which requires 
name based reporting. Participants interpreted anonymous testing as being illegal 
according to this legislation. Findings demonstrated a history of offering anonymous 
testing at all testing sites and present-day practices that fit the definition of anonymous 
testing, but were referred to in official policy and understood by participants as being 
non-nominal. An alternate definition of anonymous testing is proposed where contact 
information is not requested or recorded and pre- and post-test counseling is delivered 
face-to-face. Redefining the provision of HIV testing services in this way supports the 
call to increase the visibility of social justice in Canadian public health policy. Eighteen 
recommendations are offered to guide this legislative and policy change. 
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Human Immunodeficiency Virus (HIV) is a preventable sexually transmitted 
infection that causes acquired immunodeficiency syndrome (AIDS), which has no known 
cure. The word testing is used in this study to describe this preventative service; however, 
this inquiry was concerned with the voluntary counselling and testing (VCT) model as 
described by the United Nations Working Group on AIDS (UNAIDS) and the World 
Health Organization (WHO) (2004) and adopted by the Public Health Agency of Canada 
(PHAC) (2006a). 
In Canada, three VCT options are differentiated by the type of personal 
information collected and the coding system used to label the specimen when it is sent to 
the laboratory for testing (PHAC, 2007a). In nominal or name-based testing, test-seekers 
must provide their complete personal information including their name and MCP number. 
This personally identifying information is then used to label the specimens sent to the 
laboratory for testing. Non-nominal testing requires collection of the same information as 
the nominal process; however, the label to identify the specimen is completed with 
something other than the test seeker's' full or partial name, such as an alphanumeric 
code. The PHAC (2007a) definition of anonymous testing states that the identity of the 
test seeker is not known to the provider and a code is used to label the specimen. To 
1 Where possible, I employ the term test seeker instead of '·individual seeking an HIV 
test". I coined this phrase after reading Kodner and Spreeuwenbcrg's (2002) reference to 
.. care-seekers" (p. 3) 
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summarize the PHAC definitions, with nominal and non-nominal testing, the test seekers' 
identifying information is provided and kept confidential. In anonymous testing, 
personally identifying information is never collected or recorded. The VCT model asserts 
the importance of maintaining three key elements- confidentiality, counselling, and 
informed consent. This inquiry focused on the first ' C ', confidentiality. 
1.1 Problem Statement 
1 became interested in formally studying this subject after noticing inconsistencies 
in public information about the availability of HIV testing in a small urban centre in 
Newfoundland and Labrador (NL). I was intrigued by the concept of anything 
anonymous in this small urban centre when I saw advertisements for anonymous testing 
in local and student newspapers (The Muse, 2008). Shortly after, I found academic 
literature suggesting that anonymous HIV testing had, in fact, been available in the small 
urban centre at one point in time; however, as of 2008 there had been "no anonymous 
testing for HIV or HCV available anywhere in NL" (Gustafson, Goodyear & Keough, 
2008, p.192). Having seen the advertisements just weeks before, I wanted to know more. 
Through my coursework, I had learned that PHAC had been created in 2004 to 
provide national guidance, leadership and coordination in public health with a mission to 
"promote and protect the health of Canadians through leadership, partnership, innovation 
and action in public health" (PHAC, 2008). I turned to PHAC for answers. Two tables in 
the epidemiology update (PHAC, 2007a) were entitled "HIV testing and HIV reporting 
by province/teiTitory'· (p. 15) and '·Status of anonymous I IIV testing by 
province/territory' (p. 16). These tables demonstrated the availability of the three types of 
- -----
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HIV testing in the various provinces and territories. According to these tables, seven 
provinces offered anonymous testing. Three of the seven provinces that offered 
anonymous testing (NL, Ontario, and Alberta) had footnotes explaining various 
conditions of province-specific testing service provision. The footnotes for NL's 
anonymous testing stated that all positive results become "part of the nominal/name-
based system, in which counselling, follow-up care, and HIV data reporting are all done 
nominally" (p.15). A second footnote stated that anonymous testing was "available upon 
request but is not part of the official guidelines for the province" (p.16). 
I looked for these "official guidelines"; however, they were not available from the 
Government of NL' s Department of Health and Community Services at the time of the 
study (Gillian Butler, Personal Communication, April 2009).1 used the Mesh terms 
sexually transmitted disease, viral, anonymous testing, preventive health service, and 
public health to search the academic literature listed in the Cochrane Database of 
Systematic Reviews and Pub Med, and found no studies describing the evolution of HIV 
testing delivery in the small urban centre, nor were there any descriptions of if and how 
anonymous testing procedures were carried out in practice. I also conducted an extensive 
search for grey literature and found similar results. 
1.1.1 Research Question and Objectives 
The question that guided my research was "Are HIV testing policies and everyday 
HIV testing practices congruent in this small urban centre?" The specific study objectives 
arc listed here: 
1. Review the HIV testing policies at each of the selected sites; 
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2. Determine policy guidelines for maintaining anonymity if anonymous testing 
is offered; 
3. Examine every day HIV testing practices of the health care providers who 
have been or are presently involved in providing HIV testing information 
and/or administering HIV testing; 
4. Articulate the similarities and differences between organizational policies and 
practices at community-based organizations and in public health settings; 
5. Evaluate and interpret the congruence between established policy and 
everyday practices; and 
6. Articulate the challenges associated with offering anonymous testing in a 
small urban centre in NL. 
Given the complexity of these issues, I chose to study this phenomenon without 
introducing any kind of intervention or treatment. This is what Polit and Beck (2004) 
refer to as "non-experimental research" (p. 46). After formalizing the research question 
and objectives, I began a formal inquiry to find out what was involved in HIV testing, the 
policies that govern the process, and how it plays out at the locations where it is offered 
in the small urban centre. 
1.2 Study Background 
1.2.1 Personal Interest in the Area of Inquiry 
Kaas (2004) describes public health as a "societal approach to protecting and 
promoting health" (p.232). Its goal is to improve the health of communities by favouring 
socially-oriented strategies and it is central to the societal actions and inactions that 
13 
influence the priority of items on policy-makers' agendas (DeCock, Mbori-Ngacha, & 
Maru, 2002). While every area of health services has its own focus, the specific aim of 
public health services is to improve the well-being of communities through social rather 
than individual action. This is unique from other health services that may be clinical in 
nature or focus heavily on treating individual illness. Kaas (2004) provides examples of 
other public health initiatives such as offering vaccinations, immunizing schoolchildren, 
engaging in epidemiologic research, offering maternity services for pregnant women, and 
maintaining a safe water supply. 
I became interested in public health during a volunteer internship in South Africa 
from February to June 2007. It gave me insight on the impact ofHIV and AIDS around 
the world and when it finished, I wanted to Jearn about the impact and existence of HIV 
and AIDS in my hometown. I was particularly interested in if and how HIV testing was 
being offered given that infrastructure and resources to provide care and services were far 
more sophisticated than those I had seen in Africa. I learned that HIV testing was 
classified as a public health and community service, one of many services that make-up 
the full continuum of health services provided by the regional health authority that serves 
the region in which the small urban centre was situated. In July 2007, I began 
volunteering with an AIDS-service community-based organization. I realized that even 
the most informed local HIV/AIDS advocates were challenged to clarify the differences 
between various types of HIV testing procedures from both a theoretical and practical 
standpoint (M.B. , Personal Communication, September 2007). They had trouble 
articulating the differences between the various types of HIV tests, what was available in 
the small urban centre and the details of the process from a client's perspective. For 
example, community advocates were uncertain whether or not anonymous testing was 
available and the differences of personal information requirements during non-nominal 
and anonymous testing. 
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I started an informal inquiry during which I spoke to local health care providers 
and policy-makers. The confusion about HIV testing extended beyond circles of the 
HIV I AIDS community workers and advocates. I heard several anecdotal accounts of the 
challenges involved in developing policies to govern this service as well as the practical 
dilemmas that were arising in clinical settings (S.B., Personal Communication, March 
2007). It became apparent early on that researching preventative public health strategies, 
such as HIV testing, would require an understanding of the population for which the 
preventative strategy was intended. Research from across disciplines consistently 
supports that HIV infection is higher among some populations (Barnett, Whiteside & 
Desmond, 2001; DeCock, Mbori-Ngacha, & Maru, 2002; Dodds, Colman, Amaratunga, 
& Wilson, 2001), is associated with certain behaviour and activities (Goldenberg, 
Shoveller, Koehoorn, & Ostry, 2007; Higgins, Galavott & O' Reilly, 1991 ), and 
entrenched within the most marginalized communities (Spigelman, 2002). 
In 2007, the categories used to identify the sub-populations that are over-
represented in the occurrence of HIV infection in Canada included youth, women older 
Canadians, Aboriginal people (First Nations, Inuit, Metis), men who have sex with men 
(MSM), injection drug users (IDUs), persons living in Canada who come from countries 
where HIV is endemic, and prisoners (PHAC, 2007a). In NL, the Department of llcalth 
and Community Services (2008) recognized the following risk factors for HIV exposure 
- MSM, IDU, a combination of MSM and IOU, recipients of blood and/or blood 
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products, heterosexual activity with a person who engages in risky activities, prenatal 
transmission, medical exposure, and non-medical exposure. PHAC (2007a) uses the term 
"high-risk" (p. ll) to describe these groups. Although I use the term "at-risk" groups, I 
am cognizant of the methodological challenges associated with the derivation of such 
categories. (These challenges will be discussed later). 
1.2.2 Study Context 
This section describes several historical events that influenced the unique 
unfolding of HIV in NL including a court case, regionalization of health services, a recent 
privacy breach by a local healthcare provider, and human resources challenges for 
infectious disease specialists in NL. Firstly, between 1990 and 1995, approximately 40 
people in the Conception Bay North, a community just outside St. John's tested positive 
for HIV (Bergman & Welbourn, 1995). This represented an extremely dense rate of 
infection given that there were only 5,000 people in the region and 156 HIV positive 
individuals in the entire province at the time. The unusually high rate of infection was 
traced back to Raymond Mercer of Upper Island Cove who knowingly infected his sexual 
partners (Elliot, 1997). Eventually, Mercer was criminally charged with two accounts of 
criminal negligence causing bodily harm for having unprotected sex without disclosing 
his HIV infection. Mercer pleaded guilty to infecting only two women though many 
locals suspected that the real number was much higher. In 1991 , he was sentenced to two 
and a half years imprisonment and in 1992 his sentence increased to 11 years in a 
precedent setting court case. The sentence was appealed to the Supreme Court of Canada 
and refused. In 2000, Mercer was denied parole and in 2003, Mercer was released after 
serving his complete ll-year sentence (CBC News, 2000). 
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Mercer's arrest, trial, and legal proceedings became the focus of national media 
throughout the 90 's. This created a link in the minds ofthe Canadian public between 
Conception Bay North and HIV/AIDS. Economic activity was negatively impacted and 
declines in tourism revenues were attributed to the negative regional perception that had 
resulted from the Mercer case (Bergman & Welboum, 1995). Actions taken by high 
profile institutions such as the Red Cross, which stopped collecting blood from the area, 
further stigmatized the community. An anonymous article in the Canadian Medical 
Association Journal ( 1998) used the informal term adopted by citizens who were aware 
of the localized spread of infection resulting from Mercer's index case when referring to 
the rural community as "the AIDS capital of Canada" (p. 1 005). The article declared that 
the region may have finally lost this distinction. These events are a significant 
consideration when examining the availability of testing services in any small urban 
centre in NL. This recent history suggests there are lingering effects of stigma, a need for 
ongoing education, and a duty to provide testing services that offer the highest degree of 
confidentiality. 
The second event in the unfolding of HIV in the province was a series of 
administrative and structural changes to health and community services announced by the 
Government of L in September 2004 (Eastern Health, 2006). This process is referred to 
as the regionalization of health services and is furiher described throughout the 
document. Fifteen existing boards were transformed into four regional integrated health 
authorities - Eastern, Central, Western and Labrador-Grenfell. The original health and 
community service organizations that were merged are now commonly referred to as 
" legacy organizations" (Joan Decker, Personal Communication, June 2009). Each came 
with their own stated organizational values, culture, policies, and practices. This is 
relevant to the study context because, as Dolan et a!. (2005) explain; many Canadian 
coastal communities' access to local health and social services has been negatively 
affected by this restructuring. 
Thirdly, on November 22nd, 2007 a healthcare provider installed a file sharing 
program on her laptop while working from home. This caused her to unknowingly 
transmit 1,420 confidential medical files over the Internet that contained individual 
patient information including name, gender, health information, and test results for 
conditions including Rubella, Hepatitis A and B, Parvovirus, HIV, and other 
communicable diseases (Office of the Information and Privacy Commissioner, 2008). 
A wad, Sagrestans, Kittleson and Savela (2004) discovered that "the fear of health 
providers breaking confidentiality is exacerbated when reports of specific instances of 
breaches are made public" (p. 123). This conclusion is further discussed within the 
context of the study ' s findings, which supported that confidentiality concerns were an 
important barrier that impeded access to HIV testing services. This privacy breach is 
related to HIV testing in the small urban centre because it created a situation whereby a 
health care provider's guarantee of confidentiality may not assuage the privacy concerns 
of individuals seeking HIV testing. 
Finally, at the time of my study, the regional health authority was facing public 
discord for the loss of the province' s only infectious disease specialist who was 
responsible for treating patients with HIV and AIDS and many other communicable 
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diseases (Telegram, 2009). Community advocates were dissatisfied with the loss of this 
employee since it was the only infectious disease specialist in the province (T. W. 
Personal Communication, January 2007). 
1.2.3 Locating the Study 
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Establishing a broad definition of health as "a state of complete physical, mental 
and social well-being and not merely the absence of disease or infirmity" (WHO, 1948) 
was an important development for public health. It marked the beginning of a paradigm 
shift through which society began to acknowledge the social factors that shaped people's 
health. Documents like The Lalonde Report (1974) and The Ottawa Charterfor Health 
Promotion (WHO, 1986) have been credited as instrumental to the recognition of the 
social determinants of health framework and the importance of community involvement 
in public health policy around the world. Evans, Barer and Marmor (1994) described the 
social determinants of health as powerful influences on "how healthy we are as 
individuals and societies" that determines "why some people are healthy and others are 
not" (p. xiii). Over time, the social determinants approach has "gained widespread 
acceptance as the appropriate framework for developing and delivering public health 
policy" (Graham, 2004, p. 1 05). 
Due to its popularity in policy circles, [have not abandoned the social 
determinants of health as a fran1ework for analysis. l have, howe er, whenever possible 
and relevant used recommendations that focus on expanding the social determinants 
framework to include and make explicit the determinants ofhealth inequality drawing 
heavily from the work of Graham (2004 ). The concepts of social positioning and a range 
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of proximal, intermediate and distal factors to formulate recommendations for translating 
the expanded framework within the policy arena are discussed in the literature review and 
emphasized in the discussion to make sense of the findings. I have also used Labonte, 
Polanyi, Muhajarine, Mcintosh and Williams' (2005) critical view of the population 
health approach. In response to their call to build upon explicit social values and 
analyses, I have made an attempt to strengthen this emphasis on social determinants of 
health inequality as a means to increase the visibility of social justice as an explicit value 
in Canadian public health. To explain the principles and importance of social justice, I 
draw from the works ofBraveman and Gruskin (2003), Edwards and Maclean Davison 
(2007), Gostin and Powers (2006), and Rawls (1999). 
Social justice is a commitment to the preservation of human dignity and respect 
for all members of the community (Rawls, 1999). It aims to advance human well-being 
and improve public health by focusing on the needs of the most disadvantaged. This 
approach recognizes that there are many factors that can lead to poorer health outcomes 
and that disadvantages extend to almost every aspect of social, economic, and political 
life. Gostin and Powers (2006) believe that stating social justice as an explicit value is an 
effective way to approach challenges in public health ethics and policy. Edwards and 
MacLean Davison (2007) identify opportunities to embed social justice within public 
health values in Canada. One such opportunity is a document entitled Core Competencies 
for Public Health in Canada (PHAC, 2007b) which reflects the strategic direction for the 
future of public health in Canada by listing 36 desired core competencies to formalize the 
essential knowledge, skills and attitudes sought in public health employees across the 
country. The document is intended to improve the effectiveness and quality of the 
healthcare workforce by offering evidence-informed standards to ensure an appropriate 
practical representation of proficiency in the skill sets of providers, consultants, 
specialists, managers, and other public health officials. It is noted that the document 
lacked an explicit reference to social justice. Edwards and MacLean Davison (2007) 
argue that the way to improve public health policy and programming in Canada is 
through "the explicit recognition of social justice as a foundational value of public 
health" (p. 130). 
I explore the benefits of anonymous testing and provide evidence that certain 
populations prefer anonymous testing (Bindman, Osmond, Hecht, Lehman, Vranizan et 
al., 1998; Hoxworth, Hoxworth, Hoffman, Cohn, & Davidson, 1994; Kegeles, Catania, 
Coates, Pollack, & Lo, 1990). Certain policy measures, such as partner notification, 
contact tracing and mandatory reporting make it impossible for people who prefer 
anonymous testing to access it. I feel that legislation requiring detailed mandatory 
reporting of personal information denies some people of their right to testing in the way 
they would like it. Therefore, they are being denied their rights to a health service that 
may help them attain the highest standard of health. 
1.3 Rationale for the Study 
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The main goal of this study was to evaluate and interpret the congruence between 
the provincial policies about HIV testing as they were described in policy-related 
documents and everyday practices in the small urban centre. Doing this required 
formulating a clear and concise articulation of the procedures followed for the different 
types of tests with an emphasis on non-nominal and anonymous in the various settings at 
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which HIV testing was available. By doing so, I hoped to respond to a need identified by 
Baum, Gollust, Goold, and Jacobson (2007) for research that will enhance people' s 
understanding of the ethical challenges faced by public health providers on a daily basis 
in order to prepare them to address similar challenges in future . 
This may be of benefit to some ofthe people involved in public health services including 
providers, policy-makers, and scholars. The findings that resulted from this inquiry 
attempt to shed light on issues pertaining to anonymous testing as an appropriate 
specialized service that could be beneficial in any small urban centre in NL. It is hoped 
that highlighting areas of divergence between policy and practice, and making 
recommendations for legislative, systemic and practical improvements may inform 
academics and decision-makers engaged in future policy debates on the matter. 
1.3.1 Anonymous HIV Testing- An Ethical Tension 
Kaas (2004) describes the field of HIV I AIDS as one that has encountered many 
classic public health moral tensions, "from societal rights versus individual liberties, to 
justice and health care access" (p.234 ). HIV testing issues have evolved from being 
extremely controversial in the 1980s to now. In the early days, when treatment was not 
yet available, individuals who tested positive could end up worse off for having been 
diagnosed with a highly stigmatized disease for which there was no medication. Since 
anti-retroviral medications have become available, the ethical question of providing 
anonymous HIV testing has been widely debated. This section explains three processes 
that are often at the centre of the anonymous testing debate - partner notification, contact 
tracing and reporting. 
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Partner notification is a 'secondary prevention process through which sexual 
partners and other contacts exposed to an STI are identified, located, assessed, 
counselled, screened and treated" (PHAC, 2006b, p. 16). Partner notification is carried 
out by the individual who has tested positive for a condition, who is referred to as "the 
index case" (p. 14 ). Contact tracing, on the other hand, also involves notification of past 
partners and other contacts exposed to an STI, however, it is carried out by a public 
health provider. The provider makes contact with a list of past partners and contacts 
based on information provided by the index case. The provider does not state the name of 
the index case during contact tracing. Kaas (2004) describes the public health benefits to 
partner notification and contact tracing as aiming to protect unknowing contacts from risk 
of infection. The possibility for complete or partial loss of confidentiality is a 
disadvantage of these processes. Even when the name of the index case is not explicitly 
disclosed, contact tracing can lead to the identification of the index case by default, 
circumstance or process of elimination. 
The Canadian Guidelines on STI testing discuss the importance of 
provider/patient confidentiality for people "working in agencies receiving personal 
information" and the importance of informing service users that information is "reported 
to authorities only as required by law" (PHAC, 2006b, p. 15). There are a variety of 
circumstances that merit reporting to authorities by law; however, this document 
discusses mandatory reporting in the context of communicable diseases where the 
provincial government departments responsible for epidemiological surveillance arc 
considered the authorities. In 1 L, this process is legislated by the Communicable 
Diseases Act. In the past, the distinction bet\veen collecting information for surveil lance 
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and for contact tracing has been unclear for those accessing testing services (PHAC, 
2006b). The difference between the two practices rests with the personal identifiers: it is 
possible to conduct surveillance without personal identifiers, but it is impossible to do 
contact tracing without personal identifiers. 
Thirdly, mandatory reporting requires providers who confirm a communicable 
disease to report that case to the provincial government. Kaas (2004) summarizes the 
reasons for and against mandatory reporting. Advocates of mandatory reporting suggest it 
enhances the ability to understand the disease, which offers the possibility of targeting 
educational material and potential treatments towards those who are infected. The 
availability of antiretroviral medication strengthened the arguments of those in support of 
mandatory reporting by partially alleviating the imminent death stigmatization. Critics, 
on the other hand, maintain that mandatory reporting is an invasion of privacy. They 
remind us that mandatory reporting is not required for educational efforts aimed at 
prevention and its potential to deter people from testing due to fear of reporting. 
Furthermore, critics argue that reporting legislation requires extensive and detailed 
personal information beyond that which is necessary for surveillance. 
The Canadian Guidelines on STI testing (PHAC, 2006b) offer no explanation as 
to how providers should proceed if a test seeker is hesitant or unwilling to provide 
personal information. This introduces the possibility that a health care provider may have 
to negotiate the terms of testing for him or herself. The Guidelines do not address the 
clinical or reporting procedures to follow when a test seeker does not provide personally 
identifying information even though this information may be required for legal reporting 
purposes. Individuals seeking testing may be apprehensive about providing personal 
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information for a number of reasons; fear of partner notification and mandatory reporting 
(Hoxworth et a!., 1994; Lansky, Lehman, Gatwood, Hecht, and Fleming, 2002). The 
impact of mandatory reporting is thought to have the most severe impact on at-risk 
individuals who could be discouraged from seeking testing due to fear of the 
consequences. 
1.4 Assumptions and Scope 
In this section three important assumptions on which this inquiry was based are 
made explicit. Firstly, HIV testing is an effective strategy for preventing the spread of 
HIV I AIDS. This is supported internationally by the WHO (2006a) has declared that HIV 
testing and counselling are "key entry points for individuals and their families to access 
HIV I AIDS prevention, treatment and care services" (p. 5). Secondly, as demonstrated by 
Smith (1999), traditional health services have not and do not always service the needs of 
marginalized populations who can benefit from them the most. I respond to this by 
incorporating social justice principles (Braveman & Gruskin, 2003; Gostin & Powers, 
2006; Rawls, 1999) Thirdly, I believe that steep social gradients are associated with steep 
health gradients (Labonte eta!., 2005). That is to say, I support scientific knowledge and 
theory suggesting that social factors could play an important part in creating disparity at 
one or many points along the causal pathway that determines health. Therefore, 
improving the health of at-risk populations through any reasonable means, such as 
anonymous HIV testing, may reduce health inequity and improve the well-being of the 
community at-large. 
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1.4.1 Epistemological Assumptions 
Qualitative methodology is aligned with my epistemological and ontological 
beliefs that there are multiple meaningful components of the social world from which 
knowledge can be derived. Crotty (1998) describes this as a constructivist epistemology, 
which maintains that scientific knowledge is constructed by humans. 
1.4.2 Study Limitations 
My initial goal was to include all settings that offered HIV testing services in the 
small urban centre. Due to the closure of the infectious disease clinic near the start of my 
data collection period, the acute care setting identified in the fact-finding phase was 
excluded early in the data collection period. Realizing the need to concentrate on 
clarifying non-nominal and anonymous testing policies and procedures, I focused on 
settings that had been associated with anonymous testing in the past. As a result, this 
inquiry is heavily grounded in community-based settings in an urban centre and does not 
reflect the provision of HIV testing services in acute care settings, family physicians' 
offices or walk-in clinics. These locations represent important points of HIV testing 
service delivery whose procedures and practices are differ from community settings. 
Additionally, the findings may not accurately reflect the needs of Aboriginal 
communities given the geographic location ofthe study setting. 
Benoit, Jansson, Millar, and Phillips (2005) define community as "persons located 
outside the academy, inside or outside go ernmental or administrative policy bureaus; the 
target population itself; persons proximal to the target population (such as service 
providers); or a constituency of citizens in a particular locale·· (p. 265). When this 
26 
definition is applied to the HIV community in this small urban centre, the population is 
clearly small and close-knit. Fraser (2004) has suggested that in such situations, the 
researcher has a heightened obligation to protect individual participants' confidentiality 
due to the potential harm that could result from loss of confidentiality. It is possible for 
small amounts of demographic information to make individuals readily identifiable. 
Recognizing I was working with a small community, it was necessary to take extensive 
measures to protect the identities of the participants and their organizations. This was 
especially important in this study since, at times, individual participants would express 
personal views that did not reflect those of their organization or compliance with the law. 
A description of the steps that were taken to protect identity is provided in a later section. 
The term "small urban centre" was borrowed from Gustafson, Goodyear, and Keough 
(2008) and is used throughout this document in place of the name of the city to protect 
the identity of participants. 
A second methodological weakness of this inquiry was the wording of two 
sentences in the study invitation (Appendix A) that was made available to all participants 
and in the ethics application. The first statement in the study invitation was "all policy-
related documents including meeting minutes, emails, briefing notes, or any other hard 
copies that have been or currently are used to direct testing procedures and inquiries" 
(Appendix A, p. 1 ). My intention here was to establish a broad definition of policy to 
impress a sense of my belief that informal documents can also determine organizational 
process. However, for a regional health authority that had just participated in an arduous 
court case in' hich cmails were used as evidence, I believe this definition created 
resistance. The second tatcmcnt in the ethics application was '·if there arc no IllY testing 
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policy documents, it will be considered a significant finding." For community-based 
organizations that are short on the resources required to establish formalized policies, but 
still rely on funding from various levels of government, this likely created some initial 
resistance and may have influenced how the participants responded in interviews. 
Finally, I use the term "at-risk" for ease of writing and I consider this to be a 
limitation for the following reasons. Labonte et al. (2005) believe that a blurred 
interrelationship exists between population health and social change. They attribute this 
vague relationship to the lack of attention paid to the role of social inequality in 
traditional population health analysis and discourse. This, in part, has been caused by 
reliance on raw data in the absence of ideological positioning and theoretical support. 
More specifically, while ample numbers and statistics support that higher income 
improved health outcomes, there is little in the way of qualitative inquiry that focuses on 
the social processes underlying health inequality.~Other critiques of the population health 
approach include its reliance on quantitative datasets, ignorance of human agency, and 
the politicization of research knowledge. These areas of weaknesses have resulted in a 
failure to articulate clear and achievable policy options for governments. HIV I AIDS 
statistical data provide an excellent example of the epidemiological pitfalls that have 
permeated population health data described by Labonte et al. Categories are used to 
identify sub-populations that have historically been over-represented in the occurrence of 
HIV infection (PHAC, 2007a), which are referred to as at-risk groups. It is necessary to 
point out the potential for such classifications to propagate stigma, reinforce social 
exclusion, and risk underemphasizing health inequality (Graham, 2004). Most strikingly, 
they ignore intersecting identities and other compounding factors present in complex 
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social realities. One example illustrated by Namaste (2009) is that the MSM classification 
overlooks bisexual men and attempts to categorize intersecting and overlapping 
characteristics into neat epidemiological categories. 
1.5 Significance of the Study 
I began this inquiry with the intention of evaluating and interpreting the 
congruence between the provincial HIV testing policies and everyday practices. I hoped 
to gain an understanding of practical HIV testing procedures in the small urban centre, so 
that I could communicate this information to community-based organizations and other 
interested audiences. It was my intention to shed light on issues of disclosure and ethics 
as they pertained to anonymous testing using a social determinants of health framework 
that emphasized health inequality in the name of social justice. As I worked through this 
inquisitive journey, I felt optimistic about its potential to hold value beyond its originally 
intended scope into a broader field ofhealth ethics. 
This inquiry supports a progressive shift away from traditional bioethical 
decision-making and towards the formalization of a set of values to guide decisions in 
public health ethics as a field in its own right. Historically, bioethics has centred on sound 
decision-making in clinical and research-oriented settings about issues such as informed 
consent, patient agency, reproductive and end-of-life decision-making by emphasizing 
individual patients' rights to access health care systems and services (Baum et al., 2007). 
Specific values that guide decision-making in bioethics include individual autonomy, 
beneficence, non-maleficence, justice fairness and utility. It rarely calls upon a broad 
dctinition of health that encompassed more than the absence of disease. The inadequacy 
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of an autonomy-focused, bioethical approach to community-level public health issues led 
to the acknowledgement of public health ethics as a field of inquiry in its own right. Kaas 
(2004) has described the emergence of public health ethics as the newest sub-field of 
public health as being distinctly separate from bioethics. The relationship between ethics 
and health as a common good is complex and encompasses fundamental tensions 
between conflicting values and guiding principles. As a result, public health is a 
particularly challenging area for policy-making and service delivery as it struggles to 
maximize population-level utility and justice while minimizing infringements upon 
individual rights (Thomas, Sage, Dillenberg, & Guillory, 2002). The primary ethical 
principles that guide public health include communitarianism, utilitarianism, evidence, 
justice, accountability, efficiencies, and political feasibility. Other values that Baum eta!. 
(2007) describe as being taken into consideration include beneficence, non-maleficence, 
and autonomy. I hope to popularize the explicit use of the term social justice in such 
statements of values and guiding principles. 
In managing public health, policy-makers and practitioners confront a number of 
ethical tensions and are forced to respond to socio-political, cultural and evaluative 
concerns. This is a reality at the macro level, with issues such as resource allocation and 
disease control, and the micro level, with day-to-day decisions about clinical priorities. I 
began to see the practical challenges of developing HIV testing policy as a matter of 
public health ethics that required attention: providers and clients do not always share a 
common understanding about the differences between confidential and anonymous 
testing. As a result in the face of unclear policies and a shared language, health care 
providers may be left to negotiate potential tensions between the testing policy and 
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patients' preferences. A providers' response to a person seeking testing who refuses to 
provide his or her contact information is an example of a public health ethics dilemma. In 
the interest of population-level utility, the preferred option would be to do the test and 
hope the individual takes the initiative to contact the organization for the test results. 
However, abiding by organizational policy would require the healthcare provider to 
refuse the testing service because of the individual 's unwillingness to provide contact 
information. Other ongoing controversies in the field include the legitimate scope of 
public health, the balance between public health and civil liberties, and the appropriate 
role ofthe government. 
1.6 Thesis Outline 
This document describes my research in HIV testing in a small urban centre, 
which was undertaken as a degree requirement for a Masters in Applied Health Services 
Research. Chapter one defines the research question and objectives and provides 
important background information including my personal interest in the area of inquiry, 
the context and progression of HIV I AIDS and health service delivery in NL, and the 
significance of the HIV testing services to the broader tenets of public health in Canada 
and social justice as an explicit value. It introduces the rationale of the study by detailing 
my own impressions about the availability of the service based on policy-related 
documents and information obtained from local providers and media. My epistemological 
assumptions are explained and the methodological limitations of the study arc claimed. 
The significance of the study as a contribution to the broader tield of public health ethics 
is explained. 
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Chapter two provides detailed literature on four broad sections - sexually 
transmitted infections, HIV, HIV testing, and policy-practice issues. It begins with an 
overview of sexually transmitted infections and the Canadian guidelines for reporting and 
surveillance. It discusses the importance of preventative measures and barriers to 
accessing testing. Next it provides information on HIV including the global impact, its 
presence in Canada and the issues of stigma and harm reduction. The third section 
provides information on HIV testing such as the voluntary counselling and testing model, 
the types of tests available throughout Canada, and information about testing services in 
NL. The fourth section discusses the meaning of policy and the evolution of public health 
policy in Canada. It provides an overview of Graham's (2004) expanded social 
determinants of health framework that are used to frame the findings and discussion. It 
reviews controversial issues of HIV testing and human rights and the practical challenges 
of anonymous testing in public health service delivery. 
Chapter three provides detailed information on my methodology and methods. It 
describes the processes used to design the study, obtain appropriate approvals and various 
ethical considerations. It explains the constructivist epistemology underpinning this 
study. This chapter describes the qualitative descriptive process used to collect data from 
four testing sites using interviews and documentary analysis of current and past policy-
related documents. It also explains the significance of the reflexive journal and the 
process used to develop key themes through diagramming, coding and thematic analysis. 
Chapter four presents the study findi ngs in detail. The first section provides an 
overview of the three organizations responsible for the four testing sites and a description 
of individual participants' perceptions of non-nominal and anonymous testing and ri sk-
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taking behaviour. Introductory information about the testing policies and definitions 
provided by both community-based organizations and the regional health authority is also 
summarized. An overview of past and current HIV testing procedures at the four testing 
sites is provided, as well as concerns expressed by participants about these procedures. 
The last section of chapter four summarizes key areas of incongruence. 
Chapter five discusses the meaning of the term anonymous as it is used in 
preventative public health initiatives and clarifies other potentially confusing terms. It 
explains my theory behind the areas of incongruence noted in chapter four. The 
discussion is divided into three main sections -the role of the Communicable Diseases 
Act in the incongruence, the need to increase clear communication about HIV testing 
policies and procedures, and the need for explicitly anonymous HIV testing in this small 
urban centre within a social determinants of health inequality framework. Eighteen 
recommendations are made for consideration with regards to required clarification and 
updates to provincial legislation, increasing communication of policies and procedures in 
formalized and community-based settings, disseminating information to the public and 
changes to federal documents. Finally, it describes how I plan to disseminate this 
research and suggests areas that merit further inquiry in future research. 
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2.0 Literature Review 
The purpose of this literature review is to provide information that will allow for a 
meaningful examination of the practical implications between policy guidelines and 
public health practices. The chapter begins by expanding the traditional social 
determinants of health framework to include determinants of health inequality and 
presents principles of social justice as they apply to HIV testing and human rights. 
Background information on sexually transmitted infections and HIV is provided. The 
importance of HIV testing as a preventative health service and barriers to access are 
discussed. The availability of HIV testing across Canada is reviewed, and the advantages 
and disadvantages of anonymous testing are stated. Public health policy and Canadian 
guidelines for STI treatment, reporting, and practice are presented. The final section of 
the literature review addresses the challenges created by unclear policy guidelines at the 
point of service delivery. 
2.1 Social Determinants of Health and Social Justice 
The traditional social determinants framework is based on an understanding that 
one's location in the social structure of society has a major influence on health and well-
being. Health improves at each successive stage of social advantage as defined by twelve 
key determinants. PHAC (2003) lists the following determinants - income and social 
supports, social support networks, education and literacy, employment and working 
conditions, social environments, physical environments, personal health practices and 
coping skills, healthy child development biology and genetic endowment, gender and 
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culture. This section defines social position and health equity and provides rationale for 
expanding this traditional framework to incorporate Graham's (2004) identified areas for 
improvement. 
2.1.1 An Expanded Social Determinants of Health Framework 
Graham (2004) challenges the traditional determinants-oriented approach and 
highlights the need for researchers to place increased emphasis on the social processes 
that drive health inequalities to inform policies that will address health inequalities. Most 
importantly, when addressing a "policy audience" (p.118), Graham (2004) emphasizes 
the importance of differentiating between the social determinants of health and social 
determinants of health inequalities. 
Determinants of health inequality are "those central engines of society that 
generate and distribute power, wealth and risks, differential exposure and vulnerability, 
and the differential consequences of ill health for more and less advantaged groups" 
(Graham, 2004, p. 112-3). Failure to distinguish them from traditional determinants of 
health that promote health and prosperity suggests that policies associated with positive 
trends in health determinants are also associated with persistent negative influences and 
disparities in their distribution. This is not the case because traditional health 
determinants and their associated benefits are not evenly distributed across population 
groups. Tenninology used to describe this uneven interaction with health status must be 
available to affect change in public policy. 
Social position refers to an individual's location in the social hierarchies around 
\vhich his or her society is built. At the most distal level, social resources like education, 
35 
employment opportunities, political influence, income, and property affect the 
opportunities available in society. When these systems are accessed by members of 
society, the framework for analysis must consider the structural inequalities that are 
inherent within them. These structural inequalities exist throughout the education system, 
the labour market, property and wealth, and political influences. Depending on social 
position, some individuals will face more structural inequalities than others. As such, 
social position shapes an individual's ability to access intermediate factors that are more 
closely associated with well-being (social and material environments of home, 
neighbourhood, workplace, behaviour and physiological factors). 
Braveman and Gruskin (2003) offer a definition of health equity that helps 
illustrate how social position impacts health. This definition was created to establish 
clarity in terminology when assessing whether local, national and international policies 
are leading toward or away from greater social justice in health. Explicitly defined, health 
equity is "the absence of systematic disparities in health (or in the major social 
determinants of health) between social groups who have different levels of underlying 
social advantage/disadvantage - that is, different positions in a social hierarchy" (p. 
254). 
The highest attainable standard of health is that which is displayed by the most 
socially advantaged group within a society. The health levels of this group demonstrate 
what is biologically possible and, in theory, could be attained by every human being 
within a society. Systemic inequities, however, put certain populations at a disadvantage 
with respect to their health. Examples of groups of people who experience social 
disadvantage due to systemic factors include people who are poor and members of a 
disenfranchised racial, ethnic, or religious group, and others. Many complex and 
interrelated factors can lead to social disadvantage- some examples include poverty, 
substandard housing, poor education, unhygienic and polluted environments, and social 
disintegration (Gostin & Powers, 2006; Braveman & Gruskin, 2003). These 
circumstances can lead to poorer health outcomes and extend the disadvantage to most 
every aspect of social, economic, and political life. Discrimination, marginalization and 
stigma represent obstacles to health equity, or determinants of health inequality, for 
socially disadvantaged individuals. The relationship between poverty and HIV I AIDS 
illustrates how this expanded framework might be operationalized. 
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The nature of HIV I AIDS has been described as "complex and ever-changing" 
with an ongoing debate about the cause and effect of the complex social realities that are 
so often associated with HIV transmission and infection (Spigelman, 2002). For example, 
' is poverty responsible for HIVIAIDS because it forces people into situations where they 
are at higher risk of contracting the virus?'; or ' is poverty a consequence of having 
HIV I AIDS by forcing people to leave the paid labour force in order to cope with living 
with this condition?' Using an expanded social determinants of health framework, one 
could reason that these questions are doing exactly what Graham (2004) has cautioned 
against by "blurring the distinction between the social factors that influence health and 
the social processes that determine their unequal distribution" (p. 1 09). Specifically, these 
questions feed the assumption that '"health inequalities can be diminished by policies that 
foc us only on the social determinants of health" (p. I 09). We must treat poverty as a 
driver of health inequality driven by social processes, and the widely recognized social 
determinant of ··income"' (PHAC, 2003) as a health determinant. 
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2.1.2 A Social Justice Approach 
As Gostin and Powers (2006) remind us, there is no single organizing principle 
that can answer every question regarding the broad direction of public health; however, 
certain core commitments of social justice indubitably shed light on controversial areas of 
policy. As Braveman and Gruskin (2003) note, social justice and fairness can be 
interpreted differently by different people in different settings. As such, the principle of 
social justice is explained here. Social justice promotes fair distribution of the benefits 
and burdens of social cooperation (Rawls, 1999). With its roots in equity, social justice is 
committed to the preservation of human dignity and respect for all members of the 
community. Its aim is to improve public health by focusing on the needs of the most 
disadvantaged to advance human well-being. 
Gostin and Powers (2006) provide examples of the public health policy 
imperatives that are emphasized in social justice approaches including "improving the 
public health systems, reducing socioeconomic disparities, addressing health 
determinants, and planning for health emergencies" (p.l 054) with a constant emphasis on 
the needs of the most vulnerable. From a social justice standpoint, it is of heightened 
importance that policies and practices pertaining to conditions that impact the quality of 
life of at-risk groups are justified and are sensitive to the needs of the individuals in the 
group. An example of a public health policy that is insensitive to social justice would be a 
directive for an entire population to evacuate or seck shelter since many have neither 
private transportation nor the means to stock up on food or supplies that would allow for 
such an evacuation. 
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Young's (2006) parameters for achieving social justice focus on relating 
individual characteristics within the structural injustice along four dimensions - power, 
privilege, interest and collective ability. Each parameter is briefly explained and framed 
within an HIV testing and counselling context. Power refers to an individual's potential 
to influence a process and produce favourable outcomes. In HIV testing, test seekers have 
less power than public health service providers and policy-makers. Power differentials 
also exist within groups; for example, a test seeker who understands and advocates for his 
or her right to access a public health service has more power than a test seeker who does 
not pursue his or her right to the same service. While structural injustice is 
disadvantageous for some, it creates positions of privilege for others. 
Privileged individuals have special moral responsibilities to take action that will 
correct structural injustice because they can adapt to changing circumstances without 
suffering serious deprivation. The researcher examining the service provision could be 
described as privileged because he or she will not likely suffer from changes to the 
service nor be affected by examining areas for improvement. 
Interest describes the degree to which individuals wish to maintain or transform 
the structures that produce the injustice. In HIV testing, an at-risk test seeker may lack 
power and privilege, but he or she may display the most interest in improved anonymous 
HIV testing and counselling services. Therefore, that individual has the most interest in 
the policy change. This is consistent with Young's view that '·victims" (p.l28) often have 
the most interest in structural change. 
Finally, collective ability refers to the ··relative ease with which people can 
organize collective action to address an injustice" (p. 129). An example of a circumstance 
that would enhance collective ability would be an upcoming HIV testing policy review. 
Social justice principles were used as a tool for analysis and interpretation is central to 
the study recommendations. 
2.1.3 HIV Policy and Human Rights 
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The adoption and proclamation of the Universal Declaration of Human Rights in 
1948 was the first global expression of rights to which all human beings are inherently 
entitled (United Nations, 2008). It includes those basic human rights principles outlined 
in the WHO Constitution (1946) and other human rights treaties including the right to a 
decent standard of living, education, health, freedom from discrimination, and freedom to 
participate fully in society. Canada is a member of the United Nations; therefore, these 
doctrines are embedded in our justice system. United Nations' membership requires 
compliance with the WHO's constitutional mandate for states to develop national policies 
and programs to support the fundamental right of every human being to "the enjoyment 
of the highest attainable standard of health" (WHO, 1946, 2006a, 2009b ). The WHO 
strategy also highlights the need for collaboration at various levels and venues of service 
delivery to ensure that related initiatives will reach those at risk of sexually transmitted 
infections. 
The concept of health as a human right is now used to demonstrate why clarifying 
anonymous HIV testing and counselling policies and procedures is favourable. Braveman 
and Gruskin (2003) claim that the right to health cannot be separated from other human 
rights because all human rights are considered "interrelated and indivisible" (p.255). The 
ability to access preventative health services is an essential part of the right to health. 
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Graham's (2004) definition of social position demonstrates that access to the opportunity 
to be healthy is uneven. Individuals in the lowest social positions face the most barriers to 
health. Barriers to accessing HIV testing may include discrimination, marginalization, 
stigma, low health literacy, and fear of confidentiality breaches. 
Equalizing individuals' right to health requires addressing the most important 
drivers of social disadvantage and servicing the needs of the most disadvantaged before 
the needs of those in higher social positions. Failure to act on recommendations that 
would reduce barriers to the benefit of those in lower social positions is contrary to social 
justice principles. Acting on the recommendations offers an opportunity to equalize 
access to a preventative health services between individuals who occupy different social 
positions, which is the premise of health equity. In this way, failure to adapt systems to 
changing needs of the socially disadvantaged results in consistent denial of a fundamental 
right to health. 
Political decisions and actions that would increase health may not always be 
politically desirable as determined by cost, public opinion, or other factors on which their 
success depends. Priorities according to social justice principles do not always occur 
because policy affects that negatively impact disadvantaged groups may not be evident to 
those in positions of power. It is important for those in positions of power to consider 
human rights in decision-making. Equalizing opportunities to be healthy requires 
addressing the most important social and economic determinants of health inequality. 
A wide and growing body of literature from low-income countries where HIV prevalence 
is high supports a human rights approach to testing, suggests there will be increasing 
needs for anonymous testing, recognizes the potential for variation between policy and 
practice, and maintains that stigma is an important barrier to testing (Bell, Mthembu & 
O' Sullivan, 2007; Obermeyer & Osborn, 2007). 
41 
In Canada, advocacy groups like the Canadian HIV I AIDS Legal Network draw 
attention to domestic violations of human rights in the area of HIV policy to demonstrate 
how public policy can propagate fear about HIV systemically. At a Symposium on HIV 
Testing and Human Rights, 26 international experts declared that "practices of 
compulsory, involuntary, and 'routine' testing without informed consent contravenes 
basic human rights principles" (Canadian HIV/AIDS Legal Network, 2005). Despite 
efforts to keep the voluntary nature of testing at the "heart of all HIV policies and 
programs to comply with human rights principles and to ensure sustained public health 
benefits" (PHAC, 2006b, p.l ), some Canadian HIV testing policies challenge the fair and 
equal application of the Canadian Charter of Rights and Freedoms (Department of 
Justice, 1982). Two examples are the immigration requirements at the federal level and 
blood tests for pregnant women and healthcare workers at the provincial level. 
Foreign nationals applying for permanent residence in Canada and certain 
applicants for temporary residence are required to undergo an immigration medical 
examination. For persons over age 15 and under some other circumstances, this 
examination includes a routine test for HIV (Citizenship and Immigration Canada, 2009). 
The United Nations, however, docs not support mandatory testing on public health 
grounds and recommends that all HIV testing be confidential. subject to the provision of 
informed consent, include pre- and po t-test counselling and appropriate referrals to 
medical and psychosocial services are made for those \vho test positive ( /\IDS, 2004). 
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Policies for mandatory testing of pregnant women are in place in NL, Alberta, and 
British Columbia. Additionally, NL is moving toward mandatory testing of health care 
workers (College of Physicians and Surgeons NL, 2009; McLean, 2009). Movements 
towards compulsory and mandatory testing take away the ability of individuals to 
maintain confidentiality during the testing process and, I suspect, will result in an 
increased demand for anonymous testing as people clamour for confidentiality - real and 
perceived. The Canadian HIV I AIDS legal network (2005) highlights that in many 
mandatory testing situations, pre and post-test counselling is inconsistent and unevenly 
applied. 
2.2 Sexually Transmitted Infections and HIV 
A sexually transmitted infection (STI) is a type of infection that is spread 
primarily through person-to-person sexual contact. Some are treatable and cause no 
lasting health effects, while others are untreatable and may cause death. Sexually 
transmitted infections may also be transmitted from mother to child during pregnancy and 
childbirth, or through blood products and tissue transfer (WHO, 2009a). There are more 
than 30 different sexually transmissible bacteria, viruses and parasites, which result in a 
wide variety of conditions that can be symptomatic or asymptomatic. Globally, the most 
common STis are "gonorrhea, chlamydia! infection, syphilis, trichomoniasis chancroid, 
genital herpes, genital warts, human immunodeficiency virus and hepatitis 8 infection" 
(WHO, 2009a). According to PHAC (2006b), the most common ST!s in Canada include 
Chlamydia, gonorrhea human papilloma virus, and genital herpes. HIV is described as 
.. rare in general practice'' (p. 4). 
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HIV is controllable but is ultimately an incurable sexually transmitted infection. 
The virus attacks the immune system and compromises its ability to protect our bodies 
from infection and disease. The immune system is comprised of cells, tissues, and organs 
whose primary function is to coordinate and execute the body's response to infection 
(CA TIE, 2007a). CD4+ is responsible for activating and directing other cells in the 
immune system. Maintaining a certain threshold of CD4+ cells is essential to healthy 
immune systems. After HIV enters the body through one of the four bodily fluids (semen, 
vaginal fluid, blood, breast milk), it weakens the immune system by taking control of 
CD4+ cells. As the virus replicates it destroys more CD4+ cells and depletes their supply. 
As the immune system weakens, it gradually loses its ability to protect the body from 
disease. 
HIV can be detected in the host either by looking for the virus or by detecting the 
host' s antibody response to the virus. Following the initial infection, the antibody 
response can take up to six months to develop. This is called the window period; the 
person is infectious but the antibody remains undetectable. After a period of time, an 
untreated HIV infection progresses to acquired immune deficiency syndrome (AIDS). It 
is possible for HIV to be present in the body for a number of years before the immune 
system is severely damaged and the patient progresses to AIDS. AIDS is a clinical 
diagnosis which, by definition, requires the presence of an opportunistic infection or 
cancer. Two blood tests are imp011ant in determining the severity of the infections and 
the likelihood ofthe person progressing to AIDS (CATIE, 2007b). The first and most 
important measurement is the CD4+ count. In healthy HIV negative people, a normal 
count ranges from 400 - 1200 cells/mm3 in men and 500 - 1600 cells/mm3 in women 
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(CA TIE, 2008). When the CD4+ count is Jess than 200 cells/mm3 the immune system is 
severely compromised and the person is at risk for an opportunistic infection. The second 
test, called viral load, measures the number of copies of HlV per millilitre of blood. This 
demonstrates the activity level of the virus and a higher viral load will cause greater 
damage to the person's immune system. Viral load can range from 40 copies per millilitre 
to over one million copies per millilitre. Greater than 30,000 copies per millilitre indicate 
a high risk of progression to AIDS. If a person is receiving treatment, less than 40 copies 
per millilitre is undetectable and therefore under therapeutic control (CA TIE 2007a). 
2.2.1 Global Impact ofHIV 
The founding director of the WHO's former Global Program on AIDS described 
the socialization of HIV as an epidemic with three distinct phases. It started as an age of 
infection that focused on transmission; it transitioned to an age of AIDS and death; to a 
third, explosive age of social, cultural, economic and political responses that was 
characterized by stigma, discrimination and collective denial. The third stage was 
described as being as "central to the global AIDS challenge as the disease itself' (Mann, 
1987). Since 1987, the global prevalence of HIV I AIDS has taken on a strong localized 
presence such that some regions are heavily affected and other regions have maintained a 
fairly low prevalence. For example, it is estimated that Botswana has one of the top three 
prevalence rates where approximately 24% of the country's population is believed to be 
infected. while Canada' s is under 2% (U, AIDS/WHO, 2006). In 2006, the WHO 
(2006b) estimated that over two thirds of the 39.5 mi llion people li\'ing with HIV arc on 
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the continent of Africa. Of the 2.5 million new infections worldwide in 2007, 1.7 million 
(68%) occurred in sub-Saharan Africa (WHO, 2009a). 
The social and economic burden of the illness can have devastating impacts on a 
nation's economic and social structures. With over 30 million HIV/AIDS related deaths, 
the presence of the disease has caused a significant loss of human capital. If this trend 
continues, "the populations of the 60 most affected countries will be 115 million less than 
they would be in the absence of AIDS" (UNAIDS/WHO, 2006, p. 81 ). In countries that 
are considered poor based on household income, mortality has been concentrated in 
children under the age five and adults. This has resulted in orphaned children and 
significant economic cost of lost production due to death and disability (Barnett et a!. , 
2001 ). Dodds et a!. (200 1) describe the impacts in high-income countries where affected 
individuals are faced with diminished quality of life and the financial burdens associated 
with antiretroviral drug treatment regimes. 
2.2.2 Reporting, Surveillance and Prevalence 
A notifiable condition is one that is considered to be of such importance to public 
health that its occurrence is required to be reported to public health authorities. When an 
infection is notifiable, information about the individual who tests positive is forwarded to 
provincial or territorial public health officials for surveillance. In Canada, chlamydia, 
gonorrhea, and infectious syphilis are reportable at the national level (PHJ\.C, 2006b). 
Rep011able information includes demographic data, such as the person's age and gender, 
risks associated with the transmission and laboratory data. The Surveillance and Risk 
Assessment Division of PHAC's Centre for Communicable Diseases and Infection 
Control is responsible for the surveillance of reportable conditions in Canada. 
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By 2003, positive HIV tests results and AIDS diagnoses were designated as 
notifiable in all Canadian provinces and territories. HIV infection is not legally notifiable 
at the national level, yet notification to PHAC is voluntarily undertaken by public health 
authorities in all provinces and territories on a non-nominal basis, which allows public 
health officials to monitor the incidence and prevalence of HIV (PHAC, 2007a). At the 
provincial level, positive results obtained through a non-nominal test may or may not 
require that the positive individual ' s name and health care number be reported within the 
province depending on the legislation outlined in the applicable jurisdiction. In NL, the 
guiding legislation is the Communicable Diseases Act (NL House of Assembly, 2007). 
This Act lists 54 conditions that should be reported to the deputy minister of health 
stating the "name of the disease, the name, age and sex of the person, and the name of the 
physician giving the notice, and shall by street and number or otherwise, sufficiently 
designated the house or room in which the person is living" where possible (Section 4). 
This Act includes HIV and AIDS as separate conditions classified as reportable infectious 
diseases. 
At the end of2005, it was estimated that 58,000 people in Canada were living 
with HIV infection. This represents an increase of 16% from 2002 estimates. This 
increase of persons living with HIV can be attributed to a rising number of new infections 
and to improved treatment regimes that keep diagnosed people alive longer. Since 
reporting began in 1985, 64,800 positive HIV tests have been reported across Canada 
(Plli\.C, 2007c). Between 2002 and 2006 there was little fluctuation in the number of new 
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positive test results; new cases reported annually ranged between 2,471 and 2,559. In 
2007, the number of positive tests reported decreased to 2,432. More than 80% of 
positive tests in 2007 were reported from Ontario, Quebec and British Columbia. L had 
one of the lowest rates of new infections. 
The epidemiological categories used to describe the highest prevalence rates in 
terms of exposure category suggest that men who have sex with men account for over 
half of the estimated number of HIV infections. The second largest exposure category is 
persons who have contracted the disease through exposure to injection drugs (PHAC, 
2007a). The third largest exposure category is called "heterosexual/non-endemic" (p.2), 
which refers to heterosexual contact with a person who is either HIV infected or at risk of 
HIV because they originate from a country where HIV prevalence is high, such as sub-
Saharan Africa and the Caribbean. Nationally, there has been a notable increase in the 
proportion of positive HIV test reports attributed to women. Between 1998 and 2006, the 
proportion of positive tests reported that were attributable to women increased from 
11.9% to 27.8%. The proportion of new infections is increasing amongst adults over 40 
years of age. Aboriginal persons are also over-represented in the HIV I AIDS epidemic: 
they make-up approximately 3.3% of the Canadian population yet account for 7.5% of 
the estimated number of HIV infections in Canada. The overall infection rate among 
Aboriginal persons is about 2.8 times higher than among non-Aboriginal persons. At 
present, Canadian Aboriginal populations display higher rates of HIV infection and 53% 
of new infections were attributed to injection drug use in 2005 (PI-lAC, 2007a). 
Since 1984, 249 positive I IIV test results have been reported to the Depa1tment of 
llealth and Community Services (2008). Of those 2-l9 tests, 78% (n= I95) \Yerc male and 
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22% (n=54) were female. During this time period, the top three modes of transmission 
that were reported by infected persons were 48% (n= ll9) men having sex with men 
(MSM); 31% (n=78) heterosexual contact with an infected person; and lastly, 8% (n=20) 
were recipients of a blood transfusion or blood products. Other reported modes of 
transmission were 4% (n= 11) injection drug use (IOU), 2% (n=5) were a combination of 
MSM and IDU, and 2% (n=6) cases ofprenatal transmission. In 4% (n= 11) of cases, the 
risk factor was unidentified or not reported. The highest number of new positive tests was 
reached in 1991, when 15 males and 10 females tested positive for HIV. Since 1991 , the 
number of positive HIV test results in NL has steadily declined (see Figure 1). New tests 
reported between 2003 and 2006 fell within a range of between 11 and six per year 
(PHAC, 2007c). Zero positive HIV tests were reported to the provincial public health 
authorities in 2007. In 2008, three positive tests were reported (Department of Health and 
Community Services, 2008). 
This declining trend since the early 90' s is reflected on a global scale and has 
been attributed to the effectiveness of ongoing education and prevention efforts. Three 
significant reports suggest that incidence of HIV is on the rise in Atlantic Canada 
(Atlantic Interdisciplinary Research Network, 2006; HRU & ACNL, 2007; Oxycontin 
Task Force, 2004).; however, the positive test results reported to the Provincial 
Government is declining These reports further suggest there is a rising need for enhanced 
harm reduction sen·ices, such as anonymous testing, in future due to patterns of injection 
drug usc varied understandings and support for harm reduction, and migrating youth 
\vorking in industry-based tields and engaging in risky activities. 
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Figure I: Number of Positive HIV Tests Reported, 1984-2008 (permission for use obtained from 
Department of Health and Community Services, Government of NL) 
2.2.3 The Hidden Epidemic 
The "hidden epidemic" (p.7) is a term used by PHAC (2007a) to describe the 
significant number of undiagnosed infections. HIV statistics reported by public health 
agencies are based on the official numbers of HIV tests that have been sought voluntarily 
and subsequently reported. Consequently, the number of positive test results in a region 
may not accurately reflect the new infections for that time period due to new infections 
amongst people who vvere not tested and are unknowingly infected. As a result, HlV 
statistics are generally understated. 
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Globally, it is estimated that approximately 85% to 90% ofthe 38 to 40 million 
people living with HIV remain undiagnosed (PHAC, 2006b). In Canada, it is estimated 
that approximately 27% of persons living with HIV in Canada are unaware oftheir status 
(PHAC, 2007a). The hidden epidemic is dangerous for a number of reasons. A significant 
risk to public health is posed by individuals carrying the disease unknowingly. On a 
community basis, it creates a false sense of security and results in inaccurate measure of 
the costs related to HIV. Under-testing may be caused by any combination of the barriers 
described earlier. Additional factors that may deter HIV testing include tendency of 
healthcare providers to discount the need for HIV testing of groups that are not 
traditionally stereotyped as being at risk for HIV and individuals believing they are not at 
risk for contracting the disease (Rees, 2003). These factors demonstrate that there are 
multiple layers of stigma and discrimination surrounding HIV testing services and the 
disease itself. 
2.3 HIV Testing and Barriers 
The importance of terminology is paramount when discussing HIV testing. The 
familiarity and plurality of meaning of testing nomenclature for the various types of tests 
affects the way we interpret the provision or availability of the service. This, in turn, 
creates an expectation of what will be provided or delivered during the procedure. 
2.3.1 The Importance of STI Screening and Testing 
Screening and testing arc t\\'o distinct but related practices. Screening is a medical 
practice used to detect di sease or body dys function before an indi\'idual would normally 
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seek medical care (Occupational Safety and Health Administration, 2000). Screening 
initiatives are more broadly targeted than testing due to their underlying intent to identify 
as many individuals as possible who may have a particular condition even when they are 
asymptomatic. Screening efforts become common during epidemics in which a disease, 
condition or agent of disease, whether life threatening or transitory, occurs in 
unexpectedly large numbers, in a given population, in a given time frame. The 
classification of something as an epidemic is a relative measure and varies in terms of the 
number of cases, geographic parameter, time frame, and size of the affected population. 
Testing, on the other hand, typically describes specific procedures used to confirm cases 
where individuals may be at risk for certain adverse health outcomes. The Ontario 
Ministry of Health and Long-Term Care (2008) makes an important distinction between 
screening and testing as it pertains to HIV, "HIV testing consists of a screening test and, 
if the screening test is positive, a confirmatory test" (p.2). 
Patrick ( 1997) summarizes some of the public health benefits that are associated 
with accessible STI testing. Firstly, STis are increasingly preventable and treatable. In 
many cases, delivery of testing is a narrow opportunity to communicate prevention 
education. Testing is an effective way to reduce the potential burden of such diseases on 
individuals, systems, and at the population level. The negative health outcomes of 
undetected and/or untreated STis in the short term include persistent symptoms of the 
various infections and risk of transmission. In the longer term, individuals may be more 
seriously affected if the infection is chronic or if the original STI leads to a consequential 
condition such as pelvic inflammatory disease, infertility, and/or ectopic pregnancy. 
Goldenberg eta!. (2007) describe STis as ··synergistic'· (p. 719) because acquiring one 
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STI increases the risk of subsequently acquiring others. The importance of testing is 
internationally recognized in the WHO's (2006a) Global Strategy for the Prevention and 
Control of Sexually Transmitted Infections, which stipulates that prevention and control 
of all sexually transmitted infections must be linked to HIV prevention and sexual and 
reproductive health programs and services. Canada is a signatory of this strategy. 
2.3.2 Types of HIV Testing 
The UN AIDS/WHO Global Reference Group on HIV I AIDS and Human Rights 
(2004) made a clear distinction between four types of HIV testing and counselling-
voluntary counselling and testing; routine testing; diagnostic testing; and mandatory HIV 
screening. My main focus is the types of testing offered under the voluntary counselling 
and testing model in NL. Diagnostic, mandatory and routine processes are briefly 
reviewed here for the sake of completeness. The definitions reflect the descriptions 
provided by the UNAIDS/WHO Global Reference Group on HIV/AIDS and Human 
Rights (2004) and, where noted, have been supplemented by descriptions provided by 
independent researchers. Recent developments in HIV testing, such as rapid tests and 
home testing kits, are excluded from this review. 
Diagnostic testing occurs in clinical situations to aid in patient care management, 
specifically when a person shows signs or symptoms consistent with HIV -related disease 
(Obermeyer & Osborn, 2007). },;fandatory HIV screening for blood borne viruses is 
carried out on blood intended for transfusion or manufacture of blood products and on 
donations involving transfer of bodily 11uids or body parts. Routine testing is initiated by 
health-care providers where most users of a facility will be tested, but indiYicluals retain 
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the right to refuse testing (Yeatman, 2007). Often referred to as provider-initiated testing 
and counselling (PITC), routine testing is gaining popularity in high prevalence areas, 
such as sub-Saharan Africa and the Caribbean. The PHAC (2006a) defines two forms of 
routine testing - opt-in and opt-out. Opt-in testing requires a universal offer of HIV 
testing to all patients, but it is only done if patients indicate that they would like the test. 
Opt-out testing, also referred to as routine testing with the right to decline, incorporates 
HIV testing into standard clinical workups and patients are informed that the test will be 
done unless they decline. 
The Canadian HIV/AIDS Legal Network (2005) further explains that 
international advocacy groups differentiate between involuntary or compulsory testing 
and mandatory testing. The former, involuntary or compulsory testing, lacks some 
voluntary element such as informed consent, and occurs "at the behest of someone or 
some institution other than the person tested" (p. 2) and, sometimes, the result is not 
communicated to the person tested. The latter, mandatory testing, occurs when testing is 
performed "for some other benefit, such as donating blood, immigration, marriage, 
joining the military, or as a precondition for certain kinds of employment" (p.2). The 
Canadian HIV I AIDS Legal Network (2005) reminds us that except in the cases of 
donations of blood, organs or other bodily substances, international agencies working on 
I IIV and public health authorities have "rejected both compulsory and mandatory testing 
as unethical violations of human rights and as ineffectual in public health terms'· (p.2). 
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2.3.3 Voluntary Counselling and Testing 
The predominant model under which individuals are tested for HIV is referred to 
as voluntary counselling and testing (VCT) and relies on "an individual's right to decide 
whether or not he or she will be tested" (Yeatman, 2007, p.271). Voluntary counselling 
and testing emphasizes the need for voluntary, informed consent prior to testing as well 
as pre-and post-test counselling, and partner notification. Table 1 summarizes the 
characteristics of nominal , non-nominal and anonymous testing HIV testing. Information 
provided by PHAC (2007a, p. 14) is supplemented by information published by the 
Ontario Ministry of Health and Long-Term Care (2008), Kendall (2006) and Yeatman 
(2007). The only stated difference between nominal and non-nominal testing is that a 
non-nominal test is ordered using something other than the individual's full or partial 
name, such as a code or initials. Anonymous testing differs because the person ordering 
the test does not know the identity of the person being tested although the procedure 
including the type of demographic data collected varies depending on the legislation and 
policies in place at the testing site. 
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Table 1: Description ofThree Types ofHIV Testing in VCT Model 
Type OfTest Confidential Confidential Anonymous 
PI-lAC Name Nominal Non-nominal Anonymous 
Common Name Name-based Non-identifying or No-Name Anonymous 
Location A variety of locations including Offered in similar locations as Availability depends on province. It if is offered, it may 
clinics, hea lth providers' offices. nominal testing. be available at specialized clinics, organized and 
supported by public health departments and by some 
health care providers 
Identity Per on ordering the test knows the Person ordering the test knows the Name or identity of test seeker is not requested, recorded 
Disclosure identity of the test seeker. identity of the test seeker. or reported . 
Laboratory Test is ordered using the name of Test is ordered using a code or the Test is ordered and carried out using a code to ensure that 
Ordering test seeker. initials of test seeker (not including the person ordering the test and the laboratory carrying 
Process full or partial name). out the test does not know to whom the code belongs. 
Health Records Test result is recorded in the health Positive results noted in the health Varies by province and territory. If the result is negative, 
care record of test seeker. care record of test seeker. this is not typically recorded on the cl ient ' s health care 
record. Only the person being tested who may 
subsequently decide to give his or her name and include 
the HIV test result in the health care record. 
Personal Information collected varies by Information collected varies by Information collected varies by province/territory and 
Information province/territory and testing site. province/territory and testing site. testing sites. Examples of allowable types of information 
Examples of allowable types of Examples of allowable types of to collect include age, gender, ethnicity, and HIV-re lated 
in formation include age, gender, information include age, gender, risk factors. The care giver can visually identify the 
city of residence, name of health city of residence, name of health person who was tested, but is not able to link any result 
care provider, country of birth, care provider, country of birth, with that person. 
ethnicity, HIV-related risk factors ethnicity, HIV -related risk factors 
of the person being tested, and of the person being tested, and 
laboratory data. laboratory data. 
Obtaining Ddivered in person by a healthcare Delivered in person by a healthcare The person being tested is able to access their resu lt by, 
Results provider and counselling is provider and counselling is for example, entering their confidential code into a 
provided. provided. computerized data base to retrieve their result (Kendall, 
2006). 
Legal If pos itive, person who ordered the If positive, person who ordered the If positive, the person can no longer remain anonymous. 
Disclosure test is obligated by law to noti fy test is obligated by law to notify The provincial legislation comes into effect, outlines 
public health officials ofthe public health officials of the reporting requirements (Ontario Ministry of Health and 
positive test result. positive test result. Long-Term Care, 2008) and requires that client give their 
name and health card number to receive health services. 
--- -----
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2.3.4 Barriers to STI Testing 
Goldenberg et a!. (2007) summarize some of the barriers to STI testing in Canada. 
Limited access to information about symptoms, testing and treatment procedures as weii 
as limited access to clinic-specific information, including the time and place where 
testing is offered, are barriers to testing. Characteristics of health service delivery systems 
can also inhibit testing including inconvenient hours of operation, wait times, and clinic 
location. Characteristics of healthcare providers can also serve as barriers to testing -
gender, perceived judgmental behaviour, and inadequate training in sexual health service 
provision. Stigma, shame, and social discomfort as well as concerns related to anonymity 
and confidentiality may deter people from seeking testing. 
2.3.5 Risk, Stigma and Harm Reduction 
A risky activity is any behaviour that offers the possibility of a negative outcome 
including injury, illness, or death; for example, drug and alcohol misuse, smoking, or 
unsafe sexual practices. At-risk epidemiological categories are often negatively 
associated with risky activities that have led to a sexually transmitted infection. This 
negative association is referred to as stigma. Stigma is further discussed here to provide 
insight into factors that influence individual behaviour and choice and as an impediment 
to provision of equitable health care service delivery. Goffman ( 1963) defined stigma as 
an attribute that is deeply discrediting, spoiling, or tainting, which can make one feel 
inferior because or an inability to meet real or perceived expectations. It can be a 
response to a particular characteristic and can rc ult when an individual or group appears 
deviant from the norm. 
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Since Goffman 's original equation to "spoiled identity", stigma has received 
ample academic attention and documentation, which have unanimously concluded its 
negative social consequences (Vidanapathirana, Randeniya, & Operario, 2007). Some of 
the acts and attitudes involved in stigmatization include "prejudice, discounting, 
discrediting, and discrimination" (Herek, 1999, p.1108). Terminal conditions that have 
previously been stigmatized include leprosy, tuberculosis, cancer, mental illness, and 
many STis (Brown, Trujillo, & Macintyre, 2003). Stigma adversely affects patients and 
their families, and decreases the effectiveness of public health policy and programming 
(Van Brake!, 2006). Persons who fear stigmatization are reluctant to acknowledge risk 
behaviour, avoid seeking prevention information, and may experience real or perceived 
barriers to prevention and other health-care services. 
There have been specialized inquiries into the phenomena of HIV -related stigma, 
which is defined as the negative attitudes directed at the individuals perceived to have 
HIV or AIDS, as well as the individual , groups, and communities with which they are 
associated (Alonzo & Reynolds, 1995; Herek, 1999; Morrison, 2006). As Yang, Zhang, 
Chan, Reid path (2005) demonstrate, HIV -related stigma is more intense than regular 
stigma because of the direct or indirect links between the cause and consequences of HIV 
with the individual carrying the disease. This may result in multiple layers of co-stigma; 
for example, a person who has HIV may be automatically linked with one or many of the 
following activities- injection drug use, sex work, and unsafe sexual practices. Similarly, 
certain stereotypes exist about HIV and individual characteristics such as sexual 
orientation, ethnicity, poverty, disability, and many others. Morrison (2006) describes 
HIV as an .. illness of immorality'' (p. 5); it is considered dirty and it is associated with 
58 
·'imminent death, and exaggerated sense of danger" (p. 5). HIV -related stigma can lead to 
institutional and structural discrimination against persons living with HIV. Daily 
consequences of HIV -specific stigma include discrimination in insurance, housing, 
education, and employment and worsen the social, physical, and emotional challenges of 
terminal illness. As such, stigma poses a threat of increased vulnerability through 
ostracism, ridicule, and even physical attacks on the infected individual and his or her 
family. A systematic review by Vidanapathirana et al. 's (2007) and findings of Reid path 
and Chan (2006) demonstrate that controlling HIV stigma is central to controlling the 
epidemic because of the barrier it creates between establishing the comfort level 
necessary for people to openly discuss the nature of the issues, access prevention and 
screening services, and seek treatment in the event of illness. 
Viewing risky activities in a negative light is criticized by proponents of harm 
reduction. Coomber and South (2004) describe harm reduction as a public health concept 
that aims to reduce negative health consequences that can result from engaging in risky 
activities and is considered effective for addressing health and social problems, such as 
stigmatization of individuals who take risks. It acknowledges that people take risks as a 
normal part of everyday life and that a zero tolerance or abstinence approach is 
unrealistic and offers instead pragmatic interventions to make risky activities safer. 
Gustafson ct al. (2008) summarize the types of programs that are designed to meet people 
where they arc in terms of their personal risks and health practices; such as, anonymous 
and vo luntary testing and treatment for HIV, Hepatitis C virus, vein maintenance, 
methadone treatment, safe injection access, and needle access. Voluntary II IV testing and 
counse lling is a prcventatiYe public health service and is not considered a harm reduction 
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measure. Anonymous HIV testing and counselling, however, exhibits certain harm 
reduction principles. For example, it acknowledges risk as an everyday part of life, it 
respects individual autonomy, and it attempts to minimize stigma and feelings of shame 
or discomfort. Therefore, harm reduction principles were incorporated into this inquiry. 
Research has called for increased and improved access to harm reduction services in for 
those who engage in injection drug use, unsafe sexual practices, or exchanging sex for 
money (Health Research Unit [HRU] & AIDS Committee ofNewfoundland and 
Labrador [ACNL], 2007; Goldenberg et al., 2007; Mehradbadi eta!., 2008; Mitra et al., 
2006; Romanowski, Preiksaitis, Campbell, & Fenton, 2003). 
2.3.6 Role of Provider during HIV Testing 
Providers of public health services posses an opportunity to significantly impact 
chronic disease prevention and control the spread of sexual infections in the long-term 
given their ability to offer testing, screening, diagnosis, management and treatment 
services to a wide range of clients (PHAC, 2006b ). They have a higher volume of 
interactions in which preventative action can be encouraged within the general 
population. Gustafson et al. (2008) conclude that registered nurses are particularly well 
positioned to promote health and harm reduct ion approaches for at-risk populations in 
small urban centres. Kartikeyan, Bharmal, Tiwari, and Bisen (2007) explain that the 
burden of HIV -related stigma heightens the importance of the role of the health care 
provider during testing. 
Possessing kno\vledge about the variety of social. economic, physical, mental, and 
personal factors involved in risk taking and transmission can help dispel negative 
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attitudes or biases towards test seekers. To provide quality care during HlV testing, it is 
necessary for providers to factor in the psychological and emotional stress the test seeker 
may have experienced in the recent past and could still be a factor at the time of testing. It 
is also important for them to display a positive attitude and create comfortable 
environment in which to discuss lifestyle, sexual and drug-using practices, fears and 
anxieties openly (Oyeyemi , Oyeyemi, & Bello, 2007). Scott and Irvine (1997) suggest 
willingly listening to the patient's queries and provide explanations that are easy to 
understand and free of medical jargon. Recommendations emerging from a needs 
assessment of people who inject drugs in the small urban centre emphasized the 
important role of health providers in empowering the individual seeking services to 
minimize stigma and effectively administer harm reduction services (HRU & ACNL, 
2007). For example, instead of telling a person to stop an activity entirely, attempts 
should be made to build the person's confidence and provide timely and accurate 
information. Pergami, Catalan, and Hulme (1994) demonstrate that early interactions 
between patient and provider during testing and counselling are directly linked with the 
patient's health status; for example, the manner in which an HIV -positive test result is 
conveyed can affect the patient's stress levels and coping mechanisms. 
2.3.7 Advantages of Anonymous Testing 
The previous discussion of stigma has demonstrated its many negative impacts, 
some of which can be reduced with access to anonymous l-IlY testing. The advantages of 
anonymous testing will be discussed in this section using literature from a variety of local 
and international sources, loiJo,,·cd by a summary of its potential to bendit at-risk 
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groups. Personal identifiers and reporting requirements arc controversial; therefore, the 
disadvantages of anonymous testing are reviewed in the interest of presenting a balanced 
argument. 
One significant advantage of anonymous testing is its abi lity to addresses 
concerns about identification disclosure by excluding the requirement to provide personal 
information. As Hecht et al. (2000) explain, the structure of HIV reporting requirements 
associated with nominal or non-nominal tests may deter or delay some persons from 
being tested. PHAC (2007a) is increasingly supportive of the belief that providing an 
anonymous testing option will improve access to testing. Free and open access to testing 
could increase the number of people who are aware of their HIV status and knowledge of 
one's HIV status can lead to earlier treatment and improved outcomes and a decrease in 
risky sexual behaviours (Bindman et al. , 1998). For these reasons, anonymous testing is 
considered advantageous and beneficial to public health. Academic literature is 
increasingly highlighting the need for anonymous testing services in high-income 
countries (Jurgens & Palles, 1997; Jurgens, 2001; Obermeyer & Osborn, 2007). 
Attaching mandatory reporting and contact tracing requirements to anonymous testing 
erodes people's trust in confidentiality, which is a fundamental principle of the Canadian 
healthcare system and a guiding principle of the UN AIDS/WHO (2004) HIV testing 
guidelines. 
Research demonstrating that anonymous HIV testing was of heightened benefit 
for at-risk groups became available shortly after anonymous I-llY testing was fi rst 
officially offered in the 1980s. Studies in multiple American states revealed that people 
who engaged in risky activities who presented for anonymous testing reported they would 
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not have been tested under other nominal or non-nominal circumstances (Higgins et al. , 
1991; Hoxworth et al., 1994; Kegeles et al., 1990). Bindman et al. reported other 
advantages including a decrease in risky behaviours and unsafe sexual practices, as well 
as earlier access to treatment and care after homosexual men and persons who inject 
drugs were tested. In general, early observations suggested anonymous testing was filling 
a gap by facilitating access to a preventative service for people who engaged in risky 
activities and wanted to be tested. 
More recently, Canadian studies about HIV and testing for other sexually 
transmitted infections have concentrated on the manifestation of HIV and other co-
infected conditions in at-risk groups. Romanowski et al. 's (2003) study of sexually 
transmitted disease clinics in Alberta demonstrated that injection drug use is the main risk 
activity related to transmission of Hepatitis C. Patten (2006) confirmed that Hepatitis Cis 
often co-infected with HIV. A study of in British Columbia demonstrated a history of 
injection drug use and its association with sexually transmitted infections within an 
Aboriginal population and stated there is an urgent need for harm reduction services 
(Mehradbadi et al., 2008). A study conducted in rural British Columbia demonstrated that 
youth who have migrated to work in the oil and gas sector face five key barriers to 
accessing testing for sexually transmitted infections including limited opportunities for 
access, geographic inaccessibility, local social norms, limited infonnation, and negative 
interactions with providers (Goldenberg et al., 2007). The study recommended providing 
harm reduction services for the workers, including drop-in testing and specialized 
training for health care providers. Finally, a study of women in Ontario who immigrated 
to Canada from HIV endemic countries, found they would prefer anonymous testing over 
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any other type of testing (Mitra, Jacobsen, O'Connor, Pottie & Tugwell, 2006). Reasons 
cited were clients' perceptions of enhanced client confidentiality and increased client 
control over the consequences of being tested. 
2.3.8 Disadvantages and Challenges of Anonymous Testing 
Mitra et al. (2006) defined "cons" (p. 294) of anonymous testing from a client 
perspective and a provider perspective. Many of the disadvantages of anonymous testing 
cited by providers are founded in risks posed to public health and potential for failure to 
address other issues associated with HIV transmission (Lansky et al., 2002). Absence of 
contact information is thought to interfere with the provision of information that is crucial 
to early intervention and preventing further spread of the disease. Hoxworth et al. (1994) 
highlight that there is no way of contacting persons who fail to return to collect their 
standard test results or their past or current partners. This results in poorer post-test 
follow-up, poorer continuity of care, and inability to assist the test seeker with partner 
notification. For example, in the event of a laboratory error, it would be impossible to 
follow up on cases in which there was a laboratory error of a false-positive, a false-
negative, or a labeling error. Clients also identified many of these disadvantages and 
acknowledged that assistance with partner notification can be helpful and is, at times, 
appreciated. Mitra et al. (2006) cited additional disadvantages identified by clients as the 
lack of an established relationship with the provider. 
Chou, Huffman, Fu, Smits, and Korthuis (2005) acknowledge that anonymous 
testing is not always clearly associated with an improved uptake of testing. Gustafson et 
al. (2008) highlight that another challenge, vvhich is of particular importance to small 
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urban centres and rural areas, is related to one's ability to maintain anonymity in places 
where healthcare providers are limited and social circles closely connected. Furthermore, 
the ability to investigate disease trends and patterns and collect other important 
surveillance data is inhibited (Obermeyer & Osborn, 2007). Finally, anonymous testing 
may fail to address the main barrier to testing- fear of a positive result- any better than 
nominal or non-nominal testing does (Hoxworth eta!., 1994; Lansky et a!., 2002). 
2.3.9 Anonymous HIV Testing by Province and Territory 
Widespread division over sensitive issues, such as reporting, partner notification, 
and anonymous testing, has resulted in a unique evolution of HIV testing policy between 
provinces and territories (PHAC, 2007a) to the point that each province has different 
guidelines around its provision. PHAC (2007a) reports that anonymous testing is 
available in Alberta, Saskatchewan, Ontario, Quebec, New Brunswick, Nova Scotia, and 
NL. Jurisdictions that do not offer anonymous testing include British Columbia, Yukon, 
Northwest Territories, Nunavut, Manitoba and Prince Edward Island. 
Of those provinces that do not offer anonymous testing, Manitoba was the only 
province that was actively looking to expand its HIV testing services to be able to offer 
anonymous testing (Manitoba Health, 2006). British Columbia offers a flexible, non-
nominal testing option at selected testing sites, which has been defined by the Provincial 
Health Officer, Perry Kendall (2006): 
a flexible non-nominal testing option where testing is conducted without 
having to disclose one's true name. In this instance any care giver who is 
involved with discussing the result of the test" ith the person who had the 
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test is not aware of the true identity of their client/patient. However, this 
option may involve collection of patient information (such as age, gender, 
city of residence, name of diagnosing health care provider, country of 
birth), information detailing the HIV -related risk factors of the person 
being tested, and laboratory data 
The absence of anonymous testing in these provinces may be associated with 
other external challenges such as difficulty maintaining anonymity, stigma and 
prohibitive provincial legislation. Where anonymous testing is offered, positive results 
may be reported nominally or non-nominally at the provincial level depending on the 
legislation. In NL and Saskatchewan, positive HIV tests are to be reported nominally, 
even if conducted anonymously (PHAC, 2007a). If an individual tests positive in NL, the 
result becomes part of the nominal system, in which the individual is offered counselling 
and follow-up care. Ontario reports positive HIV test results from anonymous tests non-
nominally at the provincial level, and Alberta reports positive HIV test results from 
anonymous tests nominally at the provincial level (PHAC, 2007a). 
Thirty-six percent of Canada's Aboriginal populations live in three Canadian 
territories where anonymous testing is not available (PHAC, 2007a; Statistics Canada, 
2006a). Academic literature was consulted to find possible explanations for the absence 
of anonymous testing services within Aboriginal populations. Tseng ( 1996) highlights 
several barriers to implementing anonymous HIV testing in Aboriginal communities and 
found the main factor inhibiting such an offering was the high priority placed on other 
day-to-day health and social problems impeding overall living standards. Other potential 
obstacles include low levels of health literacy, lack of resources and government funding, 
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under-awareness, cultural issues, and language barriers. More recently, Bucharski, 
Reutter, and Ogilvie (2006) demonstrated the importance of culturally appropriate service 
delivery in HIV testing for Canadian Aboriginal women. This requires providers to 
understand the past and present life experiences of indigenous people. They identified 
barriers specific to Canadian Aboriginal women including an underlying fear of being 
judged-by the tester or others in the Aboriginal and non-Aboriginal communities; lack 
of anonymity and confidentiality; negative past experiences with testing; and the pre-test 
assessment of HIV risk behaviour. 
2.4 Policy-Practice Gap 
Policy development, implementation, and adherence is challenging due to the 
rapid pace at which healthcare evolves. Policy formulation faces competing pressures to 
be informed by evidence, but also to respond to public opinion. Public health practice and 
delivery of community services are areas that are replete with competing values, moral 
dilemmas and grey areas. There is a diverse range of needs that policy-makers must 
consider when formulating policies to be applied in these settings. The advantages and 
importance of policies that focus on the needs of at-risk populations and others who face 
systemic and/or other barriers due to social position when accessing care and services is 
fundamental to a social justice approach. An overview of the challenges of evidence-
informed public health policy and practice is also presented. 
2.4.1 Policy 
In the simplest terms, policies dictate what should happen. A policy is defined as: 
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A guiding or governing principle that mandates or constrains action(s). 
Policies are specific directives that prescribe limits and pinpoint 
responsibilities within an organization and are designed to influence/guide 
decision making and actions. A policy can be viewed as law, rule or 
expectation which provides a foundation from which an organization can 
realize its mission, values and strategic plan. (Eastern Health, 2009a) 
On a national level, the Canadian Charter of Rights and Freedoms recognizes the 
"primary fundamental freedoms, democratic rights, mobility rights, legal rights and 
equality rights" to which all Canadians are entitled (Department of Justice, 1982). By 
law, formal policies must fall within the parameters of what is permissible according to 
the Charter. Oftentimes, policies do more than simply comply with legislation rather they 
become more robust as they are supplemented by targeted professional, organizational, 
and institutional codes of ethics and standards of practice. 
Actions ofhealthcare providers are guided by the regulations that apply to their discipline 
as outlined by relevant federal, provincial and municipal legislation, professional 
associations and bodies, as well as applicable ethical and procedural codes. 
Examples of provincial legislation that outline professional requirements by law 
include the 16 health professional statutes in NL, including but not limited to the 
Registered Nurses Act, the Social Workers Association Act, and the Dieticians Act (NL 
House of Assembly, 1999). In addition to legislation, standards of practice are regulated 
by a provincial professional body whose mandate is to protect the public interest and the 
public ' s right to a competent health professional; for example, the College of Physicians 
and Surgeons of L and the Association of Registered urscs of L. In addition to 
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professional practices bodies, various healthcare disciplines have developed codes of 
ethics to serve the interests of its members. Professional codes of ethics offer guidelines 
on which parameters can be set to govern the patient-health care professional relationship 
(Abdool eta!., 2004). Examples include the Canadian Medical Association's Code of 
Ethics for physicians, residents, and medical students (Canadian Medical Association, 
2004), the Canadian Nurses Association's code for registered nurses (Canadian Nurses 
Association, 2008) and the Canadian Physiotherapy Association ( 1989) Code of Ethics. 
Though well-received by members of their respective disciplines and notable for 
the sense of solidarity they create, there are limitations to what legislation, professional 
practice standards, and discipline specific protocol can accomplish. Such limitations 
include their vague nature, broad scope, and failure to provide solutions for complex, 
real-life moral dilemmas. They lack the flexibility required to "prioritize principles when 
they conflict" (p. 34) and need to be practically resolved (Abdool et al., 2004). They are 
inadequate for guiding healthcare providers through ethically challenging public health 
decisions, such as HIV testing. 
Common characteristics of policies include a formal written expression, intention 
to reflect desired organizational practices, and are often referred to as policy guidelines. 
The following two paragraphs demonstrate that policies need not be legislation or a 
policy manual, but they also exist in informal formats. 
!\ best practices brief provides specific examples of what policy is. The brief 
recognizes that budgets are "critical statements of social policy" because they distribute 
resources and determine organizational limitations (Best Practice Brief, 2005 , p. l ). 
Similarly, "policy is reflected in strategic plans and memoranda·· (p. 1) and translates into 
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practice when persons in leadership roles would be expected to make decisions or take 
actions. These leaders are mandated to provide input on "rules and regulations, manuals, 
requests for proposals, contractual agreements, enforcement actions" (p. 1 ), which can be 
uniformly and/or formally applied and may exist within many organizational levels 
and/or structures. 
A study from a high-prevalence region uses the term informal responses to 
describe "undocumented practical responses to HIV and AIDS" (James, Dipo-Salami, 
Satali & Nairesiae, 2009, p.4). The authors note that although these informal mechanisms 
were not written down, they were effective for addressing HIV and AIDS in certain 
environments. Some of the disadvantages of written policies were noted by community-
based organizations: they reduced flexibility, were time consuming, detracted from the 
human face of support, and created a divide between staff and the community. Instead, 
the authors preferred to utilize informal responses including "staff meetings, retreats, 
discussions, advice, information and advice to test" (p. 4). 
2.4.2 Using Evidence to Inform Policy 
Evidence-based healthcare is a major theme in medical, health and social 
sciences. Grypdonck (2006) summarizes the central focus of this concept as the practice 
of basing policies and practices based on scientific research studies. He describes how, 
traditionally, randomized control clinical trials and other forms of quantitative research 
have been widely accepted as superior and, therefore, dominated \Vhat is considered 
evidence. As Raphael (2000) explains, fi elds like health promotion have led the way in 
accepting and encouraging .. alternative" (p.36 l) types of evidence for decision-making 
70 
given their ability to provide the right questions and answers for preventative health 
interventions. In this sense, alternative refers to anything other than traditional logical and 
positivist models of thinking. Traditional, positivist models that aim to test "nature with 
truth in the form of facts" (p. 361 ), are increasingly viewed as rooted in the biomedical 
model, and are giving way to post-modern programs and research protocols. This has led 
to a shift in terminology away from evidence-based, to evidence-informed. This term 
implies a wider definition of evidence and recognizes the value and credibility of other 
forms of research, including that of a qualitative nature. 
Using any type of evidence to develop policy, however, can be challenging for a 
number of reasons. Jewell and Bero (2008) summarize the barriers reported by legislators 
and public health administrators who have attempted to use or have successfully used 
evidence to inform policy, planning, and practice. This American study found limited 
resources for collecting and evaluating research, budget cuts, growing mandates, complex 
policies, and challenges in organizational culture were seen as the most difficult 
challenges. Other barriers included the time and resources needed to determine the 
usefulness of research, limited access to research database, or lack of research skills. 
Given the similarities in public health policy challenges across North America, I have 
assumed these findings are generalizable to a Canadian policy environment. As such, it is 
reasonable to assume that similar challenges are faced by the administrators, legislators 
and policy-makers in this study. 
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2.4.3 Overview of Canadian Healthcare Systems Challenges 
As a committed member of the United Nations, Canada's healthcare policies are 
expected to follow strategic directives from authoritative agencies including the WHO 
and PHAC. The majority of health care services are supported by public federal funds 
and delivered through provincially regulated systems (Health Canada, 2004). Public 
health is primarily within the purview of each province and territory (PHAC, 2008). As a 
result, vast inter-provincial differences exist in health and community services delivery. 
The lack of federal direction and coordination guiding the organization of health care has 
made it challenging to collaborate on issues that could benefit from nationally consistent 
policies. Inconsistent availability of HIV testing services across the country demonstrates 
this. 
A further criticism of Canada's health care system that has profoundly affected 
policy-making is a process known as regionalization, which has occurred in all Canadian 
Provinces. Church and Barker (1998) describe regionalization of health services as an 
clement of reform that is intended to control expenditures, provide more effective 
services, and allow for citizen participation in health care decision-making. In general 
terms, regionalization of health services involves a shift of responsibility for public health 
from a series of local boards to a larger regional agency. The challenges of 
regionalization include integration and coordination of the administration and delivery of 
services; consolidation of funding; creation of information infrastructure and 
measurement indicators for evaluation; and de\'eloping mechanisms for citizen 
involvement. To relate this to I IIV testing in the small urban centre, Gustafson et al. 
(2008) explain that marginalized populations of L have been the most ncgati\'cly 
affected by changes to community health services. Criticisms of regionalization include 
services that are inappropriate or inaccessible for localized needs, disempowerment of 
local program and communities, chronic instability, and lack of evaluative data. 
2.4.4 Anonymous HIV Testing, a Policy-Practice Gap 
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Despite the display of support and anticipated need for anonymous testing that has 
been outlined, it is only officially available in seven provinces (PHAC, 2007a) and there 
is an absence of urgent provincial or federal government action to provide local access to 
this service. Anonymous HIV testing is a challenging public health policy and service 
delivery issue for many of the reasons (human rights, partner notification, contact tracing 
and mandatory reporting). From a legislative and policy perspective, prohibitive 
provincial legislation and unclear direction from the Public Health Agency of Canada 
about the availability and delivery of anonymous testing is challenging (Jurgens & Palles, 
1997). Combined, these factors create challenges at a practical level for the providers at 
the point of service delivery. 
As Herek, Capitanio, and Widaman (2002) point out, public health policy is 
created and implemented within a context where diseases are socially constructed. When 
a condition is highly stigmatized, public health policies can either protect those who fall 
ill from public prejudice or promote discrimination among them. Certain policies can 
violate the human rights of those living with or at risk of contracting the disease. 
calc, Geller and Weir (2000) observed that when policies and clinical guidelines 
arc avai lable nurse practitioners \Vho followed clinical guidelines during interactions 
\Vith patients had higher le\·els of decision-making authority and success at \Vork. 
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Additionally, the availability of clinical guidelines increased nurse practitioners' 
productivity by mitigating their need to interact with his or her collaborating physician. ln 
the absence of policy guidelines, clinical directives, or a framework to guide ethically 
challenging clinical decisions, public health providers reportedly rely on their 
professional training and experience or view their personal moral foundations as 
sufficient (Baum eta!., 2007). 
One practical challenge of unclear anonymous HIV testing and counselling policy 
is for the provider and test seeker to establish common understanding. Providers and test 
seekers may have different notions of what constitutes confidentiality and anonymity. 
A wad eta!. (2004) believe that test seekers are more conservative in their definitions of 
confidentiality, meaning they may be less will ing to provide the personal information that 
the provider expects. In this way, confidentiality may be compromised by established 
practices in health services and by differential regard for clients' rights where the poor are 
the most disadvantaged. Obermeyer and Osborn (2007) attribute this unclear 
understanding to the uneven application of practices intended to protect confidentiality by 
providers. To clarify using an example, a provider who does not support principles of 
harm reduction and holds stigmatizing attitudes towards risk may perceive a test seeker 
from an at-risk group as irresponsible. Should this test seeker make a requests outside of 
established practice, such as anonymous testing where non-nominal is the official 
standard, the provider may view this unfavourably. The procedure is seen as an 
accommodation to protect an irresponsible test seeker. This demonstrates how a lack of 
clear direction in the form of policies leaves en·ice providers to negotiate indi\'idual 
requests at the point of service delivery, which may have different outcomes depending 
on the circumstance. 
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Through the Canadian Guidelines on Sexually Transmitted Infections, the Public 
Health Agency of Canada (2006b) has made a concerted effort to ensure that national 
prevention and control efforts are always "linked to HIV prevention and sexual and 
reproductive health programmes and services" (p. 11) to uphold this commitment in a 
visible and transparent manner. The Canadian Guidelines on Sexually Transmitted 
Infections are written and maintained by an expert working group of health professionals 
from across the country to provide updated, evidence-based recommendations for the 
prevention, diagnosis, treatment and management of sexually transmitted infections 
across Canada's diverse population (PHAC, 2006b). The Canadian Guidelines on 
Sexually Transmitted Infections place an explicit onus on providers to take advantage of 
their proximity to users of the health care system and offer screening, diagnosis, 
management and treatment services to a wide range of clients. By making such a 
continuum of STI service available "providers have the potential to significantly impact 
chronic disease prevention and control in the long-term" (p.ll). The document even 
acknowledges the ethical challenges related to practices required under STI services, such 
as reporting and partner notification. A shortfall of the Canadian Guidelines on Sexually 
Transmitted ll?fections (PHAC, 2006b), however, is the absence of directives that address 
what to do in the event that a client docs not wish to provide personal identifying 
information. 
Other practical challenges include every day job roles and responsibilities of 
public health pro iders. Everyday they grapple with new technology, changing societal 
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values, attitudes, and expectations in the face of scarce resources (J\bdool, Perez, & Lit, 
2004). They may also be varying levels of experience, time resources, or motivation to 
consider and incorporate ethics into their daily work. Ultimately, the literature on this 
topic confirmed the importance of policy guidelines to guide decision-making and del iver 
consistent and appropriate services. 
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3.0 Methodology and Methods 
This chapter describes my methodological standpoint, the study design, the 
processes for obtaining ethics approval, and other ethical considerations. It explains the 
philosophical roots of the study within constructivist epistemology. It provides an 
overview of qualitative description as presented by Sandclowski (2000), which was used 
to collect data from four testing sites using individual interviews and document review. lt 
describes data analysis including the document review process, diagramming the 
document trees, and thematic analysis. I drew from coding techniques described by Braun 
and Clark's (2006) and Strauss and Corbin's (1990), as well as Crabtree and Miller's 
( 1999) use of templates to assist with thematic analysis. This chapter also provides 
justification for keeping a reflexive journal and using it as a tool for data verification. 
Murphy and Dingwall's (2003) criteria for assessing the truth claims of qualitative 
research are used to demonstrate the rigour of the study. 
3.1 Methodology 
Fierke (2004) explains methodology as including both ontology and epistemology 
and referring "to those basic assumptions about the world we study which are prior to the 
specific techniques adopted by the scholarly undertaking research" (p.36). 
3.1.1 Suitability of a Qualitative Approach 
Belgrave, Zablotsky. and Guadagno (2007) ackno\vledge the need for detail when 
communicating qualitati\·e research strategies and encourage researchers to explicitly link 
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methodological strategies with research goals. They recognize that important, 
understudied phenomena require multidisciplinary efforts to resolve. Understudied 
phenomena are characterized by a dearth of literature on the subject and are well-suited to 
qualitative inquiry. While some aspects of HIV are widely covered in academic literature, 
such as stigma (Bogart et al., 2008; Brown et al., 2003; Parker & Aggleton, 2003; 
Vidanapathirana et al., 2007), other aspects lacking study include the ethical and cultural 
considerations of testing policy (Bell et al., 2007; Hoxworth et al., 1994; Johnston & 
Conly, 2002). As Starks and Brown-Trinidad (2007) confirm, studies that "examine 
institutional and social practices and processes, identify barriers and facilitators to 
change, and discover the reasons for the success or failure of interventions" (p. 13 72) are 
well-suited to a qualitative approach. 
3.1.2 Methodological Standpoint 
My epistemological and ontological standpoints are determined by the belief that 
multiple meaningful components of the social world exist from which knowledge can be 
derived. Crotty (1998) describes this as a constructivist epistemology, which maintains 
that all knowledge is constructed by humans. There are as many realities as there are 
perceptions and interactions: co-constructed realities can exist in particular contexts. 
Constructivism supports that a range of contextual factors, including the perceptions or 
the interpreter, influence an individual's interpretation of the truth (Murphy & Dingwall, 
2003 ; Smith. 1985). Constructi\'ism is contrary to positivism and objectivism, which 
maintain that one universal , infallible truth can become known through external reality. 
This created an opportunity for continuous enhancement of' understanding and knO\\ ledge 
through the use of qualitative description, which allows for multiple data collection 
strategies. 
3.1.3 Evaluating Congruence 
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The purpose of evaluation is to assess outcomes and the process by which they 
were achieved (Nutbeam, 1998). The evaluation of health policies and programs has 
become an increasing priority worldwide with the ongoing reform of Canadian health 
systems, and the increasing emphasis on governments and organizations to use evidence 
to inform decisions and to be transparent and accountable (CIHR, 2005). This study was 
evaluative in nature because it poses basic questions about the congruence between HIV 
testing policy and practice, determines facts about policies through a document review, 
and examines providers' perspectives through interviews. 
3.1.4 Study Setting 
This study focused on HIV testing services in a location that fits Gustafson at al. 
(2008) description of a small urban centre where there is a perception that "everyone 
knows their neighbour's business" (p. 190). In the province ofNL, over 213,000 or 42% 
of people reside in rural areas, where rural is considered to be anyone living outside 
centres with a population of 1,000 and outside of an area with 400 persons per square 
kilometre (Statistics Canada, 2007). Due to the clustering of the provincial population 
around urban areas, one of the four regional health authorities provides unique provincial 
programs and sen·ices. As such. people arc otten required to travel from rural areas to 
urban centres to receive specialized care and scrvict:s. This geographic distance has long 
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been recognized as a barrier to accessing specializing health services, which are clustered 
in urban areas. 
3.1.5 Study Participants 
Organizational study participants were identified through an environmental scan 
of the literature followed by a regionally-specific fact-finding phase. Individuals who 
participated in interviews were subsequently identified by the site principals. My goal 
was to include all the locations in the small urban centre where people would go to seek 
information about HIV testing or to be voluntarily tested for HIV. Sexual and 
reproductive health is one of the programs covered by a regional health authority's health 
promotion and public health division (Eastern Health, 2009b). Since the Community 
Services division of the regional health authority was described as being responsible for 
providing screening and other related services for sexually transmitted infections, they 
were invited to participate in this study. The regional health authority's testing sites 
represented a formalized, public health testing environment. 
In an effort to determine how a layperson may identify local testing services, I did 
a Google search for 'HIV testing in Newfoundland ' and found several of the community-
based organizations that test seekers may contact. I invited these organizations to 
participate in my study. Because of my involvement in the community I recognized the 
names of two organizations as reasonable choices for people seeking information and/or 
testing services. My familiarity with the Ottawa Charter for Health Promotion (WHO, 
1986), especially with respect to capacity de\·elopment of civil society through the active 
involvement of people and community, helped me recognize the value of this . Canadian 
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examples of successful stakeholder collaborations for HIVIAIDS testing are documented 
in Ontario (Ministry of Health and Long-Term Care, 2008) and British Columbia 
(Kendall, 2006). Bogart et al. (2008) further confirm that due to the stigmatization of 
HIV I AIDS, people tend to seek services from persons other than their family physicians 
including unaffi liated health care providers and community-based organizations. 
Consequently, these organizations were also selected to participate in the study. 
Finally, the Atlantic Interdisciplinary Research Network for Social and 
Behavioural Issues in Hepatitis C and HIVIAIDS (AIRN) completed an environmental 
scan that synthesized the HIV I AIDS specific services available in each of the four 
Atlantic Provinces. For NL, the "HIV Interdisciplinary Care Team" (AIRN, 2006, p. 73) 
was identified as the primary provider of clinical services for infectious disease. Initially, 
the HIV Interdisciplinary Care Team was invited to participate in the study, but its 
operations ceased during the data collection period due to staffing issues (Telegram, 
2009). Ultimately, one organization was responsible for two testing sites, so three 
organizations represented four testing sites. At the end of data collection, the policies and 
procedures of four testing sites had been reviewed and seven participants had been 
interviewed. 
3.2 Methods 
3.2.1 Qualitative Description 
While qualitative description is not associated with any particular discipline, it 
may be inOuenced by any of the traditional methodological research frameworks 
described by Polit and Beck (2004) including phenomenology, grounded theory, 
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ethnography, ethology, discourse analysis and historical analysis (p.249). It draws from 
the ideals of naturalistic inquiry, which require a commitment to observing something in 
its natural state with little pre-selection or manipulation of variables and no commitment 
to any one theoretical view (Lincoln & Guba, 1985; Willems, 1967). According to 
Sandclowski (2000) the aim of qualitative description is to "create a comprehensive 
summary of events in the everyday terms of those events" (p.334) in which researchers 
stay close to their data and to the surface of words and events. Plain language was an 
important consideration for my research because I recognized that it would be necessary 
to effectively synthesize this information easily for a variety of audiences and, hopefully, 
highlight areas for policy change or examination. The motivation for choosing qualitative 
description was to achieve a writing style that would help me communicate the findings 
across disciplines to many stakeholders. 
Qualitative description is consistent with constructivist epistemology as it allows 
for multiple data collection strategies and emphasizes the importance of avoiding highly 
abstract interpretations of the data. According to Sandelowski (2000), data collection 
under qualitative description can be achieved through an eclectic combination of 
sampling, data collection, and analysis techniques. This section describes the strategies 
that were used for data collection and analysis. The first step in data collection was a 
document review, which was analyzed using textual analysis and diagramming. The 
second step was individual interviews with seven participants, which \VCre analyzed using 
coding techniques and the use of a template to complete thematic analysis. Finally, a 
rctkxiYc journal \Yas kept throughout the data collection process and used during data 
analysis. 
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3.2.2 Document Review 
The goal of my document review was to find out the various organizations' H IV 
testing policies. If the setting was non-clinical, the goal was to determine past testing 
policies and current procedures for handling inquiries about testing. The correspondence 
that was used to invite organizations to participate in the study is shown in Appendix A. 
The study invitation provided the following explanation of a document review, 
It is important to note that a policy need not be a manual. The document 
review will be of all policy-related documents including meeting minutes, 
emails, briefing notes, or any other hard copies that have been or currently 
are used to direct testing procedures and inquiries. (p. 1) 
By including additional sources, I hoped to obtain access to documents supporting 
informal procedures and accepted practices that took place in the event that there was no 
formal policy. To begin the document review process, I met with the principals of each 
organization. The purpose of this first meeting was to describe the study, obtain written 
and informed consent, and explain the document review process. During the document 
review, a series of meetings were held during which I received documents, took them 
away for analysis, and initiated follow-up contact to ask questions. This process was 
repeated as many times as necessary. As such, document review data collection and 
textual analysis were overlapping processes. This section addresses the process that was 
used to select and col lect the documents. 
Based on the principal" s understanding of the study im·itation and the verbal 
explanation provided in the first meeting, initial documents \\·ere provided that explained 
the organization's testing policy, provided proof of organizational practices, or \\'ere in 
any way pertinent to testing. Subsequent meetings and correspondence were held to 
clarify any questions on the documents that I had in my possession or to collect any 
additional documents the principal had to offer. The number and type of meetings 
required to complete the collection of documents and varied with the type of 
organization. The community-based organizations ranged from four to six meetings, 
while the regional health authority's entire document review process was completed in 
three meetings. There was a higher volume of email exchange with the regional health 
authority's principals than with the other two community organizations. 
83 
After my first meeting with the first participant, I realized that participants were 
somewhat hesitant to provide documents. During the meetings, several comments led me 
to believe that this hesitation was related to the variety of forms of documents that had 
been stated as eligible for inclusion in the document review in the study invitation 
(Appendix A). Upon realizing this, I shared my rationale for the broad range of 
documents that qualified for the document review and emailed the principal a copy of the 
Excel spreadsheet I was using to record document review information. This helped 
participants understand what I was looking for and how it would be stored. This also 
helped me communicate the importance of including historical evolution of policies to 
demonstrate changes to the organization's response to HIV testing and allowed me to 
collect a series of documents that reflected past and present organizational practices -
even when a formal policy did not exist. In cases where a formal policy did exist, I 
included other forms of documents to supplement or verify the protocol in place at the 
organization. I later speculated that principals of community-based organizations may 
ha\'e been hesitant to provide supporting documents due to a phrase in the ethics 
,------------------------------------- ----- ---
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application that stated "if there are no HIV testing policy documents, it will be considered 
a significant finding. " 
The initial findings of my document review were recorded in a Microsoft Excel 
spreadsheet that I referred to as a data tracking sheet. During the data collection stage of 
the document review, I referred to this as the raw data tracking sheet because it tracked 
the documents according to the chronological order in which I received them and did not 
reflect any kind of categorical organization. At the top of the sheet, the organization's 
name and the principal's contact information were recorded. Table 2 provides a short 
description of the headings used to take notes for analysis, 
The first ten categories were descriptive statistics or procedural information about 
the document and were noted during the exchange of the documents. The remaining 
categories became significant in the later stages of data analysis. 
3.2.3 Individual Interviews 
An epistemological approach grounded in constructivism, relativism and subtle 
realism encourages a loosely structured interaction between researcher and participants so 
that an issue can be explored in a particular context. Through this exchange, data can be 
co-constructed or created. Flexibility in the sequence and phrasing of questions allows 
the pm1icipant and the researcher to do what Lofland, Snow, Anderson and Lolland 
(2006) refer to as "starting from where they are" (p.9). This approach encourages 
connections between personal emotions and perceptions and thoughtful reflection. 
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Table 2: Headings Used in Raw Data Tracking Sheet 
Heading Description 
# To identify the order in which documents were received . 
Title Recorded the title of the document, where no title was 
available an identifying phrase was generated 
Description A brief description of the content of the document 
Availability Identified who had access to the document and if it was a 
public document how and where it was displayed 
Status This described whether or not the document was in use at 
the time of the document review or out-dated 
Date Received by Amanda This is the date that I first received the document 
Original document details This describes who created the original document, when 
it was created, and why it was created 
Most recent revision This describes who did the most recent revision to the 
document, when it was done, and why it was done 
Details of Previous Revisions Describes what the last revision was 
Update Procedure to Document I Describes the procedure for updating the document 
Policy 
Content Provides a brief summary of the content 
Noteworthy Excerpts Summarizes the sections of the policy that refer to HIV 
testing 
Contact Information Provided Summarizes the contact information provided 
Contact Information Requested Summarizes whether or not the document required 
contact information 
Storage Information Describes where and how the document is stored 
Comments Records my thoughts during the initial document review 
phase 
Interviews are a popular method of data collection for qualitative researchers in 
the social sciences (Nunkoosing, 2005). In fact, interviewing is probably the most 
commonly used method in qualitative research, (Lofland et al. , 2006; Mason 2002; 
Nunkoosing 2005; Sandelo,vski 2002). Silverman (2000) goes even ft.n1her by re ferring 
to interviewing as the '·gold standard" in qualitative research (p. 291). Kvale ( 1996) 
describes interviews as ·'attempts to unfo ld the meaning of peoples' experiences, to 
uncover their lived world"' (p. I ). At the most basic level. interviews are com·crsations. 
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To generate effective data, an interviewer must not just chat with a participant, but use 
skills to listen, probe, and encourage the sharing of relevant data. Nunkoosing (2005) 
describes a skilled interviewer as one who "uses his or her person to communicate with 
people to create stories" (p. 698). Finally, advocates of qualitative interviews often point 
to the policy relevance of the insights that can be gained if we avoid imposing our own 
structures and assumptions upon participants' views of the world (Britten, 1995). 
According to Sandelowski (2000), qualitative description interviews are typically 
moderately structured, open-ended, and individualized. I wanted to ensure that my 
interviews were conducted in a manner that would support my ontology that knowledge 
is situational and contextual: interview data is constructed through dialogue. The in-depth 
nature of individual interviews offered rich data, but as in independent researcher my 
ability to obtain and interpret data from numerous participants was limited (Murphy & 
Dingwall, 2003). One or two participants from each testing site were purposively chosen 
based on their closeness to the practical delivery of the service and/or their knowledge of 
the organization's policy. Seven interviews were conducted with participants from 
community-based organizations and the regional health authority. Financial and temporal 
constraints prohibited further interviews. The average length of each interview was one 
hour and fifteen minutes. In total, there was approximately nine hours of recorded 
interview time. The interviews were transcribed into over 300 pages of data, 
approximately 43 pages per interview. 
As suggested by Murphy and Dingwall (2003) the interviews were conveniently 
scheduled to meet the time constraints of busy participants. This was particularly 
important since participants were involved with providing public health scn·ices, 
~ ~---~~~~-~--------------------------------------~~ 
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administering testing and responding to inquiries. Appendix B is a copy of the Interview 
Consent Form and Appendix C is a copy of the generic interview guide, complete with 
probing questions. 
3.2.4 Document Review Analysis 
Analysis, approached from a constructivist framework, is a process that allows 
researchers to play with the data by deconstructing and reconstructing the text in search 
of patterns and relationships in perceptions and interpretations. As Sandelowski (2000) 
put it, "all inquiry entails description, and all description entails interpretation" (p. 335). 
To keep my data analysis consistent with qualitative description's objective to synthesize 
information to communicate it across disciplines, I analysed with the intention of creating 
"a straight descriptive summary of the informational contents of data organized in a way 
that best fits the data" (Sandelowski, 2000, p.339). The analysis of documentary sources 
is a major method of social research and is commonly used in qualitative studies (Mason, 
2002). When performing textual analysis, it is important to ensure that documentary 
sources are subject to an ample degree of critical scrutiny. Mason offered this caution in 
light ofthe fact that the permanent and indisputable characteristics of text can be easily 
mistaken as a superior form of information. Relying on textual analysis was aligned with 
my constructivist beliefs as it would supplement individuals' verbal accounts of testing 
procedures. 
I photocopied the documents I received and created two envelopes per 
organization - one contained original documents and the other with photocopies. I did a 
first reading of the photocopied documents and took note of text that addressed past or 
-------~--
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present HIV testing policies or practices or offered definitions of nominal, non-nominal, 
or anonymous testing. After the first reading was complete, it became evident that there 
were certain categories that could be used to group the broad range of documents. I used 
the following categories to organize the documents received from the three organizations 
'education, prevention, and awareness ' , 'clinical', 'policy-related', and ' legal'. I adapted 
the data tracking sheet to demonstrate these categories by creating a copy of the raw data 
tracking sheet and organizing it according to the categories that had emerged. I now had 
an organized data tracking sheet that listed the documents categorically. This was in 
addition to and separate from the raw data tracking sheet that listed the documents in the 
order that I received them. 
I then did a second reading of the photocopied documents. During this reading, I 
used the comments and markings I had made in the first reading to complete the 
'Content' and 'Noteworthy excerpts' sections of my data tracking sheet. In the 'Content' 
field, I created descriptions of each document. In the 'Noteworthy excerpts' field, I typed 
verbatim those sections that were relevant to HIV testing. As I did the second reading, I 
added two columns to the organized data tracking sheet: 'Comments Round 2' and 
'Organized data code'. Under 'comments round 2' I noted things that seemed relevant for 
subsequent analysis. Under ' organized data code', I systematically assigned a number 
and a letter to each document to represent the reorganized structure and to represent that 
they were no longer listed in the order in which I received them. 
As the document review progressed and principals were able to retrieve historical 
Iiles, there were several cases in 'vvhich I had multiple versions of one document. I furthl.!r 
categorized the documents into chronological categories according to the description that 
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had been entered under' Status' on the data tracking sheet. 'Current' represented 
documents that were being used by the organization at the time of the study and 
' historical' represented documents that were outdated or no longer in use or prior to a 
certain time period. For example, the cut-off date for 'Historical' documents at testing 
site #2 was 1995. At times, I felt overwhelmed with the amount of text and data and I 
wanted to find a way to effectively portray the textual analysis and the categories that had 
emerged in an 'at-a-glance' manner. As such, I looked to the literature to confirm the 
pedagogy of using diagrams to depict findings. 
3 .2.5 Diagramming 
Diagramming is one of five analytical strategies described by Lofland et a!. 
(2006) that offer a visual representation of one or more relationships among parts of 
something. This was not a pre-determined analytical strategy that I had planned on using, 
but it ultimately helped me and the principals make sense of numerous documents. I used 
the organization chart feature in Microsoft Word to depict each organization into two 
main categories (categorical and chronological), and various sub-classifications 
(education, prevention, and awareness; clinical; policy-related; legal; current and 
historical). The diagrams took on a hierarchical shape in which one box could have many 
sub-levels. I referred to these as document trees to reflect their resemblance to branches 
and created two document trees per organization (Appendix D). 
After the interviews were completed, I returned to the organized data tracking 
sheet and copied and pasted from the column labeled ·Noteworthy Excerpts ' to ret1ect the 
findings of each organization ' s document review in a Microsoft Word table entitled 
Document Review Analysis. This table contains verbatim excerpts from the documents 
that demonstrate how each organization defines anonymous, nominal, or non-nominal 
and phrases from documents that indicate past and present organizational policies or 
provide evidence of organizational procedures. 
3.2.6 Interview Analysis 
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I used thematic analysis to analyze the interview transcripts for its flexibility and 
fit with my overall epistemology and ontology (Braun & Clark, 2006). I also believed 
that thematic analysis would effectively portray my findings based on the research 
objectives. Thematic analysis can be used as a constructivist method to explore 
experiences and meanings and their emergence from individual and socio-cultural 
discourse. Thematic analysis is a foundational qualitative method of analysis, 
incorporating the core skill of"thematising meanings" (Holloway & Todres, 2003, .247). 
Braun and Clark define it as a method "in its own right" (p. 78). The flexibility of 
thematic analysis is due to its generic nature and associated theoretical independence and 
it is trustworthy because the researcher records and reports how themes were developed, 
why and how. As such, the following paragraphs explain my data analysis step-by-step. 
To finalize the thematic analysis and highlight key findings, I used a blend of 
Strauss and Corbin's (1990) coding techniques and Crabtree and Miller's (1999) 
··template analysis'" (p.8). In template analysis, the researcher identifies themes that arc 
signiticant to the research and a template is developed to summarize the data into useful 
themes. Completing the document review helped me pre-determine three important 
themes for the template: 
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• statements that demonstrated past practices, 
• statements that demonstrated current practices, and 
• participants' definitions and perceptions of HIV testing. 
With these three themes on the template, I did what DeWet and Erasmus (2005) 
refer to as a "close reading" (p.29) of all seven transcripts for the first reading of the 
interview transcripts. While reading the electronic transcripts, I copied and pasted 
statements that demonstrated past or current practices at the participants' organization 
into the template. I also copied and pasted statements that demonstrated the participants' 
definitions, perceptions, and understandings about nominal, non-nominal, and 
anonymous testing into the template. I then used the verbatim statements to create 
detailed descriptive summaries. 
After categorizing data that were relevant to the three themes that had been 
identified in the document review, I did a second reading of three transcripts to 
systematically identify other important themes. By reading one transcript from each 
organization line-by-line, I did what Strauss and Corbin (1990) refer to as "initial 
coding". I started by identifying codes within the testing sites operating within formalized 
public health settings because these transcripts contained the most technical information. 
Twenty-six themes were identified. Subsequently, initial coding for other testing sites 
revealed an additional 36 themes. One of the characteristics of initial coding is that the 
codes are generally quite numerous and varied. 
The purpose of my next reading was to do what Strauss and Corbin ( 1990) refer 
to as ··focused coding··, vvhich allows the researcher to further refine the codes into 
meaningful categories. I entered all 63 initial codes into an Excel spreadsheet :md 
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embarked upon a third reading with the intention of condensing the themes. During this 
reading, I copied and pasted verbatim excerpts from the seven electronic interview 
transcripts into the Microsoft Excel spreadsheet and populated each of the 63 initial 
codes. This process helped me refine the themes and select the focused codes. For 
example, after placing the initial codes side-by-side in a Spreadsheet, I realized that the 
four initial codes 'Summary of current policies', 'Summary of current practices', 
'Loopholes within the current system', and Examples of incongruence between policy 
and practice' could be combined under one focused code 'Examples of incongruence 
between policy and practice'. I did this by selecting the codes that were the most relevant 
to the research question and would translate into meaningful findings for discussion. 
In the end, six focused codes were added to the template - legislation, 
understandability of testing language, perceptions of at-risk groups and concepts of harm 
reduction, identified areas of weakness in current service delivery, perceptions about the 
healthcare providers ' and community-groups involved in the HIV process and 
recommendations for change. The template now consisted of nine themes; three that had 
been pre-identified in the document review and six had been identified through initial and 
focused coding. 
I created a new Spreadsheet with the three pre-identified codes and six focused 
codes. This was the final analysis template. I used the spreadsheet containing the 63 
initial codes to populate the categories. Finally, l did a fourth reading of the even 
transcripts to ensure the richest parts of the data set \Vere reflected in the focused themes. 
At Yarious point throughout each of the four readings. I listened to the original audio 
93 
files so I could be reminded of the context of the conversation as demonstrated by verbal 
intonation and emphasis. 
3.2.7 Reflexive Journal 
As a qualitative researcher, I recognized that my presence, beliefs, and opinions 
influenced the social context in which data were created and meaning was emphasized. 
Using reflexive journals is aligned with constructivist thinking, which emphasizes the 
importance of exploring perceptions, experiences and meanings and their emergence 
from individual and socio-cultural discourse. Murphy and Dingwall (2003) recognize the 
importance of practicing reflexivity to increase the reader's confidence in the findings. 
By making this ' paper trail' available, other researchers can either explore the 
transferability of the findings of this inquiry to other contexts, or repeat the procedures I 
have used with the rich detail provided in the reflexive journal. 
I followed Ahern's (1999) tips for writing a reflexive journal and recorded 
personal thoughts and feelings that pertained to my area of research. I attempted to make 
my assumptions and biases explicit by recording the materialization of my own beliefs 
and world views into thoughts, attitudes, and opinions throughout the process. As I did 
this, I considered my own role in constructing the data. From January 30t11 , 2009 to May 
25 , 2009, I logged an 81-page reflexive journal to record my thoughts and challenges 
throughout the study design and data collection phase. Having the reflexive journal 
allow·ed me to better acknowledge the influence of my personal interpretations on the 
data and key findings. Rather than attempting to eliminate my personal intluence, I 
attempted to account by consulting my reflexive journal during analysis. The contents of 
my reflexive journal and its usefulness as a tool for analysis are further discussed in the 
following section. 
3.2.8 Saturation 
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Bowen (2008) draws from the work of many researchers to provide his own 
definition of data saturation as the process whereby new participants are brought into the 
study "until the data set is complete, as indicated by data replication or redundancy" (p. 
140). When new information is not being added and when there is substantial replication 
within categories, the data can be considered comprehensive and complete. Saturation 
became evident in three distinct ways - participants' approval of the document trees, data 
repetition within individual interviews, and data redundancy between interviews with 
different participants. 
After the documents were reviewed and the diagrams were complete, I emailed 
the document trees to one participant per organization and we set a time for the first 
interview. The participants who received the document trees on behalf of their testing 
site(s) were satisfied with the document trees and stated that there was no additional 
information required. Secondly, the structure and duration of the interviews allowed 
participants to express their opinions, perceptions, definitions and understandings for the 
type of HIV tests on multiple occasions. The following statements demonstrate how one 
participant defined anonymous testing at four separate points during the interview. 
With anonymous testing, the only thing that attaches to you to that blood 
sample, and the results of that blood sample. is an I. D. code. So. say, if it 
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was for myself, my code would probably be T.U.2 and like the first couple 
of digits of like my date of birth or something like that; but nothing . . . my 
MCP, my actual name, none . . . no information that, you know, is relevant 
to me is actually attached to that blood sample. So what you do is you 
present that code to whoever is presenting you with the results. And 
positive/negative - do you need counselling; do you need help? That 's it. 
... you ' re given a code from when you walk in the door. You don't fill in 
anything. You don ' t .. . I mean, they might ask you about your sexual 
history, but they' re not taking your name; they ' re not taking your address; 
they' re not taking your age. They might take your initials and your age 
and that might be your code, but you as a person in society and in ... you 
know, a number under the health care system has nothing to do with your 
test. 
That test has your code on it. You get the results back by that code. It' s 
never put towards your name. So it is truly anonymous where is non-
nominal is not anonymous. Irs just. .. irs not. . . you know, your name 
isn ' t given to the lab . 
.. . anonymous testing, you know. it ' s only you and the provider who ·s 
telling you results. 
2 Initia ls changed to protect confidentiality. 
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The detai led interview transcript analysis revealed multiple instances of such 
repetition, thereby confirming the completeness of the conclusions suggested by 
individual participants. I was also careful to avoid generalizing or drawing conclusions 
based on individual events or perspectives. As such, before a theme or finding was 
confirmed and used in the analysis template, at least six verbatim statements from 
multiple participants were required to support and confirm it. For example, the following 
nine statements were made by four participants from community-based organizations, 
which allowed me to conclude that participants from community-based organizations 
supported access to anonymous testing. 
I think that having access to anonymous testing is essential, and I just 
don't think that it's there. Access to anonymous testing is vitally important 
and it's not there. 
So, hence, the urgent need for anonymous or non-nominal, whatever 
you' re going to call it, but it has to be insured, that the person whose 
health information is this HIV result, that the name is never connected to 
that file because if I go in to the insurance company and I lie and say -
'·Well, if I say yes they won't insure me," right, ·'but if! say if I say no 
they'll never know - but if I had had a test through my doctor's office, or 
through the health care system using my MCP card. that could be traced 
because it 's in the system. right? 
------------------------------------------------ -----
97 
Yeah, I think it would be good to have because it would probably get more 
people out getting tested because obviously some people think about it, 
but they don't want to ... obviously, confidentiality is something that's, 
you know, on people's minds when they' re talking to us about STI's. 
So being able to get it done anonymously where they don 't have to give 
their names or anything, that's, you know, critical for a lot of people 
because there is that fear that it might, you know, leak out somehow and 
people might find out, and people worry about that 
Whatever the test is called, urgent need for a type of test that can never be 
connected to personal health information or that can be accessed by one's 
family physician . 
. . . we can explain about confidentiality to them and how imp011ant it is, 
you know, because then at least they know that in the future they have a 
safe spot that they can go to, and ask questions. They can come to us, and 
we'll try and explain the whole confidentiality process and ... you know, 
policy ... but if they . . . even if they ' re not comfortable . .. yeah, 
anonymous HIV testing would be preferable. I guess it depends on why 
they would be afraid that anyone would find out. 
Interviewer: What does anonymous testing in [small urban centre] , mean 
to you? 
3.3 Rigour 
Participant: Failing of our system. 
Interviewer: because it's not available? 
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Participant: Yeah, you know, it would be nice if it was available. It's sad 
that it's only available through, you know, special studies- or, you know, 
studies- but, yeah, in terms of anonymous testing, it doesn't mean much 
in Newfoundland because it's not available. 
Counselling pre and post is very important as well, and keeping in mind 
that that needs to be done with anonymity and protection as well and then 
also that it's not rammed down people's throats. 
I think the [anonymous HIV testing] protocol needs to be clear, and it 
needs to enforced, or best-practiced or whatever it is you do with it. You 
know, it needs to be followed. 
Morse, Barrett, Olsen and Spiers (2002) define rigour as the verification strategies 
and self-correcting mechanisms adopted by the researcher to actively work towards 
reliability and validity in the analysis of qualitative data. As De Wet and Erasmus (2005) 
point out, systematic analysis can refer to any conscious use of procedures to organize a 
mass of data methodically so that it fits into a broader, structured vvhole. Murphy and 
Dingwall (2003) outline three guiding criteria to explain efforts taken to assess the truth 
claims of qualitative research - searching for contradictory evidence, combining different 
methods, and checking research findings with research pm1icipants. This section uses the 
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first two of these three criteria and an expanded version of the third criterion to 
demonstrate the rigour of this study. The purpose of this section is to present readers with 
enough information to allow them to decide whether the findings are adequately 
supported and gauge the quality of each stage of the study. 
3.3.1 Searching for Contradictory Evidence 
"Searching for contradictory evidence" (Murphy & Dingwall, 2003, p. 174) is 
central to the quality of qualitative research because it can limit error and strengthen the 
researcher's claim to authoritative knowledge. This section describes the series of events 
that demonstrates how the underlying rationale for the entire study was to search for 
contradictory evidence, as well as steps taken within the study itself. The series of events 
that influenced my choice of research topic described in Chapter One demonstrates that 
the very reason I pursued this inquiry was to find contradictory evidence. Exposure to the 
conflicting information in PHAC's (2007a) Epidemiology update, local advertisements 
(The Muse, 2008), unavailable official guidelines for NL and community advocates 
demonstrates this. 
Murphy and Dingwall (2003) advise that in addition to being the underlying 
rationale for a study, searches for contradictory evidence also occur within individual 
studies. Steps taken through my study design, data collection and analysis reflect my 
commitment to searching for contradictory evidence. With respect to the study design, I 
recognized that examining the congruence between HIV testing policies and practices in 
the small urban centre required including a narTo\\·er set of objecti ves that \\·otdd capture 
the variety of settings in \vhich testing was offered. Specifically. there were a number of 
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locations in the city where laypersons may have looked for HIV testing. Recognizing that 
the policies and practices at one setting may be totally different than another, I set out to 
thoroughly examine multiple locations. This minimized the possibility of drawing 
conclusions about testing procedures in the whole city without recognizing the context 
and setting in which they were being offered. 
With respect to data collection, including many participants from each setting 
allowed me to search for contradictory evidence by including multiple viewpoints. 
Specifically, I included the principal of each organization, who was in a position of 
authority over the creation, implementation and enforcement of organizational policies, 
as well as one or two of the staff who were most closely involved with providing testing 
services to the public from each organization. With respect to data analysis, Murphy and 
Dingwall (2003) point out that the prior assumptions researchers bring to their study and 
those ideas generated in early field work can be valuable, but also very dangerous. 
Preliminary ideas can act as a filter through which researchers see the phenomena under 
study and the data they collect. As a result, they are alert to evidence that confirms their 
prior assumptions and fail to notice data that "contradicts or modifies these preliminary 
ideas" (p.175-6). 
Recognizing that my theoretical inferences we ·rc always and irreducibly influenced 
by my own frame of reference and assumptions, I heeded the conclusions of De Wet and 
Erasmus (2005) to make my analytical procedures as transparent as possible. I did this by 
keeping a reflexive journal and by explicitly describing the process I used to complete the 
textual and thematic analyses. The manner in which I discovered my biases and the 
transformation of my opinions speaks to the rigour or my data collection and analysis . 
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Before starting my data collection, I was a strong supporter of anonymous testing as a 
widespread solution without really knowing why. This was indicated by statements of 
recommendation in a paper written for a policy course in the first year of my program, 
such as "Federal government should support widespread availability of voluntary, 
discrimination-free anonymous testing" (Hancock, 2008). After receiving feedback that 
widespread anonymous testing may not be a one-size-fits all solution, (V.M., Personal 
Communication, March 2008), I realized that this recommendation was based on my own 
opinion that had been formulated after reviewing a limited number of studies. 
Since this preliminary position, a thorough literature review and rigorous data 
collection period helped me experience a broad range of perspectives on anonymous 
testing. Individual interviews and informal conversations with many employees and 
volunteers from the testing sites helped me gain a more comprehensive understanding of 
the issue. Before learning that anonymous testing had been offered as part of a study in 
this small urban centre, I realized that for a period of time I had negative feelings towards 
any advertising or offering of anonymous testing. I felt it was a malicious form of false 
advertising in which a person was essentially 'duped' into being tested by a false promise 
of privacy. This was indicated by statements from earlier drafts as I attempted to locate 
myself as a researcher 
... the false sense of security felt by individuals who perceive they are 
visiting a truly anonymous site under L's current testing policy is 
notevvorthy. The public health argument for anonymous testing is strong: 
it is better to test anonymously than not to test at all. llowcver the bottom 
line is that this procedure is less than transparent and what is labeled 
anonymous is, technically, non-nominal. 
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Even before participants had confirmed the availability of anonymous testing in 
the small urban centre was because of a temporary study, I became more open to the 
benefits of testing that was called anonymous after an informal conversation with an 
employee of a community-based organization. This was the first time anyone had 
articulated the challenges of understandability. This conversation inspired me to build the 
concept of health literacy into my literature review. I logged my thoughts after the 
conversation in my reflexive journal on March 19, 2009, 
We also talked about the morality of advertising this type of testing as 
anonymous. [The participant] admitted that this (advertising and offering 
anonymous testing) had happened here at [Testing site# I] under several 
past employees as part of a study and suggested that this was because the 
meaning of non-nominal is not well-understood in the public eye; 
however, the word anonymous was and continues to be. [The participant] 
pointed out that whatever word was used was done with people's best 
interest in mind. 
Finally, after speaking with an individual from a biomedical background, there 
was a period during which I was focused on the disadvantages of anonymous testing. In 
my reflexive journal on May 12, 2009 I wrote: 
Today I saw dow·nsidcs to anonymous testing \Vhcn rthe participant] talked 
about ho\ his 1her colleagues in other provinces ,,·here anonymous testing 
is available encounter obstacles, such as limited ability to do partner 
notification. 
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Near the end of my data collection phase, my last entry in my reflexive journal on 
May 25, 2009 captured how my biases and personal attachment to the issue had evolved. 
During the course of this review, I've wondered ifNL's policy 
requirement that makes all positive individuals, even if tested 
anonymously, part of the nominal system the beginning of a long road of 
stigmatization and discrimination or is it an active precautionary measure 
that decreases the threat posed to the public health? 
3.3.2 Combining Different Methods 
Murphy and Dingwall (2003) describe "combining different methods of data 
collection within a single study" (p. 183) as a way to increase the reader's confidence in 
the soundness of the conclusions. I realized that examining policies and practices to 
capture areas of similarity or difference would require distinct data collection techniques. 
To examine the policies, I performed a document review to analyze documents that 
pertained to the organizations' HIV testing guidelines or described the organization's 
involvement with HIV testing. Since the practical challenges encompassed in HIV testing 
in a real-world setting could not be captured by examining only words and text, I 
conducted individual interviews with seven pm1icipants from four testing sites to explore 
the application of the policies in the various settings. To ensure that I was informed about 
organizational policies before having conversations about everyday practice issues, data 
collection at each site was a two-step process whereby the document review and 
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preliminary textual analyses were before conducting the interviews. Using multiple data 
collection strategies helped me confirm the details of key findings. For example, at a 
testing site where the official policy was for "non-nominal reporting" a participant 
provided detail about how that process is carried out in practice, 
So if this has a positive on it (points to reporting form), [name of 
employee] who does all the data entry onto the C.D. [communicable 
disease] system - if one of these was positive, under the name [he/she] 
would have an alphanumeric code, say ST4252. That would be their name 
and age (points to form). The MCP [Medical Care Plan], [he/she] would 
generate. It would be 99. So the [provincial infectious disease 
epidemiologist] says, "Oh, but I need" ... "You know, I need to have an 
MCP," and [name of employee] says, "But you're not going to get an 
MCP because we don't collect MCP". 
3.3.3 Seeking Input 
This section includes details on how I used Murphy and Dingwall's (2003) 
technique of "checking research findings with research participants" (p. 186) and how I 
sought advice from experts to guide the direction of my study and refine data collection 
tools. 
I verified the findings of my document review by corresponding with the principal 
at each setting. I did this by emailing each of the three principals a copy of the Microsoft 
Excel tile with a list of the documents that would be included in the document review as 
well as two document trees that represented the findings of their document review. /\tier 
105 
the file was received and had been reviewed, we discussed the document review findings 
in a face-to-face meeting. This gave me confidence that my document reviews and 
document trees included adequate sources of relevant policy-related documents. While I 
did not email participants copies of their interview transcripts, I verbally advised them to 
contact me after the interview if they made any statements during the interview that he or 
she wished to eliminate. 
I recognized that I had my own personal biases and I was aware of Murphy and 
Dingwall's (2003) warnings against forming opinions based on early evidence and then 
seeking data to confirm this idea. I enlisted the support of experienced researchers, health 
care professionals, and policy experts at various points throughout the study. Prior to and 
during the document review, I met with and corresponded with Dr. Victor Maddalena on 
the focus and purpose of the document review. We devised a method for deciding which 
documents to include and a system for extracting and recording key pieces of policy-
relevant information. 
Before conducting the interviews, I received feedback on my interview guide 
from Drs. Gustafson, Mugford, and Storr who are experts in community-based health 
services research, epidemiology, and qualitative data collection respectively. Their 
feedback helped ensure that my interview guide reflected an exploratory approach rather 
than one that focused on the advantages of anonymous testing. An example of the types 
of revisions suggested to the draft interview guide by one of these experts process is 
contained in Appendix E. 
Throughout the data collection phase, I adjusted the title of my study three times 
to incorporate external advice and the opinions of my participants. A committee member, 
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Dr. Mugford, suggested that my original title came across as adversarial and competitive, 
'Anonymous HIV Testing in [city name]: Policies versus Practices'. I agreed with this 
and changed the title to 'Anonymous HIV Testing in [city name]: Are Policies and 
Practices Congruent?' This is the title with which my study received its initial ethical 
approval. I had completed two document reviews and three interviews before having a 
conversation that led me to change the title a third time. On May 81'\ 2009 a participant 
expressed concerns that the title of my study implied a narrow view of the issue. 
Specifically, since the legislation does not allow anonymous testing, he suggested I 
change the title to ' HIV Testing in [city name], NL: Are Policies and Practices 
Congruent?' On May l41h, 2009 I submitted an ethics amendment form requesting 
official change to my title. 
To strive for interceder reliability, I shared my interview summaries with my 
supervisor, Dr. Gustafson to verify that I was correctly analyzing and interpreting key 
themes. Committee members Drs. Maddalena and Gustafson reviewed early versions of 
these chapters and helped me emphasize critical points in the write-up. Finally, I met with 
medical ethicist and researcher, Dr. Brunger, about how to approach ethical issues of 
disclosure in the write-up. 
3.4 Ethical Considerations 
1\s Rossman and Rallis (2003) point out, respect for the humanity of participants 
is of the utmost importance when using qualitative methods. Appendix F contains a copy 
of the ethical approval for this study that vvas issued by Memorial ni\'ersity of NL · s 
!Iuman lnYestigation Committee (I II C). Appendices A, B. and C contain the supporting 
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documentation that contains the approved test that was used to invite organizations to 
participate in the study, study information, and consent. Prior to the interviews, 
participants were emailed a list of interview questions, study information, and consent 
forms. At the time of the interview, these documents were verbally reviewed and the 
purpose of the study, and potential harms and benetits were reviewed. This study was 
also approved by the health authority's Research Proposal Approval Committee (RP AC). 
Appendix G contains the completed RP AC application form and the correspondence 
regarding the approval of this application. 
As previously described, conducting research in small communities requires 
special ethical considerations when (Benoit eta!., 2005; Fraser, 2004). Given the 
sensitive subject matter, legal compliance issues, and the challenges of confidentiality in 
small communities, my main ethical concern was about protecting the confidentiality of 
the organizations and the participants. This became evident as I was collecting my data 
and I realized that, at times, discreet practices may not have been in total compliance 
with the provincial legislative requirements of the Communicable Diseases Act. The term 
discreet is used to describe the availability of implicit anonymous testing at testing sites 
#3 and #4, but it is emphasized that non-nominal testing was the official standard of 
practice according to policy documents and reports from participants. The term discreet 
was chosen to reflect provider descriptions that suggested procedures that fit the 
definitions of anonymous were informally employed if necessary. These procedures 
included advertizing testing as no names, testing with a fake name, testing with no name 
if necessary, testing with a first name and last initial. reporting with codes instead of 
names, incomplete lCP information on provinc ial surveillance reports, limited 
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geographic information in provincial surveillance reports, referrals to acute care settings 
when they were operational using a non-nominal code, chart number, or initials. 
After consulting with a medical ethicist within the Division of Community Health 
and Humanities who had encountered similar issues in write-up and analysis and my 
supervisory committee, we decided that care must be taken to protect the identity of the 
participants to prevent any professional or personal harm that could potentially result. As 
such, I have deleted specific details about the nature of operations at either site and 
removed organizational identifiers. Participating organizations are referred to as simply 
community-based organizations and the regional health authority. The individual testing 
sites are described as testing site #1, #2, #3, and #4 and, where possible, I have 
eliminated details that would disclose the locations of the testing sites. To protect the 
identities of individual participants I have attempted to remove identifying information 
about individual participants such as their job title and the specific number of participants 
from each testing site who were interviewed. Oftentimes, direct quotations were edited or 
a de-identified version is presented according to the specified notation. Additionally, 
personal communications are referenced with initials and limited information about the 
date of the correspondence. At times, citations that reveal the name of the participating 
organization have been altered. This was especially important in this study since, at 
times, individual participants expressed personal views that did not reflect those of their 
organization or compliance with the law. 
Furthermore, it is necessary to declare two potential contlicts of interest as ethical 
considerations of this study. Firstly, I \Vas a volunteer at one of the testing sites prior to 
and for some of the study duration. Before starting data collection. I realized that I would 
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be playing a dual role by undertaking a formal research inquiry at an organization where I 
was also a volunteer. As such, I took steps to create boundaries before starting the study. 
For example, I advised the staff with whom I had previously volunteered that any 
correspondence from my Memorial University email account would be considered formal 
and could be included as part of the study findings. I minimized my volunteering hours 
and involvement with the organization throughout the duration of data collection, 
analysis and write-up. 
Throughout the duration of the study, I was offered oftice space. gifts. and asked 
to serve on the Board of Directors of one of the community-based organizations. I 
consulted a different medical ethicist on this matter and declined o!Ters until such time as 
this document vvas approved by external reviewers. Secondly, I accepted a paid position 
with an organization that was participating in the study during the data collection period. 
The position was with a Human Resources department and unrelated to the clinical nature 
ofthis inquiry. 
At the outset of the study I planned on transcribing the interviews myself. Due to 
the length of the interviews and the time required for transcription, I decided to enlist the 
support of a professional transcriber. To verify this change with the university's ethics 
board, I submitted a Request for Amendment to an Approved Application form. This 
amendment application also requested a change in the title of the study to protect 
participant's identity. 
The sequence of the following dates that preceded the last reported update to the 
draft document is notc\\'orthy. The health authority's RPAC granted permission for my 
study on March 3rd. 2009 (Appendix G). The study invitation (Appendix J\) \\ as emailcd 
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to the public health division on March 26111, 2009. At the time of the document review, the 
last revision to the draft policy (Document E3) was on March 31 5\ 2009. This meant that 
revisions to this draft policy had been made after the organization had reviewed the study 
information and were ongoing throughout the duration of data collection. This was 
significant for two reasons. The version of the draft policy that was included in the 
document review could be significantly outdated by the time of publication. Also, 
revisions to the policy that were made after the study invitation had been received may 
have been influenced by the information provided in the study invitation or study 
information sheet. 
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4.0 Findings 
The first section of this chapter provides an overview of the three organizations 
responsible for the four testing sites and a description of individual participants' 
perceptions of testing and risk. This is followed by a summary of the results of the 
document review and formalized definitions of HIV testing that were revealed. An 
overview of past and current HIV testing procedures at the four testing sites is provided, 
as well as concerns expressed by participants about these procedures. The final section 
summarizes key areas of incongruence between policy and practice. 
These findings are based on analysis of document review resources, individual 
interviews, thematic analysis, and my reflexive journal. It is important to note that, at 
times, participants expressed their personal views, which may not have been 
representative of their organization. These findings are presented to minimize readers' 
ability to identify the four testing sites and the participants. Everyone who participated in 
this inquiry contributed to knowledge production and I expect that we will benefit 
differently from this experience. 
References to documents included in the document review are depicted in 
Appendix D. Documents labeled 'A ', 'C ' , and ' E' are classified as current documents and 
documents labeled 'B', ' D' , and ' F' are historical documents. In many places, verbatim 
quotations from interview transcripts have been condensed to present the parts of speech 
most relevant to the discussion. Deletions of text are represented by · . .. · ; emotions, body 
language, or other nonverbal cues that vvere understood between the interviewer and the 
participant are indicated by descriptions of the actions in parcnthcsi ·; finally. square 
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brackets are used where verbatim quotations have been altered to protect the identities of 
participants and/or other organizational employees or affiliates. Testing sites are referred 
to as testing sites # 1, #2, #3 and #4 to protect their identity. 
4.1 Organizational Information and Definitions 
4.1.1 Community-based Organization # 1 
Organization #1 defined itself as a "non-profit, charitable organization that 
promotes positive sexual health across the province". It was a pro-choice sexual health 
centre whose vision was "a province where all people experience positive sexual health" 
(Document 88). Its mission was "to promote positive sexual health through education, 
community partnerships, information and services within an environment that supports 
and respects individual choice" (Document 88). 
This document review revealed 15 documents that were related to HIV testing, 
eight of which were historical and seven of which were current. Of the 15 documents, 
nine were for education, prevention and/or awareness; three were clinical; and three were 
policy-related. Appendix D demonstrates the organization's document trees (p. 1-2). 
Analysis of document review resources did not reveal formal definitions for the three 
types of HIV testing; however, document 82 provided an explanation of confidential and 
anonymous testing processes and offered brief explanations of each, 
HIV and Hepatitis 8&C can be detected by a simple blood test. i\ doctor 
' ill give you a slip to ha,·e blood drawn at the hospital , or may dra\ the 
blood at his/her office. This testing is confidential. meaning that your 
1CP number and name will be attached to your tile. If you arc interested 
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in anonymous testing having no identifying information contact your local 
Health and Community Services Office. (Document B2) 
4.1.2 Community-based Organization #2 
Organization #2 believed in and encouraged "social and political advocacy to 
ensure individual and collective rights to non-judgmental education and support, thus 
encouraging responsible decision-making and personal empowerment" (Organization 
#2's website, 2009). Its vision was to be a "consumer-focused, non-profit organization" 
that provided supportive programs and services aimed at preventing HIV I AIDS and 
supported persons living with and affected by HIV I AIDS. Its mission was to "prevent the 
spread of new infection through education, provide support to those individuals already 
infected/affected, network with other groups working in AIDS related areas on a regional, 
provincial, national and international level, and advocate for social and political change". 
At organization #2, clients could access educational material, harm reduction services 
and a common area to lounge in while waiting to access services. 
Appendix D demonstrates the organization's document trees (p. 3 - 4). This 
document review revealed 40 documents that were related to HIV testing, six were 
historical and 34 were current. Of the 40 documents, 36 were for education, prevention 
and/or awareness and four were policy related. The lack of clinical documents reflected 
the fact that no clinical services were offered on-site at the time of the study. Analysis of 
document review resources revealed that this organization had formalized definitions for 
the three types of HIV tests in document C3. The dcJinitions are stated below. 
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Nominal testing - the identity of the individual being tested is clearly 
known by the tester as well as the lab testing the sample. The individual's 
name appears on the testing requisition and result. 
Non-nominal testing - the identity of the individual being tested is 
shielded by a code used by the testing clinic. The code is attached to the 
test requisition and test results. However, an individual can ultimately be 
traced to a test result. The identity of the individual may be known by the 
testing clinic. 
Anonymous testing - the identity of the individual being tested is known 
only to the individual herself/himself. No record is kept which can connect 
the individual's identity with the test requisition or result. Requires a 
completely independent fi ling system (Document C3, p.1 ). 
4. 1.3 Regional Health Authority 
The regional health authority served a regional population of more than 293,790 
people and was the largest integrated health authority in Newfoundland and Labrador. Its 
vision was for "Healthy People, Healthy Communities" and its mi sion was to "provide 
health and community services along an integrated continuum within both its regional 
and provincial mandates and available resources to improve the health of people and 
communities .. (organizational document). Participants indicated that there \\as ne\-cr a 
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charge for HIV testing services provided by the Community Services division at any of 
its testing sites. 
Appendix D demonstrates the organization's document trees (p. 5-6). This 
document review revealed eight documents that were related to HIV testing, three were 
historical and five were current. Of the eight documents, three were legislative acts and 
five were policy-related. Of the policy-related documents, two were internal documents 
that outlined specific clinical procedures for staff, two were HIV statistical epidemiology 
updates published by PHAC in 2005 and 2007, and one was the Canadian Guidelines on 
Sexually Transmitted Infections (Document E5) published by PHAC. Analysis of 
document review resources revealed that this organization had formalized definitions for 
the three types of HIV tests in document E3, which are stated here, 
Nominal -The correct name and other identifying information (such as 
MCP number) is used on laboratory requisitions and patient record. Face 
to face Pre-test and Post-test counselling is undertaken as an essential 
standard of care (Document E3, p. 7). 
Non-Nominal - Initials or a false name or an alphanumeric code are used 
instead of a name on a laboratory requisition, but the patient record, a 
confidential document, contains the true identification and contact 
information (e.g. telephone number, address). Face to face Pre-test and 
Post-test counselling is undertaken as an essential standard of care 
(Document E3. p. 6-7). 
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Anonymous - Initials or a false name or an alphanumeric code are used 
instead of a name both on a laboratory requisition and on any patient 
record. There is no address or contact information recorded that could lead 
to the identification or location of the individual presenting for testing. 
Face to face Pre-test and Post-test counselling is undertaken as an essential 
standard of care (Document E3, p. 6). 
It is important to note that the regional health authority's policies and procedures 
that were reviewed pertained to community settings only. The findings do not apply in 
acute settings or to the practices of family physicians who might otherwise be affiliated 
with the health authority. The regional health authority's policies and procedures 
described were in effect at testing sites #3 and #4. 
4.1.4 Perceptions of Testing: " ... whatever you want to call it ... " 
The interviews revealed that the meanings and procedural differences between 
non-nominal and anonymous have been vague for quite some time. The terms non-
nominal and anonymous were and are often used interchangeably. Participants at all four 
testing sites reported having referred to a process in the past as anonymous that was, 
technically, non-nominal. During the interviews, participants were asked to explain their 
understanding of the three types of testing. This section provides a summary of the 
participants' understandings of non-nominal and anonymous testing, as well as a 
summary of the reported commonalities, shared understandings and perceived advantages 
and disadvantages. 
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To illustrate the context in which these conversations occurred, it is necessary to 
point out that participants unanimously agreed that HIV was a highly stigmatized 
condition and this impacted people's behaviour when seeking testing. They believed that 
in a truly anonymous test there is no possible way for an outside agency to link this code 
to the individual or obtain the result. Similarly, there was a common understanding that 
with anonymous testing the onus to return for the test results was entirely on the test 
seeker. The results were delivered to the test seeker when he or she returned in person 
with the code from the initial visit to obtain the results. 
Beyond these shared understandings, there were three distinct understandings of 
anonymous testing. Procedures used for blood drawing, code sharing, results delivery, 
partner notification and reporting were key points of distinction between how five out of 
seven participants understood anonymous testing. Five out of seven participants 
described anonymous testing as a process in which there was a face-to-face exchange 
between the test seeker and a healthcare service provider. They understood that personal 
identifying information would never be requested, collected, or recorded. These 
participants felt that it was acceptable for the healthcare provider to ask about the client ' s 
sexual history during pre-test counselling. Similarly, these participants believed that the 
healthcare provider who administered the test was responsible for delivering pre- and 
post-test counselling. They accepted and understood the use of initials or other forms of 
representative association with personal information to generate a non-identifying and/or 
alphanumeric code. This code was then used to label the specimen when it was sent to the 
laboratory. Participants \Vho shared this perception of anonymous testing felt that it could 
be set-up relatively easily in this small urban centre. Of the live participants who shared 
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this definition, four of them described a reporting process that reported aggregate, de-
identified statistical information on occurrences of positive cases. One of these five 
participants felt that there should be no reporting component associated with anonymous 
testing. 
The first of the two remaining participants had many concerns about offering 
anonymous testing. This participant described anonymous testing as an entirely faceless 
procedure for drawing blood during which there was no guarantee of pre- or post-test 
counselling and there was no human contact when results were delivered. This participant 
envisioned that blood was drawn when the test seeker stuck his or her arm through a 
curtain. The code would be generated by the test seeker who would write the code on 
paper and handed it through the curtain. The participant shared the belief that the onus 
was on the test seeker to return for the result. The participant believed that anonymous 
testing results were communicated using a posting method whereby results were posted 
on a wall and accessed when the person who had been tested returned to match their code 
to the posted result. In this way, there was no post-test counselling available at the time 
the result was delivered and no partner notification. This participant did not support the 
availability of this type of anonymous testing in the small urban centre and said there 
were three potential complications with this. Firstly, if someone came back with the non-
identifying code or number, there was no way of knowing that it was the same person 
whose blood had been drawn since there was no identifying information to contirm this. 
Secondly, when people received their results from a posting of a code on a wall, there 
was no one there to counsel them. Thirdly. because there was no chart attached to the test 
it would be difficult to keep track of the services the indi\·idual recei\'es over time. 
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Lastly, a participant who felt there was an urgent need for anonymous testing 
defined the processes used for code generation and sharing during anonymous testing 
differently than any other participant. This participant understood anonymous testing as a 
type of test where only the test seeker knew the code with which the test was labeled or 
saw the results. The healthcare provider would never see the code, rather the test seeker 
would write the code on the specimen before it was sent for testing. This participant 
explained that their personal understandings of anonymous and non-nominal had 
changed. Despite having called it anonymous in the past, the participant felt, in hindsight, 
it was better described as a non-nominal process despite the absence of any requests for 
or recording of personal and/or identifying information. The participant's explanation of 
this shift in understanding demonstrated a unique perception of the meaning of 
anonymous testing. 
The participant described a process in which no personal information was 
requested or recorded at intake as non-nominal. The participant made this distinction on 
three grounds; first, on the basis that the code that was used to label the test was shared 
with the nurse; second, that the nurse saw the results before the client; and third; because 
positive test results had been reported to public health without any names attached. This 
does not fit with the technical definitions provided by other testing sites which suggest 
that non-nominal testing requires some attempt to record the true identification and 
contact information of the client. According to these detinitions, the di rrerence bet\VCCn 
non-nominal and anonymous testing is not merely the sharing of a code; rather \Vhcther 
or not contact information \vas obtained \Vith the intention of contacting the indi idual to 
follow-up on the results. The participant \\ent on to describe a procedure for drawing 
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blood that was similar to the first five participants', but described a process for accessing 
the results whereby the test seeker's code and accompanying result were posted on a 
wall. Only the test seeker knew the code and he or she would be entirely responsible for 
coming to check the result. It is important to note that this participant believed that the 
records of a person who had been tested could be accessed by third parties and linked by 
MCP number, 
HIV is a condition that the insurance companies don't want to cover. So, 
hence, the urgent need for anonymous or non-nominal, whatever you ' re 
going to call it, but it has to be ensured, that the person whose health 
information is this HIV result, that the name is never connected to that file 
because if I go in to the insurance company and I lie and say - "Well, if I 
say yes (I have been tested for HIV) they won't insure me," right, "but if I 
say ifl say no they' ll never know- but if I had had a test through my 
doctor's office, or through the health care system using my MCP card, that 
could be traced because it's in the system, right? And then the insurance 
company will swab your cheek anyway and test for HIV. 
This participant was challenged to find a solution to delivering post-test 
counselling with a system that used a wall posting to deliver results and felt it is 
dangerous for people who are positive. The participant specified that, preferably, the list 
would be posted in a healthcare facility, 
with anonymous you would put a code on something, and not even tell the 
person drawing your blood, and the results \Vould then be posted after 
such a period of time, and you would go and look and say, ·'Okay, there's 
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Mary" ... "Little Miss Muffett or 'x', "y,' 'z,' l, 2, 3, that's me," and 
nobody knows that but you because you wrote it on there. And the 
problem with that is what if you freak out and walk away and you don' t 
get your post-test counselling, right? 
Despite feeling that there was an urgent need for anonymous testing, this 
participant felt the posting process to obtain results was potentially dangerous for people 
who received positive results. The participant expressed strong beliefs about the human 
contact and sensitivity required to deliver results in a way that was best for the individual 
receiving them and would prefer a system in which positive cases were reported to public 
health officials and partners were notified voluntarily by the individual. This participant 
eventually summarized by saying that the defining aspect of anonymous testing was the 
inability to link any evidence that an individual had ever been tested from HIV from his 
or her permanent medical records. The participant later clarified that the importance of 
this was associated with the benefits it would have for people whose test results came 
back negative because it would allow them to maintain confidence that other areas of 
their lives would not be negatively impacted. For example, they would be able to 
continue to respond negatively to questions on insurance forms asking if they have even 
been tested for HIY. 
There were some notable differences in the way participants from community-
based organizations and the regional health authority understood anonymous and non-
nominal testing. Participants from community-based organizations were more likely to 
demonstrate strong support for anonymous testing and felt that widespread access to this 
service was urgently needed. This urgent suppmi for anonymous testing persisted despite 
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a range of differing perceptions about anonymous testing and even uncertainties about 
how certain aspects of anonymous testing could or should work. These participants 
suggested offering anonymous testing would facilitate access to preventative HIV 
services in two ways; firstly, by using a non-technical term that would be understood by 
people and, secondly, by relieving stress associated with fulfilling the information 
requirements in nominal and non-nominal tests. This stress was largely related to fear of 
third parties - people or organizations - finding out about the test. Three participants from 
community-based organizations reported that they would go out of province to seek HIV 
testing because they did not trust the current system to keep results private and 
confidential. 
Other participants acknowledged the need to increase the number of locations and 
times during which STI testing was available, but felt the current manner in which testing 
was delivered offered an adequate degree of protection for a person's identity. When it 
came to out-of-province testing, many participants from the regional health authority felt 
the current system was trustworthy and should not require that people to leave NL to get 
tested. They did acknowledge, however, that some individuals seeking testing were less 
than forthcoming about personal information or had distrust in the system. These 
participants reported varying degrees of support for anonymous testing depending on 
their definition and understanding of anonymous testing. The range of opinions expressed 
by participants demonstrated that some were against anonymous testing, others thought 
the current system was fine , and others thought that increased avai lability of anonymous 
test ing could benctit some people. 
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At various times in the interviews, participants whose experience was largely 
within formalized public health settings described clinical practices that supported and 
reflected the principles of harm reduction without using the term harm reduction. This 
supports previous studies in the region that determined providers had varied and 
inconsistent understandings of harm reduction concepts (HRU & ACNL, 2007). It could 
also mirror a philosophical understanding ofHIV testing as merely a service that is not 
necessarily a harm reduction approach. Some examples of everyday practices that were 
geared towards making the HIV testing services accessible for everyone included 
allowing testing with a fake name, testing with no name, testing with a first name and last 
initial, reporting with codes instead of names, withholding MCP information from 
provincial surveillance reports, and providing limited geographic information in 
provincial surveillance reports. For example, one participant following a non-nominal 
procedure saw no reason to change the way testing was delivered, but reported a 
willingness to test people regardless of what personal information they were willing to 
provide. Finally, one participant believed that anonymous testing would encourage 
people to be tested, could be set up quite easily, and would attract people who engaged in 
risky behaviours. 
Several perceived disadvantages of offering anonymous testing included the 
possibility oftest seekers not returning to obtain results, the limited ability to do contact 
tracing, and the potential for coding confusion. One participant identified the worst case 
scenario in terms of protecting the public' s health whereby public health officials would 
be unable to contact a positive individual responsible for transmitting the disease to 
someone else. 
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4.1.5 Perceptions of Risk: '· ... some of these people need to be tested regularly ... " 
Participants from all four sites acknowledged the concept of risk and the real ity 
that engaging in certain behaviour places people at an elevated risk of contracting HIV 
and other blood borne diseases. They acknowledged the importance of providing 
specialized services for people who engaged in risky activities. Participants believed that 
a type of testing that is called "anonymous" would encourage people to get tested who 
might not otherwise. All participants recognized the need to incorporate a discussion 
about risk into face-to-face pre-test counselling in a skilful way. Many participants 
believed there was a relationship between an individual's desire to be tested anonymously 
and their tendency to engage in risky behaviour and/or their exposure to other negative 
psycho-social circumstance. Examples of risky behaviours that were cited by participants 
included unprotected sex, sex for money, injection drug use, sharing of drug 
paraphernalia. Financial instability and low literacy levels were the two most commonly 
cited examples of negative psycho-social circumstances cited by participants. 
Participants used the term "repeat customers" to describe test-seekers who 
repeatedly engaged in risk-taking behaviours. They described the differences in pre-test 
counselling styles as well as the frequency bet'vveen tests required for test seekers who 
showed no desire to make behavioural changes that would reduce their involvement in 
health damaging activities. This was different than the cases in which a test seeker 
required a one-time only test after an isolated incident or as a prevcntati\·e course of 
action. One participant 'vvas concerned that frequent access to anonymous testing would 
be used as a \vay to gauge exposure to risk and result in continuall unsafe practices 
'' ithout making any effort to reduce risky acti,·itics or encourage bcha,·ioural changes. 
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For this reason, this participant thought that anonymous testing should be made available 
in the small urban centre, "not widely" but " for a small number of people". 
4.2 Testing Site # 1 
Thematic analysis based on the document review and individual interviews 
suggested that testing site # 1 was following a nominal testing procedure in which testing 
was done off-site. 
4.2.1 Current Testing Procedures 
Documents AS and A7 were particularly helpful in demonstrating the policy at the 
time of the document review. This information was supplemented with information 
provided by participants to create a detailed account of the procedures employed at this 
site. 
Document A7, entitled [Testing site #1} Policy Manual, was written for staff and 
volunteers. It was classified as current and policy-related and is referred to here as the 
policy manual. It was an 86-page document containing 29 separate sections. One hard 
copy of the policy manual was stored in a binder on a shelf and was distributed to staff 
and volunteers upon request. Staff had received electronic copies of the policy manual via 
email. As a result , the electronic copies of the document were stored on full-time 
employees' desktop computers at their workstations. The version of the document I 
received was in usc at the time of the study, but also under revision. This revision began 
in September 2008 and \\'as still ongoing in February 1009. Staff updated the document 
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as needed. In the event of a significant change to the contents of the policy manual, the 
updated electronic version would be sent to staff via email and discussed as necessary. 
Section 23 of document A 7 outlined Clinic Procedures and Guidelines, which 
described polices for confidentiality, professional obligation, chart recordings, hormonal 
contraceptives, test results, incident reports, disposal of urine samples, clients and MCP 
numbers and harassing telephone calls. Staff and volunteers were instructed to follow 
these policies at all times, for all clients, and all STI tests unless otherwise noted. The 
following sub-sections of the document were most relevant to HIV testing -
confidentiality, chart recordings, test results, clients and MCP numbers. Statements that 
were specific to blood work results outlined HIV testing policies, since HIV was one of 
the few tests offered at the testing site that required a blood test. 
Section 23.1 Confidentiality 
• All client documents will be stored in cabinets. Client charts are not to be 
left in a public area. 
• No client information can be released without the clients consent. In order 
for information to be released, clients must sign a "Consent to Release 
Information" form. 
• Only one file will be maintained for each client. 
• All clients will sign a confidentiality agreement when visiting the centre 
for physician care. 
• taiT and , ·oluntecrs shall avoid unnecessary corwersation regarding 
clients and must refrain from talking about clients in front of other cl ients 
and volunteers. 
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• Staff and volunteers must verify clients MCP number before releasing test 
results to a client via the phone and/or in person. (Document A 7) 
Section 23.3 Chart Recordings 
• All conversations and visits with clients will be documented in client 
charts in ink with date and signature. 
• Staff is responsible for ensuring that test results are promptly recorded in 
the Test Results Binder and that necessary referrals are made to other 
health care professionals when needed. 
• The Client Services Coordinator is responsible for ensuring that test 
results are promptly recorded in the Test Results Binder and that necessary 
referrals are made to other health care professionals when needed. 
• Inactive client charts will be house at [Testing site# 1] for 10 years starting 
from the date of the last visit. However, if the patient is not 18 years of age 
at the time, the 10 years does not start until they turn 18. (Document A 7) 
Section 23.5 Test Results 
• The treating physician must sign test results before they can be provided to 
clients 
• Blood test results are to be provided to a client by the physician only when 
the test results arc positive. When the results are negati\·e, the nurse can 
provide test results. No blood test results can be given onr the phone 
by taff or volunteers. [emphasis in originall 
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• Pap test results and other STI screening results can be provided to clients 
by telephone, or in person; only after the client provides his/her MCP 
number for identification.(Document A 7) 
Section 23.8 Clients and MCP Numbers 
• If someone does not have access to their MCP number, due to 
whatever reason, they can: 
1. Provide Family Doctor's Name and [Testing site #1] can contact them 
for it (or check with their guidance counselor. .. etc); 
2. Go Online at www.gov.nl.ca/mcp and fill out a form for MCP care 
replacement and a card will be sent to them; or 
3. Go directly to 57 Margaret's Place [Office where MCP applications 
are processed], off Newtown Road, and fill out a form in the office and 
a card will be produced on the spot. ID must be produced, and there is 
no fee. 
• [Testing site # 1] will not take any clients who do not have a MCP 
Number or Provincial Health Card, unless they pay fee for service. A 
doctor will not be asked to take clients and not be paid for this visit. If 
a decision is made to do this [Testing site # 1] will pay this expense, so 
please consider how serious or necessary you think this appointment is 
beforehand (Document A 7). 
As outlined in section 23.2, staff and volunteers had access to client charts to 
record conversations, visits and update contact information. Participants confirmed that 
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client charts were filed alphabetically using a three-letter filing system in a filing cabinet 
at the front desk. They also reported that any client chart over five years old was moved 
to a different area. Security measures, such as locks on the filing cabinets, or a 
destruction plan for client charts were not discussed. Conversations about file access led 
to discussions about the orientation and training that staff and volunteers receive. The 
volunteer manual was Section 28 of document A 7. While I did not receive a verbatim 
copy of the volunteer manual, a participant described the training process . 
. . . there's a two-day training- voluntary training course - that we 
undertake with them, so it's ... but that deals with a lot of, you know, 
different aspects of our operations. They also shadow experienced 
volunteers and staff, so before they're left on the desk to answer phone 
calls, they shadow. The staff are also trained, you know, pretty much the 
same way. You know there's the training manual. .. Yeah, and then they're 
also encouraged to just sort of keep reading that. Read the pamphlets; and 
if they ever have any questions, we encourage them to speak to us ... And 
every now and then, you know, we'll see them make a mistake. In which 
case, we ' ll type up a little memo for everyone to read just so that everyone 
can learn by everyone's mistakes. 
Participants confirmed that referrals for tests requiring blood work were written 
by one of the physicians working in the clinic. There were multiple physicians and nurses 
who shared the responsibility of operating the clinic, which according to document i\4 
(Services and Resources) ran from 9:00a.m. to 5:00p.m. on Monday, Tuesday and 
Friday; 12 p.m. to 8:00 p.m. on Thursday. and 12 p.m. to 5:00p.m. on Wednesday. As 
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mentioned in Section 23.3 of document A 7, there was a "Test Results Binder" (p. 42). 
This process was explained by a participant, who referred to the "Test Results Binder" as 
the "Test Tracking Log", 
So whenever a piece of paper comes on it from laboratory services, [name 
of employee] dates it, gives it to the doctors and they sign off on it. They 
either tell [name of employee] to call back that person (to book a follow-
up appointment time) or to file it away. So, you know, there's not a result 
that comes in here without a doctor looking at it.. . ... At the end of clinic, 
[name of employee] will look at the file and see what tests were ordered 
for the test tracking log. [Name of employee] has to know what was 
ordered so [he I she] can keep an eye on it and make sure we get the 
results back ...... If we don' t get the results back, [name of employee] can 
contact the person and say, "Hey, did you go get that requisition filled?' 
"Yes" or "No," okay. If we haven' t got the results back yet, [name of 
employee] calls the lab; gets the lab to send them over. Because 
sometimes the lab will send them to one our physicians' offices, not us. 
Which is kind of a pain in the butt, but that 's why we have a test tracking 
log. 
To summarize, the process of monitoring test results and recording which tests 
had been received in the binder involved one employee. This employee looked at the 
physic ians' and nurses' records at the end of each clinic. took note of which laboratory 
tests were ordered that day, and entered them into the test tracking log. The employee 
used this information to identify tests that remained outstanding if results had not been 
~~~~~~~~~~~~~~~~-~-~~~--~· ----
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received after a certain period of time. When this happened, the employee would pull the 
client chart, contact the client, and inquire about the status of the test for which they had 
been referred. If the client reported having already had the test, the employee would then 
call the laboratory to inquire about its location, and request that it be sent to the testing 
site. If the client reported that they had not had the test, the employee would then 
encourage them to do so. 
Section 23.5 of document A 7 confirmed that positive test results were to be 
delivered by the physicians and negative results may be delivered by a nurse practitioner 
or a physician. No blood test results were to be given over the phone by staff or 
volunteers. Participants clarified that blood test results were to be delivered in person, 
which eliminated the possibility of delivering them via any other form of one-way 
communication, such as email or post. When a laboratory test result was returned to the 
testing site, it was first received by the employee who was responsible for the test 
tracking log and then given to the clinic physicians. Depending on the result, the 
physician who had reviewed the blood work may request the employee contact that 
person for a return appointment. 
At times, people called testing site# I to inquire about results and became upset 
when they will not be given results over the phone. A participant describes how such 
inquires were handled. 
If someone calls in and wants to know if their test results arc back, we ' II 
look ... Oh yeah, you had that blood taken on so and so date. Perfect, yeah, 
v>e got them back so you want to make an appointment.·· . .. And sometimes 
people ask, .. Why can't you tell me the results over the phone. and we say, 
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"Really sorry, but regardless if you have a positive or a negative result, 
you were told when you came in that you have to get the results back 
from, you know, a general practitioner." Sometimes they'll get mad; but, 
you know, it's just like - "You know what, I'm really sorry; I can't tell 
you anything further." Ifyou go to any other office, and if they're at all on 
the ball, they'll tell you the same thing because if we just said to people, 
"Oh, you don't have to worry about that; you don't need to come in," We 
can't say that for a negative result because what if the day comes where 
we're like, "No, you got to make an appointment." We stick to the same 
rules - no matter what. 
Section 23.8 of document A7 also addressed what to do when a client did not 
have an MCP number. The policy asked employees to consider the negative financial 
impact on the organization when a client is unable to pay for an appointment. While it did 
not explicitly state that employees were to refuse services to someone without an MCP 
number, participants confirmed that its staff and volunteers would not make an 
appointment in its clinic for any client who did not provide the personal information 
requested on the intake sheet. When asked about what would happen if a client was 
hesitant about providing personal information a participant described a scenario where 
an individual would be refused service: 
Interviewer: What would happen if a person came refusing to give 
information? 
Participant: ··sorry ... (shakes head. shrugs shoulders) 
lntcrvie\\'er: You have to say no and send them away? 
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Participant: (Nods) 
The participant reported several reasons for following this procedure. Firstly, 
physicians in the clinic were bound by the Communicable Disease legislation and they 
feared that any violation of that legislation would result in the operation of the clinic 
being shut down. The loss of the clinic would mean a loss of essential revenue that the 
organization rel ied on to pay the overhead of the testing site building. Secondly, they did 
not have the resources to fund and administer anonymous testing. 
We can only function here as a clinic because our doctors pay our 
overhead fees ... Our doctors get paid by MCP. They're not paid by any 
program, any study .. .I mean, government funded and, you know ... so it's 
not fair for our doctors to provide a service after going to school for so 
many years and using our clinic's supplies, you know ... I'd love to be able 
to do it. .. But it's not possible, and on top of that, we don't have the 
means to deal with anonymous testing .... We don't have someone here to 
keep track of codes or to, you know, put a confidentiality code on a lab 
result. We can't, so we just don't have the means for it here. I would love 
it - love it if we did. 
Since the policies described above were 'vvritten for employees and volunteers, it 
was helpful to consult documents that articulated testing procedures from a clients' 
perspective. Document AS, entitled Intake Sheet, was classified in the documentary 
analysis as current and clinical. The document was last updated in February 2009. Prior 
to that, the same intake sheet had been in use since 2004 (Document B6). During the 
document review. the employees noted inaccuracies in the 2004 version of the intake 
------------------------------------------------------------- ------
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sheet. As a result, the intake sheet was updated during the course of the document review. 
The blank electronic version of the form was stored on the employee's computer who 
was responsible for updating as needed. The Executive Director's approval was required 
before reprinting the revised versions at the end of the update process. Blank hard copies 
of the intake sheets were stored in a drawer at the front desk. 
Document AS required clients to provide the following information - personal 
information, medical coverage information, medical information, history of sexual 
activity, STI risk factors, and reproductive history. It also contained a confidentiality 
policy and contact instruction agreement for the client to sign. There was space for office 
use to record visit dates and clinic notes. Upon arrival, clients were required to fill out an 
intake sheet. Participants reported that whenever this form was distributed, clients were 
verbally advised that the form was entirely optional and that name, birth date and phone 
number were the most important pieces of information. Both the historical and current 
versions of this form made it clear that it was the client's responsibility to initiate contact 
required to check on test results. Participants also reported that a number of efforts were 
taken to ensure that clients knew it was their responsibility to return to obtain the results 
of their blood work, such as verbal instructions from staff and volunteers and reminder 
signs posted in the waiting areas. Participants confirmed that this testing site had never 
been required to deliver a positive HIV test result and described the process that might 
happen if they were required to do so based on their experience with other positive blood 
test results. 
Participant: And I think that maybe, you know, if a posit ive (HIV test) 
result came back, we"d probably call that person and say, .. 1 li ,"' you knovv, 
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"your test results are back. So if you want to make an appointment", but 
that's really up to the doctor's discretion because our policy is, and people 
know, that when they're getting blood drawn that they are responsible for 
getting, you know, their results back. 
Interviewer: Is that made clear? 
Participant: Oh, it's very clear. Verbally, in signs, in the confidentiality 
agreement- you know, we can' t tell people enough that they have to make 
the appointment. If. . . you know, and a lot of people don't get their blood 
work done, you know, so [name of employee] is always calling up people, 
you know- "Did you get that done?" "No." "Okay, perfect, just want to 
know so [he I she] can write in my book saying 'not completed'." Because 
we keep track of every single blood test that. .. well, we keep track of 
every single test that is ordered by the doctors so ... 
When completed, the intake sheets were used to start or update a file on the client. 
The intake sheets were placed in the client charts and stored using the procedures that 
were described earlier. Client charts could be accessed by all staff and volunteers. 
4.2.2 Past Testing Procedures 
The document review revealed that testing site # 1 had offered anonymous testing 
in the past. Four documents were helpful in understanding past practices and their 
lingering effects; document 87, Policiesfor H!V Testing at [,Vame (~ftesting site}, 
document 81 ST!s and Your Relationship, document A2 The 5 W 's (~lSTI Testing; and 
document 82 When am/ H'here to gettl!stedjhr ST!s. 
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Document 87 was classified as historical and policy-related. Participants 
estimated that it had been created in 2004 and had last been accessed in 2005. Jt outlined 
policies pertaining to anonymous testing when on-site anonymous testing had been 
offered through a partnership with a private organization. It was unclear if the 2004 
arrangement was also part of a study or if the private organization offering the 
anonymous testing was separate from studies described by participants. The following 
excerpts from Document 87 demonstrate the process that was used for anonymous 
testing, "if the client wishes to have anonymous testing, then the requisition will not be 
used" (p. 1 ), and 
On-site HIV testing is available at the office of [name of testing site # l] on 
Thursday evenings from 5:30pm -7:30pm. [Name of private 
organization] will be providing [name of testing site #I] with an on-site 
nurse to complete the blood draw and counselling. (Document 87 p. 1) 
Prior to initiating the test, clients will be informed that if the result comes 
back positive for HIV, the nurse will ask the client for his/her name, 
names of previous and current partners for purposes of contact tracing, and 
information on where to seek medical attention. The nurse will practice 
due diligence in obtaining this information and assure clients that this 
information is confidential. All information will be reported to the 
Medical Officer of health. If names are not provided, all other information 
will be forwarded to the Medical Officer of I Icalth 
(Document 87, p. 2). 
[Testing site# 1], staff, board, volunteers, or physicians will not be held 
responsible for files maintained solely by [Private organization] and 
overseen by [name of physician)" (Document B7, p.8) 
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When this was offered, clients could be tested on-site or they could obtain a 
referral for blood work. If the client wished to have anonymous testing, a requisition form 
would not be used and the blood would be drawn on site. Document B7 outlined pre and 
post-test counselling requirements for anonymous testing, reporting processes, and 
requirements for partner notification. It specifically stated that as part of pre-test 
counselling, the client was to be informed that if the test came back positive, the nurse 
would ask for the client's name and past partners so this information could be reported to 
the Medical Officer of Health. Document B7 absolved testing site # 1 from the 
responsibility pertaining to the files maintained by the private organization that was 
offering anonymous testing. Not all of the participants from testing site# 1 were 
employed with the organization in 2004 when this anonymous testing had been offered. 
Two historical documents in the education, prevention and awareness category 
also made reference to anonymous testing. Document B2 was an 11-page booklet that 
had last been updated in 2005. Document B 1 was a six-panel pamphlet that had last been 
updated in 2005 . Both documents were replaced in June 2007 by updated educational 
pamphlets (Documents A1 and A2). Documents B 1 and B2 no longer existed in hard 
copy and were retrieved by searching for ' Testing ' on an employee's computer. Each of 
these historical documents provided the phone number to a formal public health setting to 
call for information about anonymous testing. This was evidence that in the past inquiries 
for anonymous testing had been referred to sites operated by the regional health 
authority's Community Services division 
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Participants reported that anonymous testing had most recently been offered as 
part of a study between 2006 and late 2007. For intermittent periods during these years, 
testing site# 1 provided the space and supplies for an independent healthcare professional 
to come in and offer on-site anonymous testing. Specimens were coded and taken to a lab 
for analysis. Participants recalled that the code was generated using the date of the test 
and some form of client number; it did not require initials or birth date or any information 
that was considered remotely identifying. The healthcare professional provided pre-test 
counselling when blood was drawn and post-test counselling when the individual came 
back for the result. It was the clients' responsibility to return for their results. No 
employee of the community-based organizations ever saw the results. After the study had 
finished, people would occasionally call testing site #1 and inquire about the anonymous 
testing because they had seen an advertisement for it or they had heard about it. 
Classified in the education, prevention, and awareness category, documentAl 
was intended to provide "information regarding STis, testing and safer sexual practices". 
Hard copies of the pamphlet were displayed in the waiting room for the public to read 
and take if they wished. Bulk copies were also mailed to schools and community groups 
upon request. The electronic version was stored on an employee's computer who was 
responsible for updating the document as needed. Documents A I and A2 replaced 
documents Bland 82 around the same time or near the end of the study described by 
participants through which on-site anonymous testing had been offered. Due to the timing 
ofthc offering of anonymous testing \'vith the time of the study, some of the text in the 
document A l confirms that on-site testing had been available in the past and contains 
references to anonymous testing. 
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A [healthcare professionalJ will provide both men and women with a sl ip 
to have blood drawn to test for the following infections: HIV, Hepatitis 
B&C and Syphilis. At some clinics, they draw the blood on site, but the 
majority of the times a patient will be required to go to a hospital to have 
blood drawn. This testing is confidential. If you are interested in 
anonymous testing (no identifying information) please contact your local 
Health and Community Services office. (Document A l) 
This reference to "some clinics" likely refers to the days on which the study 
clinics were held as this was the only time blood was drawn on-site and anonymous 
testing was offered. Recognizing that this was a temporary arrangement, the pamphlet 
refers inquiries for anonymous testing to the regional health authority. 
4.2.3 Participants' Concerns: " . . . fail ing of our system ... " 
Participants reported that they would like to be able to offer on-site anonymous 
testing and felt that offering the service in the past had been beneficial. One participant 
described the absence of anonymous testing as a ·'failing of our system" that did not 
provide a .. secure" option for testing. Specific concerns expressed by participants at 
testing site# l about its current testing procedures include understandability of testing 
terminology, the inconvenience of having to go off-site to have blood dra\vn, public 
misconception about services offered at other testing sites, as \Yell a uncertainty about 
the quality and privacy of services at the sites where clients \\ere being referred. 
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Participants highlighted fears reported by their clients about being tested in a formal 
environment, as well as fear of the many potentially negative impacts of people finding 
out that he or she has been tested for HIV. They also communicated a number of reasons 
their clients provided for feeling apprehensive about seeing a family doctor about sexual 
health concerns. 
Participants preferred the term anonymous because its meaning was more easily 
understood by the general public. This was because it was used more often than a word 
like nominal, which was perceived as technical and uncommon. This was demonstrated 
by the following response to a question about the general public's understanding of the 
word nominal, 
Because that's not a term that's commonly used. I don' t even think people 
would know what nominal means. It's just one of those terms that' s not 
commonly used, so I don ' t know why people would know what it means. 
In terms of STI testing, it definitely ... you know, it just. .. it adds that 
extra level that. . . you know, anonymous is pretty standard. Even nominal 
testing, I don't think people would understand that. 
Another participant, who also explained common references to anonymous testing 
as being related to the understandability of the term, preferred the term confidential over 
nominal or non-nominal, 
Interviewer: So as fa r as calling non-nominal testing anonymous goes, 
\vhy does that happen? 
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Participant: People get the meaning. They think " it 's just non-nominal -
oh, no names!" No, no, (shakes head) .... It should all be called 
confidential HIV testing. 
Another concern was that the testing procedure in place at this testing site 
required three visits; the initial appointment to obtain the requisition to have blood drawn, 
the visit to the laboratory to have the blood drawn, and the follow-up appointment to 
receive the results. These were referred to as "stops". The inability to offer on-site testing 
required a client to make frequent stops and was regarded as a deterrent to testing. One 
participant said, 
For chlamydia or gonorrhea, they either just take a swab or sample of your 
urine and get that tested which is ... you know, it's a one stop whereas for 
HIV it's two stops; and then you have to make an appointment again to get 
the results back, so that's actually three stops, three appointments- you 
know, three stops . .. steps that you have go through in order to get it done. 
Participants reported that there were times when their own clinic was "blocked" 
and they could not possibly respond to every client given this high volume of inquiries. 
Staff and volunteers often fielded urgent phone calls requesting same-day clinical service. 
At times, people were referred to other testing sites, walk-in clinics, or their family 
physician. Pa11icipants rep011ed a number or concerns about referring people to these 
settings. 
There was a variety of concerns with another testing site in the city. For example, 
there was a perception that this particular site had capacity to sec more people than were 
being seen at the time of the study. There was also potential to be recognized at the 
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testing site. One participant voiced concerns about the gaps in the delivery of testing at 
this site because STI clinics were offered intermittently, 
I wish that it [HIV testing] was easier to get done because the way it's set 
up now, you do have to go to blood clinics except for. .. unless you want 
to go to [name of other testing site]; but apparently they're taking a break 
from it until June 191h or so. So, you know, right now there's nowhere to 
go where you're sort of on your own where you don't have to worry about 
bumping into so and so. 
Other concerns with this testing site were related to participants' beliefs that the 
public either was unaware of its services, or had a misconception about the services. One 
participant noted that many people thought anonymous testing was available at that site 
when, in reality, the official protocol was non-nominal. One participant said, "People 
think that [name of other testing site], offers anonymous - no, it's non-nominal". Another 
participant attributed the public's lack of awareness about the service to the physical 
appearance of the building, 
I think there might also be a misconception about [name of other testing 
site]. I don't think people really realize what they do there. When you look 
at the building, you wouldn't necessary think that there is a clinic in there. 
One participant believed there was a $120 fee required to be tested at a formalized 
public health setting, ' · ... if you can't afford the amount of money to pay for the test, that 
shouldn't be a problem either. There should be government-funded anonymous testing". 
Another concern about being tested at a site operated by the regional health authority was 
the perception that positive cases would be reported to the government. Part icipants 
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assumed that a positive HIV test result would automatically appeared in Meditech and 
could then be looked up by healthcare professionals. Meditech is an electronic system of 
personal health information accessible to all healthcare professionals providing clinical 
care. Participants demonstrated low levels of trust for healthcare professionals in 
formalized settings to be entrusted with confidential information. One participant 
compared the ability of employees of a community-based organization to the level of 
trust she felt for healthcare professionals in formalized settings in NL, 
... at [local formalized healthcare site], people talk. You know, people 
who work there and staff and ... I mean, at [community-based 
organization] they sign a confidentiality agreement, and are very choosey 
about the people they pick ... if [community-based organization] ever 
found out that someone told someone else about someone being here, let 
alone what their test results were, you know (shakes head). Newfoundland 
is small. 
Participants from testing site # 1 pointed out that there were many potentially 
negative effects of people becoming aware that an individual had been tested for HIV. 
These negative impacts included stigma and discrimination, negative impact on an 
individual's abi lity to obtain insurance, find a family physician, increased barriers to 
accessing future medical treatment, and restricted opp011unities for travel and 
employment. Other fears were linked to ideas about the requirements of formalized 
testing sites: for example, negatiYe associations about reporting to the province and 
mandatory partner noti lication. 
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Yeah, well then there's the implication that all the tests are confidential 
because it's within your health care system but the health care system is 
like you and everyone ... and then the health care system gets accessed by 
the insurance system: ... and then the employment system .. . and then 
everything is a big vicious web. 
Participants also confirmed that while the organization supported and encouraged 
regular visits to family physicians, they did not typically recommend family physicians as 
the client's first point of contact for HIV testing. They recognized that many clients 
accessed their services because they did not want to see their family doctor. They cited a 
number of reasons clients had stated for not wanting to see their family physician about 
sexual health concerns including "too many family connections", "uncomfortable", 
"worried what might get said to the rest of the family", or fear of not being able to get an 
appointment with their family doctor soon enough. 
4.3 Testing Site #2 
Analysis of documents and interview transcripts suggested that testing site #2 was 
directing inquires about HIV testing to other locations and offered no on-site clinical 
services at the time of the study. 
4.3 .1 Current Referral Procedures 
This section provides details about the processes in place at testing site #2 that 
were followed when responding to inquiries about HIV testing and re ferring people to 
~---------------------------------------------------------------------------------· -- ---
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services. There was not a formal policy manual that outlined procedures for responding to 
inquiries about HIV testing, rather the employees who responded to testing inquiries 
followed an informal process. This was possible because of the employees' tenure with 
the organization. Having been exposed to a variety of situations over time had provided 
the longstanding employees with access to informal training about how to react in 
different situations. Exchanges between co-workers and with clients were frequent 
enough to keep employees informed about changes to a testing service and general 
occurrences in the community. For example, the employee who was responsible for 
fielding incoming calls and greeting patrons sat in close proximity to the employee who 
was described by participants as the most knowledgeable about the harm reduction 
services and the availability of testing services throughout the city. The receptionist knew 
to direct any callers or walk-in inquires for HIV testing services that required more 
information than a phone number to this employee. 
Document C7, entitled HIV Testing Public Health NL - Phone Numbers, provided 
a textual example of the implicit processes that were followed at this site. This document 
was classified as current and policy-related document. It had been generated by an 
employee "a few years ago" (J.G., Personal Communication, Apri l 2009). The update 
procedure for this document was for that same employee to make revisions as needed. 
The last revision was made to the hard copy a few months before the document review 
began when the phone number for public health's main switchboard was penciled in on 
the poster. At that time, the employee made the same change to the electronic document 
and emailed it to another employee. As such, the electronic tile and the hard copy file 
were listed as separate documents in the document trees (Appendix D). 
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At the time of the study, an employee was planning to update document C7 in the 
near future. The document listed contacts for the Health and Community Services offered 
by the four regional health authorities throughout the Province. There were six phone 
numbers for the eastern region, three for central, two for western, one for Grenfell and 
two for Labrador. This demonstrated evidence of the practice of referring inquiries for 
HIV testing services to a formal public health setting. Posting this document at eye level 
allowed the person answering the phone to have a quick-reference guide when people 
inquired about HIV testing either in-person or on the telephone. 
Document C9, HIV Antibody Testing in NL, was classified as current and policy-
related. Information about update procedures and intended use of the document was 
limited since it had been created by a past employee. Participants were unsure if it had 
been intended for external distribution or internal purposes. The file was retrieved for the 
purposes of the study by performing a file search for documents with test in the title on a 
current employee's computer, which still contained documents belonging to a past 
employee. This document stated that the only type of testing available in NL was non-
nominal testing. It outlined the purpose and advantages of anonymous testing, which 
seemed a natural fit with participants who described the history of the testing site as 
having offered anonymous testing in the past and its ongoing advocacy and support for 
anonymous testing despite the lack of formalized documents. 
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4.3.2 Past Referral and Testing Procedures 
A participant described how anonymous testing had formerly been offered on-site 
as part of a research study. Similar to testing site# 1, anonymous testing had been offered 
on-site through a partnership and was advertised as anonymous testing. 
We used to offer testing. We don't at the present moment. I think it was in 
2004 -a [healthcare professional] from public health was doing some 
research into a rapid HIV Hep-C test. So there was a partnership struck 
between the [healthcare professional] and us, which resulted in a 
[healthcare professional] working out of our office .... .. So we turned one 
of the offices into a clinic; and if anybody came in for ... like if anybody 
called us for an HIV test, we could say, "You could do it here as part of a 
research study." "It' s anonymous and" yada, yada, yada. So that 
[healthcare professional] was working with us for three hours a week or 
so, people would come in because we had advertised we offered testing, 
anonymous testing. 
It is important to point out that this participant had referred to the study testing as 
anonymous at the time it was offered, but during the interview felt that the testing that 
had been offered was, technically, non-nominal. This is discussed in detail in a later 
section. The participant described the coding process that the healthcare professional had 
used to deliver the anonymous testing under the study. 
Because [name of healthcare professional] knew who it was just by virtue 
of the fact that, you know, we usc( d) a code that's alphanumeric .. . So it ' s 
your first initial , your mother' s first initial - of your first name; your 
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father's first initial ; the month you were born, two digits; and the year you 
were born, two digits. So you know, it's alphanumeric and it's very 
random and it's not very likely it's going to be repeated and, you know, so 
the [healthcare professional] used that code. The person would have to 
come back in two weeks and get their results, which is when the 
counselling would be offered. 
One participant described the advantages of offering HIV testing at a community-
based organization over offering it at a location associated with the formal healthcare 
system. The participant pointed out that community-based organizations have more 
flexibility to practice a non-judgmental, harm reduction approach using the time period 
when testing services were offered on-site at testing site #2 as an example, 
I think it's something that we certainly adhered to when we had things 
running here, was a real level of care that involves taking people where 
they are, full respect for people's privacy and personhood, and without 
any value judgments placed on that at all, and doing more than just sort of 
saying that that's the approach we take, but ensuring that it becomes 
paramount to who we are in the practice ... We' re completely non-
judgmental and non- discriminatory - ensuring that is part of our regular 
practice on a daily basis. You know, on a person-by-person, client-by-
client basis, and sometimes ifs easier to do that as a smaller NGO than it 
i when you're par1 of something that 's a little broader in scope like a 
hcalthcarc organization. As a non-profit organization with a certain 
mandate, there is more J1exibility to be able to kind of be that \\'ay. 
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The study had allowed testing site #2 to provide space for licensed professionals 
to come in and do clinical testing procedures. When the study ended, employees looked 
into continuing this service, but could not due to the increased liability insurance and 
operational resources that would result. A participant described the challenge of offering 
testing after the study ended, 
the board took a look at the liability situation, and when we had the 
testing ... under the research project, all the liability was within the 
research project. The [healthcare professionals] had their own licenses and 
liability insurance, right? Now the research is over. The [healthcare 
professional] is working for [name of other testing site] now so they are 
still covered by their own liability practice insurance, right; and the clinic 
here then becomes our program [name of testing site #2]. So the health 
care liability insurance would have to be paid by us. To have a health 
clinic operating in our building, and the board looked at it and said, 
"Okay, we've gone from a non-profit with no real assets except office 
equipment and furniture," right, " to a community based non-profit that 
owns [list of assets] ; and if that clinic were to be sued because of some 
mistake" ... Or, you know, any ... that's an invasive procedure because 
you' re drawing blood, right? Any invasive procedures brings up the 
liability issue, so the board suspended the clinic, suspended the operations 
of the clinic. So, in other words, we had to close the clinic temporarily 
because if people came in to get testing, and you say, .. No, we·re not 
testing, but the [hcalthcarc professional] is here·· - you know, close it, 
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right, until this whole liability insurance thing is ironed out; and since then 
we've been trying to work different ways to do it because as a community 
based non-profit, we don ' t have the money to buy the health care 
insurance from [name of insurance company], right? So we tried to work 
with [the regional health authority] in a number of different ways to make 
it work, and it just didn ' t work. 
A participant questioned whose responsibility it should be to pay the operational 
expenses of testing, such as health care professionals' salary and insurance to operate the 
clinic. 
And it's something that, you know, we may look ahead to. We just have a 
little ... we have a very small little station there, but the challenge within 
comes from our end in ensuring that we' re able to connect up the dots on 
it, that we have liability coverage to be able to do that, and who does it fall 
under? Does it fall under us as an organization, or does it fall under [the 
regional health authority]? And there's been a little bit of greyness there 
from my understanding, and so we've had to kind of step back from that a 
little bit based on liability, and looking at it as something that we hope can 
become part of our factor right back into our work plan again. 
4.3.3 Participants' Concerns: " ... they all had different answers .. . " 
Participants reported that they would like to be ab le to otTer on-site anonymous 
testing and felt that offering the service in the past had been benelicial. Concerns 
expressed by participants about their current referral procedures examined in this section 
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include understandability oftesting terminology, uncertainty about the services received 
at other sites to which they referred clients to access testing services, inconsistent or 
unsatisfactory communication with the regional health authorities in NL, and a general 
lack of understanding of specific aspects of the formal testing and reporting processes in 
place at the regional health authority. They had concerns about quality of service as well 
as the degree of privacy maintained in the process. There were also concerns about the 
quality and consistency of care provided by family doctors and other healthcare providers 
as well as the increasingly technological systems used to store personal health 
information. 
Participants from testing site #2 expressed similar issues about the meanings and 
use of testing terminology understandability as participants from testing site# I. This 
participant equated the issue of understandability as being more severe for people with 
lower literacy levels, "if you use words that are too big - if someone has a literacy issue, 
they're not going to get the message. So and again that's why I think the word 
anonymous is ... more understood by everybody than non-nominal". 
Participants' believed that the poster series transition, which involved documents 
01 to 05 and C 1 to C5, was an example of poor communication with the regional health 
authority. These documents were two sets of posters that had been updated as a result of 
an exchange between testing site #2 and the regional health authority. This exchange 
demonstrated some of the rationale for the uncertainty participants at testing site #2 felt 
when referring people to formalized settings for testing. These ten posters v;ere classified 
as belonging to the ·education, pre\·ention. awareness· categories and demonstrated the 
type of acti itics undertaken by the organization to promote testing services. 
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Reportedly, the historical posters (OJ to 05) had been updated to the current set 
of posters (C 1 to C5) due to a request from the regional health authority. The historical 
poster series was prepared for display and distribution at a Hepatitis C Symposium in 
2008. It was a joint venture between testing site# 1 and several other community-based 
organizations who did not participate in this study. The poster campaign advertised the 
availability of testing services using images of tattooing, drug paraphernalia, and unsafe 
drug and sexual practices. It contained three contact numbers - two for public health 
settings and one for testing site #2. Participants reported that public health officials' 
concerns with the historical posters were related to the potential role they could play in 
driving traffic to the public health setting. They were concerned that widespread 
advertisement of the service using posters with explicit images would result in an 
increased number of inquiries and appointments that the public health clinics did not have 
the resources to handle. To compromise, the historical poster series was revised by 
removing the phone numbers for the public health settings from the poster. These 
revisions led to the current poster series, which contained the same five images and 
overall message, but a revised list of phone numbers. Despite the fact that testing site #2 
was not providing testing services, their phone number was the only contact number on 
the current poster series. The ironic part was that telephone inquiries to this testing site 
were being referred to the same public health setting whose number had been included in 
the original poster series but removed for the revised Yersion. 
The community-based organization· s main concern with the regional health authority 
was the unclear communication about \Yhat IllY testing policies v\·ere in place and what 
service were offered in what locations. While the poster incident pro\'ided a glimpse of 
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this, the specific concerns were captured in document C l 0. Document C I 0 was entitled 
Letter to Chief Medical Officers. 3 This document was provided for the purposes of the 
document review and was classified as current and policy-related. The document was a 
copy of an email that had been sent by the participant in March 2009 to all Regional 
Medical Officers of Health, representing the province's four health districts. The 
electronic copy of this email was stored on a participant's computer and one hard copy 
was printed for the purposes of the document review. The correspondence requested 
clarification about the type HIV and Hepatitis C testing that was available at testing site 
#3 in the small urban centre. It also inquired about alternate locations that offer testing 
throughout the whole province and plans for expansion within the region. The following 
excerpt from the document clarified the organization's position on the availability of 
anonymous testing: 
Given the stigma associated with HIV and HCV many people are reluctant 
to come forward to be tested for either of these infections due to their fears 
of anyone finding out that they have even been tested regardless of the 
results. Due to the fact that illicit drug use (injecting, smoking or snorting) 
3 This document was titled ' Letter to Chief Medical Officers of Health' during the 
document review data collection phase because that was how a participant described it. It 
was noted in data analysis that there is only one Chief Medical Ofticcr of Health at the 
provincial government. This letter was addressed to the Regional Medical Officer of 
Health \ ·ho arc employed at the regional health authority level. 1\s such, the document is 
inaccurately titled. 
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can be major method of transmission, we believe that there is a clear need 
for easy access to this less stigmatizing method of (anonymous) testing. 
(Document C 1 0) 
The participant who sent the letter described the purpose of the correspondence and the 
dissatisfaction with the responses received. 
We were going to write letters and express our concerns, and one of the 
members said, "Well, did we ask the medical officers of health what the 
procedure was?" So I asked them three questions. Where are testing 
services available; if they're non-nominal or anonymous; are there plans to 
improve on access to anonymous or non-nominal testing; and what was 
the third question . .. How do you plan to promote the fact that this testing 
is available, and they all answered. (In response to) do you offer 
anonymous or non-nominal - they all had different answers, and nobody 
addressed expansion, and nobody addressed education around avai lability. 
Another participant summarized concerns about the inconsistency and uncertainty 
about the regional health authority 's policies that had resulted from this correspondence. 
What concerns me sometimes is that what the protocol is maybe not be 
adequately communicated. In talking to some of our staff who are more 
directly involved with testing and harm reduction. In trying to find out and 
get a straight answer on it, depending on who you talk to . .. you can talk to 
tvvo or three or four different people, and sometimes the view is a little bit 
di f!crent as to exactly \Vhcthcr or not anonymous or non-nominal testing 
takes place, so that" s frustrating . .. it kind of tics into maybe the next 
question which is where we send people because we sometimes don ' t 
know where to go ourselves. 
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Amidst this unclear communication, testing site #2 continued to refer inquiring c lients 
to the regional health authority's testing sites- both the community and acute care 
settings. Participants felt that beyond the procedure for making the appointment at testing 
site #3, they did not have a good understanding of the processes. One participant 
commented, 
Now we send them to [the regional health authority] and, you know, 
people have showed up (here), walked in, say, "Can I get a test or" .. . have 
to turn them away. Mostly it' s phone calls. Mostly phone calls, and then 
the odd walk-in or. .. And then they are referred to the regional health 
authority, and given basic information about how ... told well, it's just like 
what you do is you phone up and you make an appointment and, you 
know, just tell them you want an appointment to see the nurse. You don ' t 
have to tell the reception what it' s about. You want to see the nurse in the 
clinic, and then you'll see right now [nurse] , or whoever is up there, and, 
you know, it goes from there. Like I don ' t know what their protocol is ... 
Similar to test site # 1, participants cited additional concerns with referrals to testing 
site #3 because of the provision of multiple services at one location. Due to the high 
volume of traftic and services available at that site, the participants worried about the 
possibility of clients being recognized by social workers \Vho also vvorkcd in the building 
\Vherc testing site #3 operated , 
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... but that's not a solution either because it's up in [testing site #3] where 
Child Protection Services is. So if a woman is going in to get tested and 
her children are in care, I don't care who says what about boundaries and 
stuff like that, the social worker sees her going in, she's going to be, 
"What the hell are you doing down at this clinic?" 
Participants referred to the acute care setting identified in the AIRN (2006) 
environmental scan as "the HIV Clinic" and reported that it was closed at the time of the 
study. A participant noted being unsure about the acute care settings' openness to 
confidential testing when the clinic was open, 
Without a nurse practitioner in place (at the acute care setting)- and we 
understand someone is being hired - ... is there someone there who can 
carry out that testing? Are people who just suspect they might be HIV 
positive allowed to seek treatment there? Or maybe they don't suspect at 
all; they just want to get tested. They may be reluctant to go to an HIV 
clinic based on the fact that. .. you know, their status is unknown, and that 
comes down to stigma, and I think that is something that ... the stigma is 
bigger than just having the HIV clinic as a place that people could 
possibly go for testing. 
Ultimately, participants did not know what it meant to be ··in the system'· at the 
regional health authority within a formalized setting of care and services. They did not 
have a clear understanding about what happened to test results; specifically, what was 
recorded in their permanent medical record depending on the type of test, location of test. 
and rcsul t of test, how were the results recorded, and who could access them. There was 
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an elevated sense of concern about the possible consequences of there being a record of 
having had an HIV test - even if it was negative. There were questions about potential for 
outside agencies ability to access a person's medical records, particularly insurance 
companies. Without this information, they did not feel they could accurately inform their 
clients or members of the general public about what to expect when they went for testing. 
One key informant stated, 
If you're positive and that's in Eastern Health's database .. . now I know 
Eastern Health has a database of HIV positive people, but it is not a part of 
the larger Eastern Health database. But still if you end up in the hospital 
somewhere along the way the fact is that that test is on file is going to be 
seen by somebody, and is it someone you know? Is it someone you would 
ever want to know your status? The stigma of HIV is not to be 
underestimated. 
As a result of concerns and uncertainties about referring clients for testing at 
formalized healthcare settings, participants did not feel they could accurately inform their 
clients or members of the general public about what to expect when if they decided to 
seek testing service at either location. In general, participants felt unsure of where the 
regional health authority stood on privacy and confidentiality issues related to HIV 
testing. One participant from testing site #2 used the term privacy six times to voice 
concerns about what the cuncnt testing and reporting procedures, 
With regard to reporting, it ' s one more HIV positive test result. . . I think 
by even narrowing it dO\·vn to, you know, we have one from White Bay -
why is it necessary to have that information? Are we going to name 
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streets? Or say it's a blue house? ... .! think it kind of comes down to how 
we respect people 's privacy. 
This participant also noted his concerns with the technological shift towards 
electronic health records. 
When you're out around the bay, you know, what's to keep it from being 
Aunt Nelly who's working at the clinic or who is part of the mental 
facility? It brings up a whole other issue in and around privacy and 
privacy legislation about some of the changes going on with the pharmacy 
network right now. We have some concerns that the province is going to 
change the way that we receive our medications and everything else, that 
it's all going to be electronic. 
The participant continued to describe a scenario when a positive HIV test result is 
displayed on an electronic health record and at the touch of a button, all healthcare 
professionals can access this information. 
Finally, concerns with referrals to family physicians and healthcare providers at 
walk-in clinics, were related to clients' reports of stigmatizing treatments and 
unacceptable testing and counselling practices. Participants had heard "horror stories" 
from their clients and people within the community about the stigma clients faced when 
seeking HIV testing from family physicians. They doubted family physicians' ability to 
deliver adequate care, referrals. and client counselling on I-llY testing. They relayed 
anecdotal examples during which family physicians had delivered test results oYer the 
phone, made inadequate referrals to l-IlY services, provided inaccurate information. and 
adjusted the type and quality of care provided based on a pcrson·s IllY status. As a result, 
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staff at the community-based organization felt uncertain about the ability of healthcarc 
providers to deliver non-judgmental services and consistent levels of care. Other concerns 
related to stigma included clients not feeling safe to request testing within an existing 
client-physician relationship or there was a fear that requesting an HIV test would 
damage a positive relationship. 
4.4 Testing Site #3 
Testing site #3 was following a draft non-nominal testing policy. Participants 
reported that non-nominal testing was the preferred testing procedure when it was 
possible to obtain a test seeker's personal identifying and contact information. If 
necessary, participants would carry out a test without contact information. In such 
instances, participants reported following up with efforts to collect the individual 's 
contact information at a later date. Certain practices fit more closely with various 
definitions of anonymous; however, the offic ial testing protocol was non-nominal 
because that was the regional health authority's policy to comply with legislation. 
This testing site received the most referrals for on-site testing services from community-
based organizations. 
4.4.1 Current Testing Procedures 
Testing site #3 offered on-site testing services at one half-day clinic per week on 
Wednesdays from 9:00a.m. to 12 p.m. Appointments were occasionally booked outside 
of these hours to service demand. Testing si te #3 \Yas located in a building where other 
public health services were offered including but not limited to social work, 
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immunization and breastfeeding services. It was reported that testing site #3 was busier at 
certain times of the year, such as the start of the university fall term and around 
Christmas and New Year's at which time extra clinics were offered to service demand. 
When someone called to book an appointment at testing site #3, they first spoke 
to a receptionist. Only the first name and last initial were recorded during this initial 
phone call and instructions were given to prepare them for the appointment. Specifically, 
the caller was advised to tell the receptionist that they were there for ' [name of nurse)' s 
clinic' upon arrival. In this way, the client would not have to declare the reason for their 
visit or verbally identify the reason for their visit in a potentially busy waiting room. 
From that point on, the receptionist referred to the client by the first name and last initial 
with which the appointment was made if, for example, a name had to be announced to 
indicate the next client's turn was up. 
Document E3, Testing, Treatment and Reporting of Sexually Transmilled 
Infections, HIV and Bloodborne Infections', was a 13-page document classified as 
current and policy-related. It was described and labeled as being in draft format. 
According to a participant, document E3 was originally created to update policies to 
reflect the changing needs of health service delivery for HIV testing, treatment and 
reporting in a community setting. Internal consultations to develop the policy had been 
ongoing for since 2007 (a year and a half prior to the study). Participants suggested that 
due to the numerous and ongoing nature of revisions to document E3 , including earlier 
versions in the document review \vould be futile because they would be replete with 
inaccuracies and irrelevant statements. As such, earlier versions of this document \\Cre 
not avai lable for inclusion in the document review. 
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Consultations had been held with employees and other key stakeholders to 
develop the draft policy. Through this collaborative process, the policy had been drafted 
with the intention of reflecting actual practice settings. Staff involved with delivering 
these services and performing related procedures had been emailed a copy of the 
document. Due to its draft status, there were no documents available at the time of the 
study that attempted to communicate this policy to patients or clients. A senior level 
employee was responsible for updating the draft policy document. Participants could not 
estimate a date when the policy would be finalized due to the lengthy approval process 
for organizational policies. When finalized, there were plans to make the policy 
electronically accessible to all staff. 
This draft policy applied to all community health staff in the regional health 
authority. The following positions were named in the policy as the providers who could 
deliver the service - communicable diseases control nurses, community health nurses, 
and nurse practitioners. Participants explained that a community health nurse, nurse 
practitioner, or any public health nurse required additional credentials to be qualified as a 
communicable disease nurse who could perform STI testing. This included successful 
completion of vein maintenance and phlebotomy courses, demonstrated familiarity with 
the Canadian Guidehnes on Sexually Transmitted Infections (Document E5), previous 
community experience, a mentorship with an experienced communicable disease nurse 
inYolving clinical observation, and clinical orientation and evaluation. The healthcare 
providers responsible for administering testing in community health settings noted that 
offering STl testing was just one pat1 of many job roles they were required to perform 
and report to their manager about. 
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The draft policy specified that the official procedure to be used in all public health 
settings was for non-nominal testing and reporting. "All tests will be undertaken using 
non-nominal reporting as the testing/reporting procedure of choice. Nominal testing is 
acceptable but anonymous testing is not permitted" (Document E3, p. 2). It required the 
provider to obtain the following personal identifying information in a non-nominal test, 
first and last name and date of birth AND at least one of [emphasis in 
original] the following, Mother's/Father's Name, Address, MCP #, Photo 
JD, Referral Documentation) from the client to be recorded in the clinic 
record. An alphanumeric code will be assigned to the record (Document 
E3, p.3). 
According to the policy, the client's chart should contain, at a minimum, the first 
and last name, date of birth, and one other piece of personal information. At a client ' s 
first visit, participants reported emphasizing that the most important piece of information 
to collect was contact information. During pre-test counselling, the nurse would get a 
sense of the client's level of comfort to provide information. Typically, the client's name 
and phone number were also requested. An MCP number was not required but could be 
provided if the client wished. Participants discussed the importance of other aspects of 
pre-test counselling, such as explaining the meaning of the non-nominal system and that, 
if they tested positive for HIY, that the client would be required to notify his or her sexual 
partners or provide their names and contact information to community health for the 
communicable disease nurses to contact them. The client vvas ahvays advi sed of their 
responsibility to come back to the clinic to retric\'e their test results. Participants noted 
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that the points that were emphasized during pre-test counselling depended on the needs of 
the client. 
Document E3 stated that non-nominal reporting would ensure the confidentiality 
of any "information recorded on laboratory and epidemiological reports" (p. 2). It stated 
that "the client record will contain sufficient information to facilitate timely treatment and 
follow-up of the individual and contacts'' (p. 2). Personal information collected was used 
to start a chart on each client after the first visit. Charts were stored in a locked filing 
cabinet or room and organized by chart number. The policy stated that an alphanumeric 
code was to be assigned to each client record and used to send the blood sample to the 
laboratory. Participants reported that no record of an HIV test was ordered through a 
community health testing site was entered in Meditech. When returned from the 
laboratory, tests for reportable conditions ordered by public health testing sites (including 
#3 and #4) were first sent to the Medical Officer of Health before being returned to the 
provider who had ordered the testing. 
At testing site #3, the client charts could be accessed by two or three employees. 
At times, participants referred to this system of paper records as the Communicable 
Disease Database or the "CD system" because it housed information for all reports of 
HIV, Hepatitis C, Salmonella, Norwalk virus, and any other communicable diseases in 
the region. Keeping a complete record meant this paper record system tracked instances 
of communicable diseases that had been confirmed through tests that had been ordered by 
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other community health sites or an external source, such as a family physician.-t If a test 
result came back negative, confirmation of the negative test result was stored in the paper 
record of the client's char1 at the site the client had visited for the test. Though all 
laboratory tests results ordered by testing site #4 were first sent to testing site #3, they 
were only recorded in the Communicable Disease Database, which was located at testing 
site #3, if the result was positive. If negative, the laboratory results were forwarded to 
testing site #4 where the chart would be updated accordingly. 
There were specific procedures to follow for reporting and partner notification of 
positive results. In the event of a positive result, document E3 stated that "individuals 
testing positive will be reported to the Department of Health and Community Services 
through the Communicable Disease Reporting System using the assigned code" (p. 5). 
This meant reporting was done to the Provincial Government' s Department of Health on 
a nameless basis. Participants confirmed that positive results for reportable 
communicable diseases (including HIV) were reported to the Department of Community 
4 If the test had been performed at a location other than a community health testing site, 
the same procedures for non-nominal coding, reporting, and no direct entry into Meditech 
may not apply. Negative tests returned to family physicians are neither transmitted to the 
community health staff at testing site #3 nor stored in the Communicable Disease 
Database. Positive results returned to family physicians, required that the reporting 
physician complete a form providing basic information for the Communicable Disease 
Database. The timing or input procedure used by famil y physicians to record infectious 
di seases in Meditech is beyond the scope of this inquiry. 
-------------------------------------------------------
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Health using a Communicable Disease Reporting form. The form had space requesting 
the following information on positive reports- name, age, MCP number, and home town. 
The form was completed by the data entry clerk at testing site #3 and sent to the 
provincial epidemiologist. The only way that information from the database was released 
to anyone other than for these reporting purposes was with the consent of the individual 
whose information it is or on court order. 
According document E3, staff conducting the tests were to record the "names of 
contacts and contact information" (p. 5) for contact tracing. It described how clients were 
encouraged to advise their partners to come forward for testing, but also acknowledged 
that detailed information about contacts may not be easily obtained at the first or 
subsequent visits. If partners failed to come forward through the partner notification 
process, only then would public health staff undertake contact tracing. With contact 
tracing, public health staff initiated contact with the partners identified by the client 
instead of leaving the responsibility to the client. With regards to names and contact 
information for past partners the policy stated, 
Names of contacts and contact information will be recorded in confidence 
for contact tracing by [regional health authority] staff. Clients will be 
encouraged to advise their partners to come forward for testing (Partner 
otification) at the initial visit. Detailed information about contacts may 
not be easily obtained at the tirst or subsequent visits. but every effort 
should be made to document contact information. The client will be 
advised that actiYe contact tracing by public health staiTwill be initiated 
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after a negotiated time frame only if partners fail to come forward through 
the partner notification process. (Document E3, p. 5) 
With regards to post-test counselling, document E3 stated that post-test 
counselling would not be done over the telephone. "No test results will be given over the 
telephone to ensure confidentiality and to ensure that counselling occurs" (p. 2). 
Participants from testing site #3 reported that at the time of their first visit, clients were 
always scheduled for return appointments approximately two weeks after the date of their 
first test. This was done to ensure that post-test counselling was delivered in person 
regardless of whether the result was negative or positive. At the second appointment, 
results were released to the client only when he or she could confirm the identifying 
information provided at the first appointment. 
Document El and E2, the Communicable Diseases Act and the Health and 
Community Services Act, also influenced the regional health authority's policy. The 
Communicable Diseases Act (Document E 1) was the statutory basis for the control of 
communicable diseases in NL. Under the Health and Community Services Act 
(Document E2), the Minister of Health and Community Services has the ultimate 
responsibility for the Act; however, this authority may be delegated to the Chief Medical 
Officer of Health and the Regional Medical Officers of Health. 
Document E2 defined communicable disease as "a disease mentioned in the 
Schedule, and includes other diseases that may be added to the Schedule by the minister''. 
The Schedule listed HIV and AIDS as reportable conditions. The Act had been passed in 
1970: sections pertaining to the reporting of communicable diseases and, therefore, most 
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relevant to HIV testing and reporting had not been updated since it was first passed and 
are stated below, 
Notice by physician, 
4. (1) When a physician knows, or has reason to believe, that a person is 
infected with a communicable disease he or she shall within 24 hours give 
notice to the deputy minister, or to the health officer in whose jurisdiction 
the person is, and to the hotel-keeper, keeper of a boarding house or tenant 
within whose house or rooms the person lives. 
(2) The notice to the deputy minister or to the health officer shall, where 
possible, state the name ofthe disease, the name, age and sex of the 
person, and the name of the physician giving the notice, and shall by street 
and number or otherwise, sufficiently designate the house or room in 
which the person is living. 
RSN 1970 c52 s4 
Cases in which people were unwilling to provide any information whatsoever 
were rare, but they did happen. In such cases, clients were allowed to provide a 
pseudonym or alternate pieces of identifying information. When this did occur, pre-test 
counselling and follow-up was adjusted to emphasize the importance of returning for the 
results. One participant recalled a situation in which one person did not want to provide 
any information, 
I think it was one person who did not want any idcnti fying .. . didn "t want a 
phone call, like a phone number or an address, didn"t feel comfortable 
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with that. So, you know, I talked about some other identifying information 
for him like his mother's name and that sort of thing ... I did take his 
mother's name as the other- you know, as the third part of the identifier; 
and I said, you know, you have to make sure that you come back for your 
appointment. 
Challenging cases like this emphasized the special skill set required of 
communicable disease nurses and any healthcare provider who engaged in HIV testing 
and counselling. One of the many specialized skills they need to possess is the ability to 
build rapport when people feel uncomfortable and the ability to tailor information needs 
for individuals who continuously engaged in risky activities. 
4.4.2 Past Testing Procedures 
Document F2, Partner otification andfollow-up/counselling guidelines.for 
sexually transmilled diseases, was classified as a historical, policy-related document. It 
had been issued by a legacy boards prior to regionalization. It became effective in 
February 1996 and applied to the entire communicable disease and epidemiology 
program. Due to the age of the document, participants could provide little information 
about the document itself; such as how it carried it out in practice who was responsible 
for it. or what had replaced it. Similar to the draft policy that was in effect at the time of 
this study, document F2 also specified that a ll specimens were coded and the clients' 
names \\·ere not included on .. either the specimen or the laboratory requi ition'" to en ure 
confidentiality. 
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Since document F2 was the last record of any official policy that stated finalized 
and formal procedures for issues relating to sexually transmitted infections, I assumed 
that this was the most recent version. Participants also suspected that this was the case. In 
cases where policies had not been finalized, polices from legacy organizations apply 
(J.D., Personal Communication, July 2009). Since the draft organizational policy that had 
not yet received official approval, document F2 would be the last official policy under 
any legacy organization and, therefore, would be discretionally applied. While it did state 
that community health nurses were to carry out reporting, it did not specify how 
information was to be transmitted when reporting. 
Without making any specific reference to this historical policy document, 
participants recalled aspects of past testing practices such as the location of availability, 
personnel who performed the tests, and information storage. One participant recalled a 
time when testing site #3 was the only place in the small urban centre in which testing 
was available. The participant recalled how at that time, the health authority had often 
allowed people to be tested without providing accurate information, " I think to a certain 
extent we had pushed the limits in terms of allowing people to come and be tested using 
false names or identification". 
Another participant was likely referring to the same time period when testing had 
been offered at this centralized location. The pa1ticipant recalled how past testing 
services had been offered more frequently by many public nurses. To do this, nurses were 
periodically pulled from their job sites to come to a central location to offe r testing 
services. A participant described how this capacity was lost as those nurses retired, 
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I think historically - and this . .. I'm going back probably ten, 12 years ago 
- I think it (the STI clinic) was run more often; but then as nurses ... and 
what they used to use was they used public health nurses out in the 
district. I think there were a couple that were trained to do clinics. So 
they'd be pulled from their districts for that half day a week or whatever; 
but as those nurses retired, they were never replaced. 
Finally, participants noted that at one time, files had been stored in an electronic 
Communicable Disease Database; however, the electronic database had not been working 
for over a year and they had reverted back to a paper filing system. 
4.4.3 Participants' Concerns: " ... we have to define our parameters ... " 
Participants from testing site #3 expressed concerns related to low availability of 
the service, the importance and shortage of qualified communicable disease nurses, the 
inadequacy of testing and counsell ing services provided by some family physicians, 
confusion ofterminology used by staff, organizational complexity, lengthy bureaucratic 
processes, political agendas and misleading documentation from PHAC. Despite referrals 
from other testing sites, testing site #3 was not "over-run with requests". Nonetheless, at 
least one participant felt that there should probably be an STI clinic four days a week. 
This participant reported having advocated to her manager for the resources required to 
do this. 
All participants from this site emphasized the importance building rapport with 
clients to deliver the most effective education and information during pre- cmd post-test 
counselling. At kast one participant expressed concerns about the quality of I !IV testing 
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and counselling services provided by family physicians. These concerns were related to 
reports that family physicians had provided inaccurate information during post-test 
counselling, inadequate follow-up on individuals who had been tested, lack of ordering of 
HIV tests for patients, and avoidance of addressing issues about sexuality or 
uncomfortable with STis. 
Participants reported to having historically referred to the service they provide as 
anonymous testing, but upon closer examination of the definitions and the processes 
realized that the processes were actually non-nominal. This was demonstrated by the 
following statement, 
they realized that what they were doing was in fact non-nominal testing. 
They might have been talking about anonymous; but when we sat down 
and looked at the definitions where anonymous means that you have no 
recorded information about the individual, no way of contacting and no 
way of whatever, then they realized that, in fact, our practice has been 
non-nominal. 
When speaking about how document E3 had been in draft format for over a year, 
a participant pointed out the length and process required when operating in large 
organizations. The participant explained that before policies were finalized, they were 
required to pass through numerous internal and external consultations, multiple layers of 
approval, and be presented to a committee. Changes to legislation required shared 
understanding and support from a large group of people and a political appetite for the 
issue. The participant called on community-based organizations to advocate for change, 
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... Legislation is complex. It requires a large number of people 
understanding the issue and deciding to move on it. Legislation is passed 
by the House of Assembly, and I think we would need that support in 
order to move towards anonymous testing capacity. Now I would say the 
government is not going to act on our request at the moment. If 
anonymous testing truly is something that is useful and desirable, it's 
going to have to be a matter of public debate, and outside agencies are 
going to have to bring it up to government independent of whether 
you' re ... we're discussing it or not because that. .. unless that information, 
or unless the discussion is occurring, it' s not going to be ... recognized as 
an issue that needs to be dealt with. 
As it attempted to expand HIV testing services, participants acknowledged that 
after the legacy organizations merged to form the larger integrated health authority it was 
necessary to be more consistent with clinical directives and, in particular, its approach to 
testing. Participants described the past efforts to create standardized protocols and a 
shared understanding of the practical aspects of testing. They attributed the draft policy as 
evidence of this effort, but admitted that creating policy vvas a lengthy process within the 
large, bureaucratic organizational structure. One participant recalled that prior to 
regionalization, testing site #3 was the only place where testing had been offered, which 
allowed informal procedures to be more accepted, 
But the problem that arises now is that more people arl: . . . more locations 
are looking for testing, so we have to define our parameters. \1 e can 't 
operate as a qu iet little operation working under the radar. We're part of a 
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much larger organization. If we want to make sure that things are done 
comparably; and so, in fact , the demand for more testing availability, 
particularly in relation to outside agencies, has meant that we' ve had to 
write down our policy instead of operating under the radar. That has meant 
that we' ve had to think about the issue of non-nominal versus anonymous, 
and acknowledge that in fact anonymous testing is not covered by 
legislation, and therefore was probably not something we should be 
actively pursuing. 
Finally, at least one participant felt that document E4, the PHAC (2007a) 
epidemiology update which stated that anonymous testing is available in NL, was 
"misleading" or irrelevant. The participant believed that the explanations provided in the 
footnotes to the tables regarding the delivery of anonymous testing were "splitting hairs" 
and would rather that the tables did not state that anonymous testing was available here 
because technically test sites offer only nominal and non-nominal. 
the statement here (gestures to document E4) is that if you' re positive 
through anonymous testing, then you have to be reported by name. It ' s 
splitting hairs. I think . .. I mean, it' s true, although I don ' t think there's 
any written documentation other than ... that states government policy. I 
think the testing itself doesn' t need to have a name attached to the test, but 
the law requires name-based reporting .. . If anybody is suspecting they' re 
positive, they need to understand the fact that basically it' s not 
anonymous. 
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4.5 Testing Site #4 
Since it was also operated by the regional health authority, testing site #4 was 
following the same draft non-nominal testing policy as testing site #3. As such, it was 
reported that non-nominal testing was the preferred testing procedure when it was 
possible to obtain a test seeker's personal identifying and contact information. If 
necessary, participants would carry out a test without contact information. For the most 
part, testing at this site followed the same procedures that were described for testing site 
#3 as defined by documents El toES and Fl to F4. Several exceptions discussed here 
include the target population, time of operation, appointment making procedures, number 
of staff, circulation of test results, and the perceived risk tolerance of test seekers at this 
site. To demonstrate the limited public profile of this site, it is important to note that I 
was unaware of this particular site prior to the study and it was not identified in the scan 
for testing services to include in the list of participants. It was discovered through 
information provided by participants. 
4.5 .1 Current Testing Procedures 
Testing site #4 was situated in a downtown residential area and targeted youth. 
This site first started to offer STI testing in 2007, after which there was a short hiatus due 
to personnel issue. At the time of the study STI, testing had resumed for approximate ly 
one year. The clinic was situated on the ground t1oor of a small building that vvas shared 
with another community-based organization, which was also dedicated to the needs of at-
risk youth. 
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Testing site #4 attempted to tailor its services to the needs of youth. Posters were 
used to advertise when "No-names" STI testing was available. Youth could call to make 
an appointment or come to the drop-in STI clinic hours. The drop-in schedule had been 
decided upon by collaborating with a community-based organization about how to best 
attract neighbourhood youth. 
The healthcare professional at the site was responsible for taking the phone calls 
to book appointments as well as all testing and reporting requirements. As such, specific 
instructions about arriving in waiting room set-ups like testing site #3 were not required. 
At testing site #4, client charts were accessed by only one employee. Similar to testing 
site #3, participants reported scheduling the client's return appointment for approximately 
two weeks after the date of their first test. This was done to ensure that post-test 
counselling was delivered in person regardless of whether the result was negative or 
positive. 
Though targeted towards youth, testing site #4 also offered services to clients, 
including some adults when requested. It was reported that this clientele had very 
different needs than those typically seen at testing site #3. This comparison was possible 
because at least one participant had spent time at both testing sites #3 and #4 and in doing 
so had observed that more clients who led "high-risk lifestyles" accessed services at 
testing site #4. Many of the clients at testing site #4 regularly engaged in risky activities 
such as unprotected sex, sex for money, injection drug usc, sharing of drug paraphernalia. 
Pregnant women and youth were reported as regularly fi·equenting the clinic to access 
services. When speaking about the differences in the needs of the cl ientele at testing sites 
#3 and #4, one participant said, 
176 
If I had somebody who is, you know, on the street and in the sex trade 
business or using I.V. drugs, I' ll say you should be tested every couple of 
months because like at [testing site #3 J, the counselling goes in-depth with 
the window period and, you know, it (the testing) is probably a one-time 
thing, whereas here ... they should just keep getting tested. r had one 
person in here who had STis in the past, and was really afraid (because) 
she had symptoms and stuff; but then when I asked about the last time she 
had unprotected sex, she had had it that day. So it's like ongoing .. . you're 
trying to educate them and you're trying to say every time you have 
unprotected sex, really, you need to be tested again, you know, but 
that's . . . like that could be the norm for some of the people here, so they 
need to be treated ... they need to be tested like every two months, not so 
much like . . . you know, "Come back in six weeks" and then "Come back 
in six months." These people need to be tested regularly, or if they' re I.V. 
drug using or if they ' re snorting or using equipment ... on a regular basis, 
they're putting themselves at risk. They need to be tested on a regular 
basis so there are some differences like that. It depends on your 
population .... you have to respond to their needs differently. 
Laboratory results of ordered from testing si te #4 were first sent to testing si te #3 
where, if positive, they would be recorded in the Communicable Disease Database before 
being forwarded to testing site #4. If negative. the laboratory results were forwarded to 
testing site #4 without any data entry or follow-up and the client chart, \Vhich was kept 
and maintained at testing site #4. \\as updated accord ingly. 
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4.5.2 Past Testing Procedures 
Testing sited #4 had begun offering testing around 2004. The first year after the 
service was offered, there was a short hiatus due to personnel issue. At the time of this 
study, STI testing had resumed for approximately one year. A general description of the 
regional health authority's past testing practices are the same as those described for 
testing site #3 since the health authority also over saw testing site #4 . 
4.5.3 Participants' Concerns: " ... I' m not getting a lot of people down here . .. " 
Participants' from testing site #4 expressed similar concerns as testing site #3 
about low turnout, the importance of qualified communicable disease nurses and the 
inability of family physicians to provide adequate testing and counselling services, 
confusion of terminology used by staff, organizational complexity, lengthy bureaucratic 
processes, political agendas and misleading documentation from PHAC. 
A participant from testing site #4 reported a desire to see an increase in the 
volume of people reasoning that the low volume at this site could be related to staff 
turnover, 
The volume hasn ' t been great. We ' re trying to increase it and things but 
I'm not getting a lot of people down here, so I don ' t know why. I mean, 
it ' s something, I guess, in time we'll look at· and if the numbers don ' t. .. I 
think some of it is the inconsistencies of the nurses. 
When staff turnover occurred, the pa11icipant felt that rapport was lost and it took 
time to create an en\'ironment in which trust could be re-established. Participants 
considered provider-client rapport to be extremely important at testing si te #4 since 
clients often reported being involved with risky activities, such as sex trade, injection 
drug use, sharing drug paraphernalia, and unprotected sex. 
4.6 Areas of Incongruence: " . . . It's not mandatory ... " 
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It was evident that community-based organizations had a history and current 
practice of referring people to formalized settings for testing despite the concerns that 
were reported about doing so. These concerns included a lack of understanding the 
formal processes for testing, reporting, and the procedures for third party access to 
information and test results. Other areas of concern included the location of testing site 
#3 including the look of the building and the multiple services offered within it. This 
section examines key areas of incongruence, such as the past practices of offering 
anonymous testing by each of the three organizations. Similarly, incongruence was noted 
between the various definitions of testing, between legislation and official policies at 
testing sites, between reports from participants about procedures used in practice, and 
between the policies and procedures outlined in the documents and reports from 
participants. 
The three organizations operating the four testing sites reported having a record of 
offering anonymous HIV testing as part of a research study or as part of a partnership 
with a private organization. Participants reported that the ability to offer anonymous 
testing in the past had been beneticial. After describing the complexity of process 
required to change legislation and influence policy and the range of external forces at 
play, one participant commented, 
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. .. I think there's a place for anonymous testing. You know, I think it can 
be set up. We don't have it, I don ' t think that we should pretend that we 
have it, and I don't think we should be pretending we have it through 
research studies because I don't think that 's ... Well, it's ... you know, it ' s 
either doing research or it's doing testing ... I think we're actually 
providing a service. If the environment changes to allow us to provide it, I 
would encourage it. . . 
One key area of incongruence was between document El (the Communicable 
Diseases Act) and E3 (the draft policy entitled Testing, Treatment and Reporting ofSTls, 
HIV and bloodborne infections). Document El was a piece of legislation stating all 
reports of communicable diseases transmitted from the health authority to the provincial 
government should state "the name of the disease, the name, age and sex of the person, 
and the name of the physician giving the notice" (p. 3). This is commonly referred to as 
name-based reporting. Document E3 was the health authority's draft policy addressing 
HIV testing. Section 15 of document E3 stated that "individuals testing positive will be 
reported to the Department of Health and Community Services through the 
Communicable Disease Reporting System using the assigned code" (p. 5). The meaning 
and definition of "assigned code" (p. 3) was clarified in document E3 as the 
·'alphanumeric code" (p. 5) that is assigned to the record. This is the same code used to 
de-identify the sample vvhcn sent to the laboratory for testing. It docs not identify the 
individual or provide his or her name, age and sex as outlined in the legislation. There 
was no explicit definition in the policy for generating this alphanumeric code. Several 
statements from participants demonstrated wide acceptance of the idea that alphanumeric 
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codes were some combination of initials, chart number, or age and did not contain the 
information requested in document El. To summarize this key area of incongruence: the 
legislation outlined detailed personal information requirements for reporting to the 
provincial government when a test result confirms an individual is HIV positive; 
however, the health authority's policy suggests a non-identifying alphanumeric code is 
used to report positive cases to the provincial government. 
The definitions of non-nominal provided by community-based organization #2 
and the regional health authority had a notable area of difference. Specifically, the 
regional health authority ' s definition of non-nominal clearly stated that a client's true 
identity and contact information are included in the client's record. Community-based 
organization #2, however, used less forceful language, "identity of individual may be 
known by the testing clinic". This demonstrates the uncertainty about the differences in 
procedures expressed by community-based organizations. 
Participants reported current practices of advertising the service as no-names, 
performing tests knowing that the information that they have recorded about the person 
being tested may not be accurate, allowing clients to provide fake names or no names, 
and reporting to the province with less information than required by official reporting 
standards. Participants viewed these practices as being within the scope of non-nominal 
testing. Upon closer examination and comparison, however, these practices were 
incongruous with non-nominal testing standards according to the definitions and policy 
guidelines outlined by the regional health authority in document E3. The health 
authority' s definition of non-nominal suggests the test seeker' s personal information 
(including name and contact information) was collected and on file . As such. these 
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practices fit more closely with the definitions of anonymous testing provided by both the 
regional health authority and community-based organization #2, which states "there is no 
address or contact information recorded that could lead to the identification or location of 
the individual presenting for testing" (Document E3, p. 6-7). Clearly, a situation in which 
testing is carried out with no name could create an anonymous situation. In addition to 
the incongruence between non-nominal policy and practice standards, there was 
incongruence between these practices and the legislative requirements for name-based 
reporting previously described. Interestingly, participants' consistently expressed the 
view that anonymous testing was not legally permitted. Since the above practices were 
described as non-nominal, however, they were permitted within the scope of allowable 
practices according to participants' interpretations of the legislation. 
The term I used to describe the above practices was "discreetly anonymous". I 
will now explain the rationale for this. It seemed that anonymous testing could be made 
available on certain occasions under some circumstances. For example, participants were 
okay with limiting or waiving information requirements for test seekers who were 
uncomfortable providing the information required for the non-nominal test, or to those 
who declined to respond to providers' requests for information at intake, or to a test 
seeker who simply insisted on receiving the service in this way. Even if they had not 
encountered the situation personally, many participants indicated how they 'vvould 
respond if placed in one of these circumstances. Their responses indicated that 
participants shared the view that it was better to proceed to test with limited personal 
information than to have the test seeker leave the si te without being tested at all. Despite 
delivering the service in this way, all participants \\Cre uncomrortablc rercrring to any 
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aspect of their service as anonymous because of their perceptions of what was permitted 
by the legislation. A participant who described the service at their site as non-nominal 
described how testing services were advertised" ... it's written on the sign that you don't 
have to use your name because when I was orientated to this position we were told that 
you didn't have to ask for a name". The participant explained that even in situations 
where a name was obtained it could still be advertised as "no-names" because no names 
were sent to the laboratory. Another participant from a non-nominal site stated, 
Well, we don't do anonymous testing, number one, and I guess it's also 
for reporting. They can still be reported as - because we just take 
initials .... We use initials and a code that goes on a lab slip and on the 
specimen. The chart that I have is .. . I do like to have a name because of 
positive patient identification. I do take a name. I ask for a name. If a 
person doesn't feel comfortable giving me a name, it's not mandatory, but 
I do need to have, you know, some way so that I know that this is, you 
know, John Brown in front of me. If a person wants to give me a false 
name, they can. Some people do. They might give me their first name and 
their middle name, or their middle name and their last name. I use a chart 
number. I do use a date of birth, and I do like contact information, and the 
contact information is only if they have a positive test result and they 
don't come back to clinic for some reason. To get their results, they must 
come back to clinic. 
i\s alluded to in this quotation, policy document E3 permitted reporting by an 
.. assigned code .. (p.J) despite the fact that document E I (the legislation) requested name-
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based reporting and other identifying information. There were also inconsistencies with 
the way the reports were completed. The forms used for the Provincial Government's 
Communicable Disease Reporting System were reportedly completed in a manner that 
was inconsistent with legislation and protocol. Specifically, the forms used for the 
Communicable Disease Reporting System had a box where the participants ' addresses 
and MCP numbers were requested. Participants from more than one testing site reported 
that a certain city was always written down as the address when reporting positive cases 
regardless of the test seeker's reported address. Similarly, ' 99' was always written down 
for the MCP number. Participants reported that provincial government officials, at times, 
requested patient MCP numbers; however, since they were not routinely collected nor 
requested at these testing site(s), they could not be provided on the forms used for the 
Provincial Government's Communicable Disease Reporting System. It may also be worth 
pointing out that at times, participants from the same testing site had conflicting reports 
of how reporting process was carried out; for example, one participant reported that the 
reports were transmitted by name and another participant reported that they were 
transmitted using initials. This demonstrates inconsistencies within practice between 
employees in a situation where there is incongruence between policies and practices and 
variation in the interpretation of certain legislation and terminology. 
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5.0 Discussion and Recommendations 
This chapter discusses the meaning of the term anonymous as it is used in public 
health and clarifies other potentially confusing terminology. It explains my theory behind 
the areas of incongruence noted in chapter four. The discussion is divided into three main 
sections- the role of the Communicable Diseases Act in the incongruence, the need to 
increase clear communication about HIV testing policies and procedures, and the need 
for explicitly anonymous HIV testing. The discussion is presented and recommendations 
were made based on social justice principles within a social determinants of health 
inequality framework. In this small urban centre, providers who discreetly deliver 
anonymous testing or have done so openly in the past contribute to overall population 
health by providing test seekers an opportunity to reduce health inequities. Eighteen 
recommendations are made for consideration with regards to required clarification and 
updates to provincial legislation, increasing communication of policies and procedures in 
formalized and community-based settings, disseminating information to the public and 
changes to federal documents. Finally, this chapter describes how this research will be 
disseminated and suggests areas that merit further inquiry in future research. 
5.1 Summary of Key Findings 
My original objective was to evaluate the congruence between HIV testing 
policies and everyday testing practices in community-based organizations and public 
health clinics. In addition to identifying areas of incongruence. I have expanded on the 
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analysis of various systemic issues to offer possible explanations for the key areas of 
mcongruence. 
5 .1 .1 What is Anonymous? 
I have spent a significant amount of time in this small urban centre and am 
intimately familiar with its small social circles. I was not surprised that some academic 
literature that suggested it is a place where there is a perception that "everyone knows 
their neighbour's business" (Gustafson et al., 2008, p. 190). I doubted the possibility of 
anonymity and struggled with its meaning. To me, anonymity represented the opportunity 
to receive a service without anyone knowing you had sought the service in the first place. 
It was interesting to explore and compare the usage of various definitions of anonymous 
as provided by the participants, the policy documents, and in other preventative health 
services contexts. 
I determined that it was possible to otTer truly anonymous HIV testing both 
explicitly and discreetly. The successful operation of past HIV testing studies in this small 
urban centre demonstrated the success of explicit testing, and variations of current 
reported procedures used for non-nominal testing demonstrated the possibility of discreet 
testing. Once again, this is with the understanding that the distinguishing factor between 
anonymous and non-nominal testing is the absence of a request for or recording of any 
contact information on the client, or any other information that could lead to the 
identification of the test seeker. This fits with the use of the term anonymous in other 
widely accepted and beneficial health promotion programs across Canada that usc this 
term. such as alcoholics anonymous (Mann, Zalcman, Smm1, Rush & Suurvali. 2006). It 
also fits with anonymous HIV testing guidelines in provinces with established 
anonymous testing programs in Ontario (Ontario Ministry of Health and Long-Term 
Care, 2008). Further references to truly anonymous testing in this document describe a 
testing situation in which contact information is not requested or recorded. All 
participants demonstrated acceptance of and support for the need for human contact at 
various points during anonymous HIV testing. This is also a standard of practice 
suggested by PHAC (2006b) guidelines. 
5.1.2 Explaining the Incongruence 
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This section focuses on the circumstances and contextual factors that explain dual 
role that the Communicable Diseases Act and conceptual confusion played in creating the 
inconsistencies that first inspired me to do this study. At the outset of the inquiry, there 
were several conflicting messages pertaining to the availability of anonymous HIV 
testing in this small urban centre. PHAC (2007a) Epidemiology update and the 
advertisements for anonymous testing in local student newspapers had indicated that 
anonymous testing was available (Muse, 2008). The Communicable Diseases Act, 
however, required name-based reporting. To add to the uncertainty, members ofthe 
community were unsure about whether or not anonymous testing was, in fact, available 
and what personal information was required to be tested for HIV as defined by the three 
different types of tests. 
The most likely explanation of these events is related to a temporary offering of 
anonymous testing that became available through a research study, which finished before 
my data collection began in January 2009. Participants n:rificd the anonymous testing 
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study had been underway prior to 2007 at both community-based organizations that 
participated in this inquiry. The document review confirmed that various community-
based organizations in the city had offered anonymous testing through the study. A 
participant who had been closely involved with this study confirmed that it had received 
ethical approval from two separate boards and granted organizational participants the 
ability to conduct testing anonymously free of any legislative restrictions. The document 
review analysis also confirmed that if anonymous testing was not available on-site at the 
community-based organization through the study, referrals were made to anonymous 
testing services elsewhere in the city. In a literature review of harm reduction strategies 
directed at controlling the spread ofHIV, Hilton, Thompson, Moore-Dempsey, and 
Janzen (200 1) note that harm reduction programs are often are frequently run as pilot 
projects, under-funded, and insufficiently coordinated. Vancouver 's safe injection site, 
InSite, is evidence of a similar temporary program that also received ethical exemptions. 
InSite "operates under a waiver of Federal rules that allow it to provide services as a 
research project" (Drucker, 2006, p. 1 ). Despite having positive outcomes for users of the 
site as measured by Wood eta!. (2004) it has not achieved long-term, sustainable 
operations. 
The temporary offering of anonymous testing through a study was likely reported 
to PHAC at the time the 2007 Epidemiology Update was being prepared for publication. 
Knowing about the research study helped me make sense of the initially perplexing 
footnote in the PI-1/\C (2007a) Epidemiology update that read '·Anonymous testing is 
available upon request but is not part of the official guidelines for the pro\'ince" (p. 16). 
The availability ofthis service \\as referring to past offerings of anonymous testing 
through the study, whereby "not part of the official guidelines" meant it was available 
through a temporary research study. In this way, it was excluded from legislative 
violations. 
5.1.3 Other Potential Pitfalls in Testing Terminology 
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Kodner and Spreeuwenberg (2002) demonstrate the importance of terminology in 
determining how providers "think about, shape, deliver, manage, regulate, finance, and 
evaluate health care" (p. 1). Throughout this inquiry, I noticed loose understandings of 
certain key concepts and became concerned about the potential for confusion of linked 
and unlinked information, as well as technicalities in the definitions of privacy, 
confidentiality, and security in the context of anonymous testing. 
Phrases that suggested variations of the concept of link that were used in the 
organizational definitions of anonymous included " lead to the identification of" 
(Document E3) and "connect to the individual's identity" (Document C9). Participants 
made multiple references to the word link when describing anonymous testing in their 
own words. For example, one participant described his perception about anonymous 
testing with statements such as "it should be impossible to link the test result to the 
individual" . I suspected that a likely deduction of this participant's statement could result 
in a layperson equating anonymous as a type of unlinked testing. This is an important 
distinction that is discussed here. 
The Council for International Organizations of Medical Sciences (2002) states 
that personal information collected for health purposes can be stored and classified as 
linked or unlinked. Unlinked information ··cannot be linked, associated or connected 
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(even by deduction) with the person to whom it refers'" (p. A). Linked information can be 
linked, associated or connected with the person to whom it refers. There are three 
categories of linked information including anonymous, non-nominal, or nominal. Within 
this linked category, anonymous information means that " the information cannot be 
linked to the person to whom it refers except by a code or other means known only to that 
person, and the investigator cannot know the identity of the person" (p. A). Non-nominal, 
on the other hand, is when the personal information can be linked to the person by a code 
known to the person and the investigator in which the code does not include personal 
information. Finally, nominal is when the information can be linked to the person by 
means of personal identification, usually the person's name. According to these 
definitions, anonymous testing is still considered to be linked to an individual ; however, 
only the individual to whom it is linked knows his or her code and is, therefore, the only 
individual who can identify this information. In this way, it is considered anonymous. 
This fits with the explanation provided in the previous section. 
On a related note, much work has been done surrounding the concept and practice 
of unlinked anonymous testing in the field of HIV I AIDS (Johnston et al., 1992; Kessel, 
Watts & Weiss, 2000; Rennie, Turner, Mupenda, & Behets, 2009). While an in-depth 
discussion about unlinked anonymous testing is beyond the scope of this analysis, 1 draw 
it to the attention of the reader here as something that could potentially lead to further 
confusion in the field . Unlinked anonymous HIV testing refers to screening of blood that 
has been de-identified and, therefore cannot be traced back to an indi idual. Unlinked 
anonymous testing is a controYersial screening practice that is done without an 
individual's explicit consent and is considered to be a survei llance technique. 
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Many references to broad concepts of privacy, confidentiality, and security were 
made, but participants lacked a demonstrated understanding of the distinctions between 
them. This paragraph differentiates between these terms to make this information 
accessible for providers. According to the Newfoundland and Labrador Centre for Health 
Information (NLCHI) (2004), confidentiality refers to "the obligation to protect, respect 
and maintain the confidentiality of personal information from unauthorized persons, 
processes, or devices" (p. 7). The NL Department of Justice (2009) describes 
confidentiality as the right of a person to withhold information from others. Privacy, on 
the other hand, is referred to as the "protection of personal information" (Department of 
Justice, 2009) or "the right of an individual to control the collection, use, and disclosure 
of personal information about himself or herself' (NLCHI, 2004, p.8). Finally, the 
concept of security has a narrower focus. It refers to the "establishment and maintenance 
of safeguards to protect personal information from unauthorized access, use, disclosure, 
modification, loss or theft" (Department of Justice, 2009). It focuses on the means used to 
protect data and/or information from "accidental or malicious disclosure, modification, 
removal or destruction" (NLCHI, 2004, p. 8). In general, people expect that in situations 
involving medical and financial services that their personal information will only be 
shared with people they intend to share it with. 
5.2 Communicable Diseases Act: " ... because you can get in big trouble .. ... , or can you? 
Laws to provide powers necessary to counter public health threats have existed 
since early times (Coker & Martin. 2006). /\II part icipants interpreted the Communicable 
Diseases Act in the same way: it \\ US bel ieved that anon)mous testing has al\\ays been 
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illegal and will be illegal until there is some change in the legislation that absolves 
responsibilities around mandatory name-based reporting. Since this interpretation was 
widely accepted by the study participants and other community members, I presumed this 
was an accurate interpretation and conducted the study on this premise. For instance, 
some participants from community-based organizations feared that offering anonymous 
testing would result in prosecution and/or eventual shut-down of their clinic. Similarly, 
participants from the regional health authority recognized their close connection to the 
provincial government and the need to abide by provincial laws. During the interviews, 
participants were quick to point out that anonymous testing had been offered as part of a 
study and it was no longer available to illustrate that they were now complying with 
legislation. I eventually speculated that participants were hesitant to discuss their 
organization's practice of offering anonymous testing because they perceived that doing 
so was illegal. 
In the final stages of the write-up, I corresponded with two provincial government 
representatives who dealt with communicable diseases within the Department of Health 
and Community Services and the Department of Justice. The representative from the 
Department of Health confirmed that while there were some legal complexities to the 
interpretation of the Act, it was "safe to assume" that the widely accepted interpretation 
that had been expressed by the participants was correct (G.B., Personal Communication, 
March 4, 20 I 0). This confirmed the Department of Health and Community Services 
supported the widely accepted interpretation that an /\ct requiring mandatory reporting 
prohibits anonymous testing My inquiry \vas then forwarded to a solicitor with the 
Department or Justice \\ho pointed out that Section 4 outlines mandatory reporting 
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provisions and Section 34 sets out the offences section where a person wilfully commits a 
breach of the Act. The solicitor was unsure if Section 4 has ever been enforced and that 
there were at the time of the correspondence, no Regulations adopted under this Act. 
Finally, the Solicitor noted that the Act is dated and may be in need of updating (G.S., 
Personal Communication, March 8, 201 0). 
This section examines this interpretation of the Communicable Diseases Act and 
explains my suspicion that legislation is the root cause of much policy-practice 
incongruence and the biggest barrier to transparent communication and conceptual 
clarity. I address whether or not the interpretation of anonymous testing as an illegal 
practice is a correct interpretation of the Communicable Diseases Act 4(3) on the 
following grounds - absence of historical prosecution, silence about testing, ethical issues 
surrounding reporting requirements, and antiquated legislation. I conclude by examining 
reasons why this could be an incorrect and outdated interpretation based on a comparison 
to legislation in provinces where anonymous testing is available. These reasons offer 
possible explanations for key areas of incongruence and provide further rationale for 
excerpts from key documents. 
Coker and Martin (2006) examine the role of law in the protection of public 
health. Not only does law have direct consequences, such as providing reason for penalty 
in the event of a breach, it also has a wider role to play by helping shape socio-cultural 
norms. Laws create expectations of standards of health and safety and public perceptions 
that certain behaviours or actions represent the minimum standards o f health protection 
that are accepted by society. The findings of this inquiry have led me to question both the 
enforceabi lity of the Communicable Diseases Act given the accepted standards of 
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practice observed in this study. [t seems that providers from formal and informal settings 
unequivocally see the need for HIV testing that docs not require collection of personal 
information or other modifications of service delivery that would increase the likelihood 
of a person receiving preventative treatment or education. The law has failed to keep pace 
with the changing needs and demographics of the clients seeking services and the 
changes to clinical environments required to suit them. Valdiserri (2004) points out that 
this has significant negative impact on program and policy development. 
I question how reasonable it is for us to consider the act of offering anonymous 
testing as an illegal activity for which a service provider will be prosecuted. For example, 
at no point during the history of confusion about testing terminology where non-nominal 
testing was referred to as anonymous was there ever any mention of illegality or 
prosecution. This was also the case for widespread advertising of anonymous testing, and 
the offering of anonymous testing through the specialized research studies. Coker and 
Martin (2006) explain that a lack of penalizing action creates a precedent that this 
practice is acceptable. 
The Communicable Diseases Act is very specific about reporting requirements, 
but it is silent with respect to testing for communicable diseases. It docs not explicitly 
describe procedures permitted for preventative testing and screening programs. Within a 
public health context, Coker and Martin (2006) point out that the absence of law sends a 
message about acceptable behaviour through implication. Specifically, if the law is silent 
it implies that the action is okay even if it is not in the interest of publ ic good. l Iigh fat 
food is a good example. In the absence of a law to prcYent the adverti sing of junk food to 
chi ldren. it is implied that there is nothing unacceptable about targeting chi ldren in such 
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advertisements. If this rationale is applied to the Communicable Diseases Act, which is 
silent about anonymous HIV testing, it would be implied that the provision of anonymous 
testing is okay. As such, I question my participants' and the widespread interpretation of 
anonymous testing as an illegal practice. If this practice is, indeed, legal, it still begs 
important questions about the feasibility and ethical appropriateness of offering 
anonymous testing when there are name-based reporting requirements. 
Walsh (2007) describes this ethical tension as a "legal-regulatory limbo". To 
explain this conundrum, it is helpful to separate the testing and reporting processes. Any 
jurisdiction that permits anonymous testing, but also requires name-based reporting is 
asking people to think of testing and reporting as mutually exclusive processes. 
Specifically, you can be tested anonymously, but positive cases are reported and followed 
up on using names. Therefore, once a positive result is confirmed, the anonymity of the 
test that was initially offered quickly dissipates. 
While it does have specific procedures for the reporting process, the wording of 
the Communicable Diseases Act as it pertains to reporting are open to interpretation. The 
relevant section of the Communicable Diseases Act reads as follows, 
(2) The notice to the deputy minister or to the health officer shall, where 
possible, state the name of the disease, the name, age and sex of the 
person, and the name of the physician giving the notice, and shall by street 
and number or otherwise, sufficiently designate the house or room in 
which the person is living. 
This definition raises questions about a dl!finition for possible . Would situations 
''here individuals seeking testing refused to provide personal information for a \'aricty of 
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personal reasons merit a situation in which it was " impossible" to record and report the 
personal information stated in the Act? If a healthcare provider deemed it inappropriate 
or insensitive to request or insist on this information due to an individual's personal 
circumstance, would it be " impossible ' to report the personal information stated in the 
Act? I discovered that Quebec, New Brunswick, and Nova Scotia, three of the provinces 
that officially and publicly offer anonymous testing without fear of prosecution for 
engaging in an illegal activity, use similar wording to describe the requirements for 
transmitting personal information in their applicable legislation. Terms such as " if it is 
available" (Quebec), "if known" (New Brunswick), and "to the extent possible" (Nova 
Scotia) seem to leave flex room for the reporting provider to omit personally identifying 
details, or possibly never make an effort to collect them at all. 
This argument is strengthened by the fact that the last update to this section of the 
Act was in 1970. Coker and Martin (2006) note that a fundamental shift has occurred in 
public health overtime in the balance between common good and individual rights 
protection. Kodner (2009) points out the increased need to reduce the gap in health 
systems' ability to service the complex and growing needs of vulnerable populations, 
instead of continuing to enlarge their "overwhelming and increasingly anachronistic 
acute, episodic medical orientation". Coker and Martin suggest an environment in which 
biomedical values permeate the attitudes and beliefs of providers poses an increased risk 
for human rights breaches. For example. in situations vvhere the authorities who arc 
responsible for exercising public health powers without regard for the impacts on the 
population ha\'e the potential to apply certain public health measures with little 
consideration lor individual rights. They emphasize the importance lor such interference 
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measures to occur under certain conditions. Specifically, when and if it is necessary to 
protect public health, where the interference it is proportionate to the public health threat, 
and where the relationship of power of a public health provider over an individual is 
known and regulated by law. 
A need for a shift away from biomedicine towards public health measures that 
service the needs of vulnerable populations has been acutely pronounced throughout the 
HIV I AIDS movement. In 1996, a new class of antiretroviral agents was introduced and 
resulted in a marked decrease in HIV-related mortality. Valdiserri (2003) concludes that 
since the availability of highly active antiretroviral therapy, the real and perceived public 
health risk of HIV I AIDS has decreased. Real risk is demonstrated by measureable 
decreases in key indicators, such as mortality. For example, after one year of availability 
of treatment it was estimated that there was between 15 to 20% fewer HIV -related deaths 
in the United States and Canada. Valdiserri explains that perceived risk is related to 
public perception of the unknown. When perceived risk is high, a layperson will have 
more negative feelings towards and react more strongly to a risk this is perceived to be 
dreadful, unknown, new, and unobservable. It is of fundamental importance to point out 
that law and policy-makers in 1970 when the Communicable Diseases Act was last 
updated may have had far higher levels of real and perceived risk about HIV I AIDS than 
present-day law and policy-makers. 
Outdated provincial legislation that no longer reflects practice and a decrease in 
alarmist attitude towards HIV/AIDS offers a possible explanation for the inconsistencies 
that were observed in this inquiry. Most notably, the regional health authority's draft 
policy outlined non-nominal rcpot1ing, \vhcrc cases m:rc reported to the Department of 
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Health and Community Services using an "assigned code" (p. 5) as a matter of routine 
practice; however, the Communicable Diseases Act requests detailed personally 
identifying information ("name of the disease, the name, age and sex of the person, and 
the name of the physician giving the notice, and shall by street and number or otherwise, 
sufficiently designate the house or room in which the person is living"). A participant 
from the health authority noted that the intention of the draft policy was to reflect the 
changing needs of health service delivery for HIV testing and the current practices of the 
providers who do testing, counselling, and reporting. Similarly, participants reported that 
when the HIV Clinic in the acute care setting was open, clients had been referred to it 
using a non-nominal code, chart number, or initials. While no one from the acute care 
setting was interviewed to confirm this, it suggests healthcare providers in acute care 
settings also provided anonymous care when necessary to the extent possible despite the 
reporting requirements outlined in the Communicable Diseases Act. This suggests further 
and longstanding incongruence between the Communicable Diseases Act and practice in 
the acute care setting. Taken together, these areas of incongruence suggest the 
Communicable Disease Act is prohibitive and has failed to keep up with changing nature 
of this highly stigmatized disease in which psycho-social factors play an important role in 
accessing preventative services and treatment. 
5.2. 1 Legislation in Other Provinces 
To inform my recommendations on the legislative aspect of the inquiry, I looked 
at the applicable legislation of those provinces that PHAC (2007a) had identified as 
offering anonymous II IV testing that did not ha\'e footnotes indicating that positive tests 
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became part of the nominal system. Provisions in provincial legislation that making 
anonymous testing legal included recent updates to allow anonymous HIV testing 
(Saskatchewan), unique reporting forms for HIV I AIDS (SK), exclusion of HIV from the 
list of reportable conditions with inclusion of AIDS (Ontario), and the use of careful 
wording. 
In Saskatchewan, the legislation was updated in 2003 to allow a unique reporting 
format for HIV I AIDS that was different from other communicable diseases (Government 
of Saskatchewan, 2003). Under the Public Health Act, Saskatchewan's Disease Control 
Regulations defined anonymous test sites as a "a place where a person may have a 
specimen collected for the purpose of testing for human immunodeficiency virus 
infection without the person's name being disclosed" (p.3). As of2003, anonymous 
testing sites had been permitted with the approval of the minister under the condition that 
the operators provide "a monthly report of information to the co-coordinator in the format 
approved by the department" (p.5). 
In Ontario, the Health Protection and Promotion Act Section 3 I (I) specifies that 
"every medical officer of health shall report to the Ministry in respect of reportable 
diseases and in respect of deaths from such diseases that occur" (Ontario Ministry of 
Health, I 990). However, HIV is not included on the reportable communicable diseases 
list, but AIDS is (Regulation 559(9 I), Health Protection and Promotion Act). 
In Quebec, the Minister's Regulation under the Public Health Act states that when 
there is a confirmed case of HIV, the ··name and permit number or the health proCessional 
who requested the analysis .. and .. if it is available, the patient's health insurance number'' 
must be transmitted to the national public health director (Go\'crnmcnt of Quebec. 2003 ). 
There arc stricter repot1ing parameters if the transmission is in a ''person who has 
received blood, blood products, organs or tissues" (Section 3(4)). 
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The Government of Nova Scotia's Health Protection Act (2005) refers to the 
Reporting ofNotifiable Disease and Conditions Regulations to outline all reporting 
procedures. Under these regulations, HIV is considered a notifiable condition (Schedule 
A, Part I). The Regulations stipulate that occurrences of notifiable conditions are to be 
reported and "to the extent possible" the report must include the following information 
about the individual with the condition "the name, age, address, ethnicity and sex of the 
person who is the subject of the report; the name of the notifiable disease or condition or 
the illness that is being reported; and all clinical and epidemiological details pertinent to 
the diagnosis and follow-up of the person who is the subject of the report". These 
regulations came into effect in 2005. 
Under the New Brunswick Health Act, Section 94 outlines public health and 
communicable disease legislation. "AIDS related complex, and any confirmed HLTV-III 
virus antibody reactive status" (Section 94(1) p. 24) are listed as notifiable diseases. The 
notification procedure requires the district medical health officer or the nearest public 
health inspector to immediately notify the district medical health officer (Section 94(3), 
p. 24). The report '·shall contain the name of the person infected or suspected to be 
infected, the place of residence and the name of the disease, if known" (Section 94(3)). 
5.3 The eed to Increase Communication between Service Providers 
Three areas of concern expressed by participants who v\'Orked in a community-
based organization were different than those expressed by participants'' ho \Yorkcd for 
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the regional health authority. Firstly, participants from both community-based 
organizations voiced concerns about the regional health authority's lack of 
communication about the official HIV testing policies and procedures. This concern is 
referred to as ' lack of communication of official policies and procedures'. Secondly, 
participants from both community-based organizations felt there was an urgent need for 
access to anonymous testing services, while participants from the regional health 
authority demonstrated varying levels of support for anonymous testing depending on 
their personal understanding of anonymous testing. This concern is referred to as 'sense 
of urgency for desired changes to testing services'. Finally, aside from recognizing the 
need to scale up the availability of testing service delivery and improve volume at testing 
sites, participants from the regional health authority were more likely to express 
satisfaction that current testing procedures were highly confidential and provided 
specialized services when needed. Participants from community-based organizations, on 
the other hand, displayed lower levels of trust in the security of data provided during the 
HIV testing process and were more suspicious about its intended and potential usages due 
to their damaging effects. This concern is referred to as 'community distrust in the 
current system'. Based on Valdiserri's (2003) theory that perceived risk is related to 
public perception of the unknown, this section discusses why there is a need for increased 
communication between community-based organizations and the regional health 
authority using the dimensions of risk, trust and accountability. Increasing 
communicat ion could play a role in bridging the gap between levels of trust displayed by 
employees of community-based organizations, \Vhich arc more likely to reflect the views 
ofthe general population, and healthcare \Vorkers. 
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5.3.1 Exploring the Differences in Service Providers' Concerns 
The concerns expressed by participants from both community-based organizations 
and the regional health authority support those of previous studies that have demonstrated 
the importance of and need for increased collaboration between community-based 
organizations and formalized medical settings (Rutledge & Robinson, 2009). To provide 
"seamless, high-quality psychosocial care" (p. 29) required to prevent chronic illnesses, it 
is best to utilize community-based organizations that exist to provide support for people 
with diverse needs. Literature concerning the conditions necessary to prevent HIV deems 
effective information exchange a vital component of collaboration between community-
based organizations, researchers, and policy-makers (Roussel, Fan & Fulmer, 2004). 
Participants from community-based organizations listed a number of concerns 
with the HIV testing system in place at the time of the study, through which anonymous 
testing was not officially available. They described the benefits of anonymous testing 
based on their experiences of having been able to offer it in the past and the gap in 
service delivery that was created by losing it. What participants from community-based 
organizations did not realize was that discreet anonymous testing was available under 
certain circumstances, but this was not widely communicated or even realized by the 
people offering the service. 
Based on Gilson and Erasmus' (2006) finding that communication is a 
foundational principle of the accountability required to build trust in health service 
del ivery, the lack of understanding the ·'official'' process is likely a main factor in all 
concerns identified by participants from community-based organi zations. Participants 
ti·01n community-ba ed organizations expressed a sense of urgency about the need to 
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establish anonymous HIV testing services in the small urban centre far more than 
participants from the regional health authority did. This is because participants from 
community-based organizations associated the current system with a higher degree of 
risk. Most importantly, there was much uncertainty about what it means to be " in the 
system". Knowledge deficits displayed by participants from community-based 
organizations included the belief that there was a fee associated with HIV testing at any 
site that was operated by the regional health authority, and the belief that during a non-
nominal test the MCP number was recorded in the file making test results accessible for 
third party information requests from family physicians and insurance companies. 
Along with the complexity of language and ambiguous history of HIV testing 
services, uncertainty is a key dimension of perceived risk (Morgan et al., 200 I) that was 
observed in this study. Participants of community-based organizations believed that there 
were too many unknowns about HIV testing in this small urban centre. Community-based 
organizations had unanswered questions about specific aspects of the testing procedure 
(personal information requirements, costs, waiting room set-up, quality of service 
delivery, and other aspects of the testing services to which they are referring their 
clients). This was a sharp contrast with their past experiences of offering on-site truly 
anonymous testing through a study, which was a process they were physically close to, 
which allowed them a high degree of control and the opportunity to gain a sophisticated 
understanding of the process. 
Participants from the regional health authority, on the other h~md were more 
content with current IIIV testing services from a security perspective and felt there \Vas 
no need for drastic or urgent change. This could be because they enjoyed implicit 
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knowledge that the participants from community-based organizations lacked, which 
could only be acquired through in a formalized setting. For example, they were aware of 
the security measures taken to protect the identity of those who have been tested for HIV, 
such as the absence of MCP numbers on reporting forms that are sent to the provincial 
government, the number of people who accesses the files, the ability to be tested without 
providing one ' s true name or contact information, how Meditech operated, and the 
processes surrounding random code generation. Furthermore, they were confident in their 
own and other members ' of their professions' abilities to keep clients' information 
confidential despite local privacy breeches that had recently occurred. Finally, this 
inquiry demonstrated that the regional health authority permits only experienced public 
health nurses who have undergone extensive training to be communicable disease nurses. 
This finding is consistent with previous harm reduction studies such as Gustafson eta!. 's 
(2008) finding that registered nurses are well-positioned to play a role in harm reduction 
efforts and could benefit from transparent communication on specific harm reduction 
practices. 
5.4 Social Justice and an Expanded Social Determinants ofHealth Inequality Framework 
to Support Explicit Anonymous HIV Testing in Small Urban Centres in NL 
Public health is based on social justice and human rights, which aim to reduce 
factors that perpetuate vulnerabi lity (Burris, 2004) and is often analysed using the social 
determinants approach. Graham (2004) highlights the need for researchers to place 
increased emphasis on the social processes that dri\'e health inequalities to develop 
policies that address health inequalities. Most importantly, \Vhen addressing a .. policy 
audience" (p.l 1 8), Graham emphasizes the importance of differentiating between the 
social determinants ofhea/th and social determinants ofhea/th inequalities. 
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To help with differentiating between these two things, it is helpful to review 
Braveman and Gruskin's (2003) distinction between equality and equity. Equal means the 
same opportunity to access a service, but does not address the variety differences that 
exist within the broader social context. Equity refers to the fair opportunity for all 
population groups to be healthy and focuses on the distribution of resources that drive 
different health outcomes. Equal opportunities to be healthy are fundamental to the 
concept of health equity. While it is possible to assess equality with respect to specified 
measurable outcomes, there are more considerations and interpretations when judging 
whether a process is equitable or not. A health disparity is inequitable if it is 
systematically associated with social disadvantage that puts a previously disadvantaged 
group at a further disadvantage. Resource allocation, policy and program development, 
and decisions about those directives shaping systemic factors should be distributed and 
designed in ways that are most likely to improve the health outcomes of disadvantaged 
social groups with the outcomes of their more advantaged counterparts. In this way, 
governments and systems strive to be non-discriminatory. This section reviews 
regionally-specific academic research, demographic trends and statistical information that 
demonstrate health inequality in NL by focusing on three determinants (education and 
literacy, personal health practices, and health services) that \vere relevant to the findings. 
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5.4.1 Literacy Rates and Discreet Testing 
NL has one of the lowest health literacy rates in Canada, where health literacy is 
defined as ·'the ability of individuals to access and use health inf01mation to make 
appropriate health decisions and maintain basic health" (Canadian Council on Learning, 
2007, p.3). Health literacy encompasses one's ability to obtain, understand and act upon 
health information and services and to make appropriate health decisions for his or her 
own health. In general, health literacy decreases with one's social position and resulting 
access to education, labour, property, wealth, and political influence (PHAC, 1999). 
Literacy rates are particularly relevant to this study because of the requirement for a test 
seeker to understand and act upon words used to describe testing services, such as 
anonymous, nominal, and non-nominal. Participants' attributed the interchangeable use of 
testing terminology to the belief that most test seekers do not understand the technical 
differences between the terms non-nominal and anonymous. They suspected that people, 
providers and test seekers alike, preferred the term anonymous because they knew what it 
meant. The assertion that familiar terms are preferred seems likely given these statistics 
on health literacy levels. Embedding complex language and terminology into public 
services creates a systemic barrier. The current delivery of testing, as well as the 
Communicable Diseases Act and the regional health authority's policy exempl ify how 
policy can propagate power imbalance and health inequity. 
A key barrier to accessing STI testing in Canada identified by Goldenberg et al. 
(2007) was limited access to information. Aside from the controversial poster campaign 
launched by testing site #2. there was no evidence of efforts to communicate the 
a\'ailability of testing services. the type of testing services, or the procedures used in each 
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type of test and setting. Absence of such communication places the general public, 
especially people with low literacy levels, at a disadvantage when it comes to accessing 
information about testing services. Obermeyer and Osborn (2007) confirmed that 
providers and test seekers have different notions of what constitutes confidentiality and 
anonymity and suspect that this unclear understanding is related to the uneven application 
of practices intended to protect confidentiality. When providers and clients do not share 
an understanding about the differences between confidential and anonymous testing, the 
negotiation of potential tensions between testing policy guidelines and individual clients ' 
preferences is left to providers and test seekers at the point of service delivery 
(Obermeyer & Osborn, 2007). 
Combining this observed lack of communication with the finding that test seekers 
are more conservative in their definitions of confidentiality (A wad eta!. , 2004), suggests 
that a power imbalance between provider and test seeker becomes evident at the very 
early stages of the testing process. The likelihood for test seekers who demonstrate a 
more conservative definition of confidentiality to receive the service in the manner they 
would like decreases with literacy rates as does their ability to negotiate. The highly 
technical nature of HIV testing language takes away one's ability to enjoy the advantage 
offered by health literacy - " to obtain, understand and act upon health information to 
make appropriate decisions for his or her own health., (Canadian Council on Learning, 
2007, p.3). 
Effective education for children and lifelong learning for adults are key 
contributors to indi\·idual and population health (PI lAC, 2003). With literacy lc\'cls as an 
indicator, education contributes to health and prosperity by equipping people \\ith 
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knowledge and skills for problem solving, and helps provide a sense of control over life 
circumstances. Graham (2004) has cautioned against "blurring the distinction between 
the social factors that influence health and the social processes that determine their 
unequal distribution" (p. l 09). We must treat low health literacy as a driver of health 
inequality in NL. To incorporate Graham's (2004) work, I urge increasing the emphasis 
placed on inequality: low health literacy limits people's ability to access HIV testing 
services due to lost negotiation power and a lack of communication of understandable 
material that explains HIV testing. Policies that have provisions that account for the 
likelihood of a test seeker to display low health literacy should become central to the 
delivery of HIV testing services. 
5.4.2 Perceived Irresponsibility 
In addition to having different understanding of confidentiality, providers may not 
view requests from test seekers for enhanced confidentiality in a positive light especially 
if it is seen as an accommodation for an individual who is perceived as irresponsible 
(Obermeyer & Osborn, 2007). Goldenberg et al. ' s (2007) work on barriers to testing to 
make the connection with irresponsibility; real and perceived judgmental behaviour by 
healthcare providers is a barrier to testing. This could create feelings of stigma, shame. 
and social discomfort could deter people from seeking testing as well as rclatt:d concerns 
about anonymity and confidentiality. Yang et al. (2005) describe how I IIV stigma is 
often coupled with multiple layers of co-stigmas that can be directly or indirectly related 
to both the cause and consequences of the infection including injection drug usc. sex 
\\:ork, sexual bchaYiour, cthnicity. poverty and disability. Instead or examining all or the 
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characteristics that result in multiple layers of stigma described by Yang et a!., I focus on 
the risk factors that participants said were present within their client populations that 
could be related to irresponsibility, including injection drug use, sex for money 
unprotected sex, and sharing of drug paraphernalia. 
There is a strong presence of injection drug use in NL (HRU & ACNL, 2007· 
Oxycontin Task Force, 2004). Patten (2006) has demonstrated the link between injection 
drug use and the risk of transmission of HIV and other sexually transmitted infections. 
Individuals involved in injection drug use are considered to be at-risk of HIV and shown 
to be more likely to access anonymous testing services than nominal or non-nominal 
testing (Hoxworth eta!., 1994; Kegeles eta!., 1990). On the topic of injection drugs, it is 
necessary to point out that 53% of new HIV infections among Aboriginal Canadians are 
attributed to injection drug use, which is much higher than the 14% of new infections 
within the general population that are attributed to injection drug use (PHAC, 2007a). 
Since this is a Canadian statistic, it is impossible to conclude whether it is indicative of 
HIV infection within NL's Aboriginal population. According to Statistics Canada Census 
data (2006a), NL's self-identified Aboriginal population repre ents 5% of the provincial 
population, which is higher than the national average. Given the strong presence of this 
population in NL and the challenges of delivering culturally appropriate HIV testing 
services presented by Sucharski eta!. (2006) and Tseng ( 1996), it is necessary to draw 
attention to the increasing number of infections attributed to injection drug use on a 
national scale to highlight the need for further investigation of I IIV testing sen ·ice 
delivery to NL 's Aboriginal populations. 
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Another area of intersection between social exclusion, injection drug usc and 
stigma is the MSM category. Of the 18,560 adult male AIDS cases reported in Canada, 
76.1% were attributed to men who have sex with men and an additional 4. 7% were 
attributed to the men who have sex with men who also reported being injecting drug 
users (PHAC, 2007a). In NL, 51% of infections are attributed to men who have sex with 
men (Department of Health and Community Services, 2008). There was a dearth of 
academic literature on lesbian, gay, bisexual, and transgendered populations in small 
urban centres in NL, so I consulted a Canadian study that recruited its sample of lesbian, 
gay and bisexual youth from rural communities in British Columbia. Poon and Saewyc 
(2009) revealed that this population experienced feelings of victimization, had 
experimented with substances, and had special needs to consider when accessing 
preventative health services. I suspect lesbian, gay, bisexual and transgendered 
populations in this small urban centre face similar challenges. 
In an examination of community-based HIV prevention research, Shannon et a!. 
(2007) note that women who exchange sex for money, drugs, shelter, or other 
commodities as a means of basic subsistence face an elevated risk of HIV transmission. 
While there was a lack of academic literature on the sex trade in NL, local grey literature 
suggests that there is a growing presence of female prostitutes in the downtown area who 
face similar challenges (Walsh, 2008). Part of the increase in local prostitution was 
attributed to the economic gains that have resulted from the recent economic prosperity 
related to the oil industry. As a result of increased oil-related traffic to the region, the 
demand to trade sex for money had increased, as well as the price people were willing to 
pay. 
210 
Prior to recent oil-related economic prosperity, increased exposure to STis was 
previously observed in other areas related to industry and employment. Due to 
interprovincial migration, NL temporarily loses youth who seck temporary employment 
in other provinces, often in industry-related jobs such as oil and gas, and later return to 
the province (Statistics Canada, 2006c). Research demonstrates the growing trend for 
youth involved in industry-based interprovincial migration have a propensity to binge on 
alcohol and drugs and access the sex trade (Goldenberg et al., 2007). This places them at 
a higher risk for infection in a stigmatized environment where access to health services 
for sexually transmitted infections is low. This creates a need for specialized prevention 
and screening services and an elevated risk of bringing the infection home to their home 
communities. 
In summary, people who use injection drugs, participate in the sex trade, and 
engage in unsafe sexual practices experience feelings of stigma or shame about the 
activities in which they engage. Goldenberg et al. note that perceived judgmental 
behaviour by healthcare providers on an individual's personal choices can result in 
stigma, shame, and social discomfort. This stigma could deter people from seeking 
testing and related concerns about anonymity and confidentiality. These individuals may 
need additional services and support when seeking testing. Under a social determinants 
model, we might try and fit these activities into the "personal health practices'' box. This 
is defined as those actions by which individuals can prevent diseases and promote self-
care, cope with challenges, and so lve problems that prevent sickness and enhance health 
and well-being (Pl-1/\C, 2003). As Graham suggests. these practices ha\"C damaging 
health effects and arc by no means evenly distributed throughout the population. Their 
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presence suggests an examination of a broader psycho-social context of inequality, rather 
than focusing on the individual making the health decision. 
5.4.3 Health ervices as a Deterrent to Testing 
Goldenberg et al. (2007) state that characteristics of health service delivery 
systems that can prevent people from accessing STI testing services include inconvenient 
hours of operation, wait times, and clinic location. There was evidence of this with 
participants' concerns about testing in formalized environments such as the location and 
accessibility of testing site #3, under-awareness of the services avai lable at testing site #3, 
and concerns about the quality of STI services provided by family physicians. There were 
specific concerns about the numerous services offered at testing site #3. f made the 
assumption that many community-based organizations focused on testing site #3 because 
it had been established for a longer period of time than testing site #4. Additionally, 
testing site #4 was focused on youth and since opening has maintained a relatively low 
public profile so participants may not have been aware of this service. One participant 
described a situation in which a person who injected drugs was afraid to be tested at 
testing site #3 because of the possibility of bumping into a child protection social worker. 
The person thought the social worker would find out that he or she was there for an HIY 
test. This would indicate that we was an unfit mother and she would lose her children. 
While healthcare professionals have a duty to prevent this from happening, I 
believe this supp01ts the conclusion of A wad et al. (2004) that the public"s '·fear of health 
providers breaking confidentiality is exacerbated \\'hen rcpo1ts of specific instances of 
breaches arc made public .. (p. 113). I remind the reader about the November 2007 
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incident described in Chapter I in which a healthcare provider installed a file sharing 
program on her laptop while working from home and unknowingly transmitted 
confidential medical files over the Internet (Office of the Information and Privacy 
Commissioner, 2008). PHAC (2003) refers to health services as those services that are 
designed to improve the health of individuals and populations by maintaining and 
promoting health, preventing disease, and restoring health. This inquiry has demonstrated 
how HIV testing is a health services that is situated within a broader structural inequality 
as described by Young (2006). Certain aspects ofthe current service delivery, in fact, 
deter individuals from accessing preventative health services. This drives health 
inequality, denies the individuals their fundamental human right to health, and 
demonstrates social injustice. 
5.5 Implications and Recommendations 
Thus far this chapter has outlined a number of theoretical and practical 
implications of the research findings. This discussion has highlighted systemic inequities 
within the current testing system, such as the expectation that people with low literacy 
levels will be able to understand the nuances between non-nominal and anonymous. Such 
expectations and requirements demonstrate how, through policy mechanisms, the system 
can favour basic human needs and the rights of some more than others. Despite 
differences in individual understanding of the definition of anonymous testing, all 
participants supported the need for specialized services to some extent. Community-
based organizations supported this enthusia tically, \Yhile support from participants at the 
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regional health authority was on an as-needed basis, and fluctuated with their individual 
understandings of anonymous. 
Based on these findings, I believe that explicit anonymous testing should be made 
available through a province-wide policy in a transparent manner and supported at all 
levels of government, healthcare, and community in NL. Risk behaviours that could have 
a negative health outcome for which specialized services are provided arc typically 
viewed as a harm reduction approach, which traditionally centre around substance use 
and the sex trade (Shannon et al., 2007). Anonymous testing, as a specialized service, 
should be made available not as a harm reduction effort for drug users and sex trade 
workers, rather for the general population of test-seekers. I refer here to individuals who 
may not be affiliated with any risk group or engage in any health damaging activity, but 
who may want more confidentiality than offered by non-nominal testing. This section 
provides recommendations for change at various levels of responsibility (federal, 
provincial, and organizational). It identifies areas in which future research would be 
beneficial, reviews the dissemination plan, and offers concluding remarks. The 
recommendations that follow take into consideration that official anonymous testing may 
not be supported by all stakeholders and recognizes the time required for legislative 
change. I have attempted to make pragmatic suggestions that could lead to realizable 
change. 
5.5.1 Recommendations to the Provincial Go\'crnment: Clarify and pdate Legislation 
Knowing that other proYinccs otTer anonymous testing despite w·ording of their 
respective provincial legislation that closely resembles that of 1 L ·s ommunicublc 
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Diseases Act, questions about its interpretation and application must be addressed. The 
provincial government Departments of Justice in partnership with Health and Community 
Services should take the following steps to alleviate uncertainty for providers in testing 
situations. 
1. Issue a statement that clarifies whether or not the Communicable Diseases 
Act prohibits or permit anonymous testing; 
2. If anonymous testing is prohibited, provide justification given that 
a. positive outcomes were noted when explicit anonymous testing 
was made available during a previous research study; 
b. discreet offerings of anonymous testing occur in practice 
environments; and 
c. research participants unanimously support the provision of 
specialized services and the presence of at-risk populations. 
3. If anonymous testing is permitted, the Department of Justice and the 
Department of Health and Community Services should coordinate a forum 
in which all regional health authorities and other service providers of STI 
prevention services are given a chance to clarify the language in the 
current legislation and discuss its challenges. 
a. This forum should provide clarification for all parts of section 4(3) 
ofthe Communicable Disease Act including ··where possible" 
4. Examine the possibility of updating this legislation as many other 
Canadian provinces have by looking at changes that ha\'c been made to 
other pro inces' communicable di cases legislation to reflect the changing 
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nature of HIV as a communicable disease. Regardless of how NL ·s 
legislation is interpreted at present and whether or not stakeholders 
support anonymous testing, this legislation should be updated to reflect 
changes in accepted standards of practice for HIV testing, the decrease in 
alarmist attitudes of HIV -related risk and dread that have resulted from 
advances in treatment. Interference with individual information is required 
only to an extent that is proportionate posed by the public health risk it 
poses. 
5.5.2 Recommendations to the Regional Health Authority: Reduce the Unknowns 
Due to a lack of communication about the HIV testing procedures at the 
formalized testing sites operated by the regional health authority, employees of 
community-based organizations were uncertain about various aspects of HIV testing 
procedures. This precluded them from being able to help their clients by answering 
questions or volunteering information that would reduce the unknowns about an already 
stressful situation, HIV testing. Limited understanding of this process takes away 
community-based organizations' ability to provide current and detailed information. This 
is significant when the critical role the community-based movement has had in 
responding to HIV/AIDS in Canada is examined. Initial efforts to respond to I-llY/AIDS 
originated within communities and expanded to their present fortitude of being available 
in all Canadian provinces and territories (CIHR, 2009). The services provided by 
community-based organizations in British Columbia \Vere described as being ··ncxible. 
timely, innovati,·c and creati\'c, often \Vith minimal financial resources·· (Pacific AIDS 
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Network, 2009, p. 7). While there are many contextual factors that differentiate the 
response ofNL's community-based organizations from that of British Columbia's, it is 
safe to say that it is challenging to provide information about HIV testing services in the 
absence of a clear definition of anonymous testing and without a complete description of 
testing procedures. The fact that a policy directing employees to use non-nominal 
reporting has been in draft format for over a year was evidence of the slow-moving 
policy process in the large organizational structure. Action to communicate an 
organizational policy internally or externally cannot occur until the policy is approved. 
In the absence of policy guidelines on which to develop clinical directives, public 
health providers rely on their professional training and experience or view their personal 
moral foundations as sufficient to solve an ethically challenging clinical decision (Baum 
et al., 2007). Without an intricate knowledge of the details ofthe process, it is impossible 
for providers to understand the process themselves, which precludes them delivering this 
knowledge to an inquiring client. Clear communication of the procedures followed during 
the three types of HIV tests at the regional health authority's testing sites is required. 
After finalizing the policy, details of procedures used at public health settings should be 
communicated to the community-based organizations. This will require revisions to the 
current policy document. Messages should be disseminated using knowledge translation 
principles outlined by Graham et al. (2006), which include techniques such as tailoring 
the message to the needs of the audience. The regional health authority should take the 
following steps: 
5. the draft HIV testing policy should be revised to address the question of 
\vhat to do \Vhen a test seeker withholds personal information required for 
- - ----------------
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non-nominal testing. Examine the possibility of including a clause that 
states "in a special circumstance or any other event in which there a client 
is hesitant to provide personal information, anonymous testing may be 
performed"; 
6. When the policy is finalized, create descriptions for all staff providers 
involved with providing testing services; 
7. the regional health authority's Community Services division should take 
leadership of defining the various types of testing and their availability in 
a formalized public health setting. Plain language definitions should be 
proactively communicated to all community-based organizations. This 
communication must include a list of the sites where testing is available 
and the type of test that is offered at that location. 
8. Any formal public health site that offers HIV testing must have access to a 
clear, non-technical description of the testing procedures followed at that 
site. This description should aim to eliminate all the unknowns about the 
testing process. For each type of test (nominal, non-nominal, and 
anonymous), this detailed description should include: 
a. the address and phone number of the testing sites, 
b. the type of testing available (vvhich type and if it is on-site or off) 
c. a description of the clinical set-up 
d. the procedure for making an appointment, 
c. a description of the waiting room and call in process 
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f. (in bold letters) the personal information required to be tested for 
HIV with a specific mention of what contact information is 
required and acceptable 
g. (in bold letters) the procedure that will be followed if a test-seeker 
is unwilling to provide personal information 
h. (in bold letters) state that there is no charge for the HIV test, 
1. (in bold letters) a description of if, how, and when a client's MCP 
number is used and stored in the testing process 
J. a description of the process used to send specimen to laboratory 
k. what happens with positive tests results - how are they stored, 
where are they stored, who can access them, how (paper or 
electronic, what steps are taken to keep them secure) 
I. what happens with negative tests results - how are they stored, 
where are they stored, who can access them, how (paper or 
electronic, what steps are taken to keep them secure) 
m. a description of how third party requests, including but not limited 
to family physicians and insurance companies, for information are 
handled 
n. a description of the reporting process including when is it reported. 
\vhy is it reported, and how is it reported 
o. a description of the partner notification requirements 
p. a description ofhow having an IllY test \Viii impact future 
interactions \'vi th the he a( the are S\'Stem if the result is neuati \·e 
, e 
q. how having an HIV test will impact future interactions with the 
healthcare system if the result is positive 
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9. Full and detailed version ofthis information should be made available to 
community-based organizations on the regional health authority's website 
and upon request. 
5.5.3 Recommendations to Community-based Organizations: Two-way Communication 
and Advocacy 
Once the preceding steps are complete and community-based organizations have 
received clarification about both the Communicable Diseases Act and official HIV 
testing policies and procedures, there is an onus on community-based organizations to 
communicate their own policies and procedures to the regional health authority. 
I 0. Any community-based organization that offers on-site HIV testing or has a 
clinic that refers test seekers off-site, there must be a clear, non-technical 
description of the testing procedures followed at that site. This description 
should aim to eliminate all the unknowns about the testing process. This 
detailed description should include all the information outlined in items a 
to q under recommendation #8 above for each type of test (nominal, non-
nominal, and anonymous). This information should be provided to the 
regional health authority's Community Services Di vi ion. 
II. For a community-based organization that refer testing inquiries ofT-site. 
providers must be familiar" ith the details of the Ill te ting process at 
that site; and 
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12. Community-based organizations must make it possible for Community 
Services staff and other staff from the regional health authority to easily 
access information about services provided by their organization. If staff 
working in formalized environments were aware of the services that are 
available in community-based settings, they could better communicate this 
to clients upon request or when it could be otherwise beneficial to access 
services through a community setting. 
13. Community-based organizations should publicly and cooperatively 
advocate for systemic changes that will better service their needs. 
5.5.4 Recommendations to Stakeholders when Communicating to the Public 
After communicating this information about their respective services to each 
other, community-based organizations involved with HIV testing and referrals and the 
regional health authority Community Services Division should communicate information 
to the public. Chiarelli (2006) suggests using a grade six level when communicating 
messages to the Canadian public about preventing chronic disease. Random testing of 
institutional documents describing the difference between anonymous, non-nominal , and 
nominal testing using were as high as 13.3. Although these documents arc circulated 
among providers, it may indicate one reason for the confusion that persists among 
providers who could be expected to have literacy proficiency abo\'e a grade six lc el. It 
also gi\'eS an idea of the complexity of the subject matter and the extreme changes 
required to reduce the technicality of the language lor a public audience. 
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Other techniques Chiarelli (2006) suggested included usc of images and visual 
aids whenever possible. It should be noted that information from "diseasc-spccitic 
charities'' (p. I 0) has historically been at too high a reading level to benefit the groups to 
which it is targeted. Reported cuJTent problems with messaging to be irrele ant content, 
overuse of posters and brochures, and uselessness of standalone leaflets. 
14. the regional health authority 's Community Services division should 
communicate the availability of testing services using a variety of 
mediums grounded in formalized settings. This includes posters at the 
testing sties, posting information on the website, health promotion fairs, to 
family physicians and pharmacies. 
15. Community-based organizations should take the lead on special measures 
that will ensure this information reaches at-risk populations and other test 
seekers who require a higher degree of confidentiality. Basic information 
about service availability can be verbally delivered at the following 
locations - street reach, food banks, mobile vans, harm reduction sites. 
5.5 .5 Recommendations to PHAC and F/P/T AIDS 
This inquiry has demonstrated that federal guidelines such as the Canadian 
Guidelines on exually Transmitted Infections (PI-lAC, 2006b), do not address vvhat to do 
in the event that a client docs not wish to provide personal identifyi ng information. It has 
also revealed the participants viev\Cd the PI I/\C (2007a) Epidemiology update as 
misleading or irrelevant. The Federal/Provincial/Territorial Advisory Committee on 
AIDS (2007) ··is a liaison committee that faci litates strong kdcral ' provincial/tcrritorial 
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intergovernmental collaboration in addressing a pan-Canadian approach to HIV I AlD 111 
Canada, while respecting jurisdictional responsibi li ties/activities" ( p. 26 ). It has been 
'·proactive and responsive'' (p.l ) in addressing HIV/AIDS issues and informing policy 
and program development for over eighteen years. 
16. The next PHAC Epidemiology update should contain a condensed version 
of the information identified in recommendation #8 with full transparency 
about the testing practices instead of the summary tables and footnotes 
that offer little opportunity to access follow-up information; 
17. The Canadian Guidelines on Sexually Transmitted Infections (PHAC 
2006b) should be updated to address a situation in which a test seeker is 
unwilling to provide personally identifying information and there are 
legislative restrictions at play. 
18. The F/P/T AIDS should review the findings of this inquiry and provide 
input about the development and implementation of a formal provincial 
anonymous HIV testing policy in NL and identify possibilities for inter-
jurisdictional collaboration in this endeavour. 
5.6 Future Research 
My study revealed concerns about family physicians· ability to provide adequate 
and effective HIV testing and counselling and the inability of family physicians to deal 
with sexual health issues, particularly those related to HIV. These concerns included loss 
of confidentiality especially among family members. feeling uncomfortable. wait times 
for appointments. and quality of service dcli\'ery. :'vly study. ho,,·eyer. was limited to 
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community-based organizations and public health clinics and I cannot draw conclusions 
about the degree that participants' concerns are reflected in practices of family physician 
service delivery. It would be useful to examine issues pertaining to prevention and 
treatment of STis in a family physician setting in NL. Pertaining to HIV testing, it would 
useful to know more about the procedures used by local family physicians when referring 
people to HIV testing. Areas that merit further inquiry are family physicians' practices 
for making referrals for HIV testing, their awareness about non-nominal services and the 
possibility of non-nominal blood requisitions, referrals to treatment and services for HIV 
positive people, and level of comfort with discussing issues related to sexual health. 
A second area in which to consider future research is examining how the move 
toward electronic health records will impact people living with HIV I AIDS and HIV 
prevention strategies. At the time of the study, participants from community-based 
organizations had doubts about the confidentiality and privacy of health information 
within small circles of healthcare providers where there is a perception that information is 
inappropriately shared. They had questions about how this would worsen with the move 
toward electronic health records and the impact this would have on people who had been 
tested for or are living with HIV/AIDS. Just as offering anonymity in the face of name-
based reporting, participants raised questions about confidentiality with electronic access 
to personal health information. They wanted to know where and who could see non-
nominal test results that are recorded electronically. Similarly. there were questions about 
whether or not all staff of the regional health authority would be able to s~:e a client' s 
prescription for anti-retroviral medication or paramedic's ability to open the electronic 
lile of anyone v,;ho boards an ambulance. 
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A third area for future research is the inconsistent and disjointed nature of HlV 
testing policy between Canadian provinces. This presents an opportunity to highlight 
testing programs and efforts in place, within Canada and internationally, that display 
positive outcomes and merit of application to a Canadian setting. This would create a best 
practices approach to HIV testing in high-income, low-prevalence countries. The needs 
oftest seekers within Canada's diverse geography and inter-provincial differences should 
not prevent such an endeavour. 
5.7 Plans for Dissemination 
Lomas' (1993, 2000) definitions of diffusion and dissemination are integral to the 
logic I used to develop my dissemination plan. Diffusion describes passive efforts that 
result in uptake only where the audiences are highly motivated, and the latter entails a 
push approach designed to bring the research to a range of audiences. I chose qualitative 
description for its emphasis on plain language summaries that can be synthesized for 
policy audiences and communicated across disciplines. The diffusion efforts I am 
planning include presentation of these findings at two conferences - the Aldrich 
Interdisciplinary Graduate Student Research Conference in St. John 's, L, April 2010 
and the Canadian Association of Health er ices and Policy Research Conference in 
Toronto, Ontario May 10 to 12, 20 I 0. I also plan to submit an artic le about my findings 
in one academic journal. .·1/DS and Behat•iour, and having my thesis on file at Memorial 
niversity of L 's library. 
To disseminate my findings. I \\ill synthesize the findings into one-page reports 
~nd provide them for the three organizations that participated in my study. I \\ill tailor the 
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reports to highlight the findings and recommendations that are relevant to each 
organization. If the organizations wish to disseminate them further, [ will meet with them 
to discuss their dissemination needs and move forward collaboratively. [will also 
highlight parts of the report that are relevant to the reporting process and Communicable 
Diseases Act and forward them to the Provincial Government's Department of Health 
and Community Services as well as the Department of Justice. At the time this document 
was printed, one dissemination interview had been completed. The participant agreed 
with all key themes and findings, and supported moving forward with the proposed 
recommendations. 
5.8 Conclusion 
In this thesis, I have argued that social justice principles should inform policy and 
situated the findings within an expanded social determinants of health framework 
(Graham, 2004; PHAC, 2003). Some Canadian provinces allow official anonymous 
testing; others do not (PHAC, 2007a). This demonstrates an uneven application of social 
justice principles across the country (Braveman & Gruskin, 2003; Gostin & Powers, 
2006; Rawls, 1999). Based on this inquiry, [ support a movement towards a legislative 
change that would allow a transparent policy that permits explicit anonymous testing in 
NL 's urban centres. In this sense, the meaning of anonymous would resemble the 
dctinition of truly anonymous testing used in this document where contact information is 
not requested or recorded and pre and post-test counselling is delivered face-to-face . In 
addit ion to providing an opportunity for people in this small urban centre to access harm 
reduction measures, it will also be a specialized service available to anyone seeking a 
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higher degree of confidentiality than is offered by non-nominal testing procedures 
regardless of their involvement in health damaging. stigmatized activities. Providing this 
service supports the call to increase the visibility of social justice in Canadian public 
health policy (Baum et al. , 2007; Edwards & Maclean Davison, 2007). It is an equitable 
way to honour the right to health provision outlined by the UN/WHO ( 1948, 2006a, 
2009b). This will increase health equity by decreasing the gap in our community between 
test seekers who require a higher degree of confidentiality and the legislative restrictions 
that create fundamental tensions at the point of service delivery. Thes findings may also 
be considered relevant to other small urban centres in NL. 
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J\ppendix A - tudy Invitation 
Dear __________ __ 
Insert name of organization is being invited to take part in a research study that aims to address t he 
challenges of offering anonymous HIV testing in [small urban centre], NL. I have received approval from 
Memorial University of NL's Human Investigations Committee to conduct this research (REFER TO 
DOCUMENT PROVIDING PROOF OF CONSENT). 
I would like to know about (insert name of organization)'s HIV testing policy. I am particularly interested 
in your anonymous testing procedures. I would like to do a document review of (insert name of 
organization)'s HIV testing policies. It is important to note that a policy need not be in a manual. The 
document review will be of all policy-related documents including meeting minutes, emails, briefing 
nu::.:-;;. or any other hard copies that have been or currently are usee! to di;-f'c:t testing procedures. 
I understand that (insert name of organization) has its own research protocols with respect to providing 
access to historical and current policy documents. I would like to meet with you to explain the discuss 
how this can be completed in a manner that ensures minimum disruption to (insert name of 
organization)'s daily activities. 
Please contact me at (709)680-8139 or r63ajh@mun.ca to discuss the details of this request. 
Sincerely, 
Amanda Hancock 
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Appendix 8 - Interview Consent Form 
Consent to Take Part in Research 
TITLE: H IV Testing in [small urban centre]: Are Po licies and Practices Cont,rruent? 
INVESTIGATOR(S): Amanda J. Hancock 
You have been invited to take part in a research study. It is up to you to decide whether to be 
in the study or not. Before you decide, you need to understand what the study is for, what 
r isks you might take and what benefits you might receive. This consent form explains the 
study. 
The researchers will: 
• discuss the study with you 
• answer your questions 
• keep confidential any information which could identify you personally 
• be available during the study to deal with problems and answer questions 
If you decide not to take part or to leave the study this will not affect your professional status. 
I. Int roduct ion/Backgr ound: 
This research project aims to address the challenges of providing HIV testing in a c ity that has a limited 
number of healthcare providers and stigma towards such conditions. The findings will not attempt to 
solve, rather shed light on, issues of public health ethics and privacy. 
2. Purpose of study: 
This is an exploratory study that aims to evaluate the congruence between HIV testing policies and 
practices in [small urban centre], NL. 
3. Description of the study procedures and tests: 
Participants will be asked to complete a confidential interview where they will be asked about their 
professional experiences with HlV testing. 
3. Length of time: 
The interview will occur in a s ingle citing and could take anywhere from 30 - 90 minutes. 
5. Possible risks a nd discomforts: 
This is a low ri sk study. Participants '' ill be asked to describe prokssional experiences from memory 
and speak in general terms about organizational policies. 
6. Benefits: 
V ersinn date: - 1- Initials: 
----
-- ---------
It is not known whether this study will benetit you. 
7. Liability statement: 
Signing this fom1 gives us your consent to be in this study. It te lls us that you understand the 
infonnation about the research study. When you s ign this form, you do not give up your legal rights. 
Researchers or agencies involved in this research tudy sti ll have their legal and professional 
responsibilities. 
8. What about my privacy and confidentiality? 
P:·o ~r.cting your privacy is an important part of this study. Every effc.11 tc protect your privacy will be 
made. llowever it cannot be guaranteed in instances where legal violat ions are disclosed. 
When you sign this consent form you give us permission to 
• Collect information from you 
• Share information with the people supervising the study 
• Share information with the people responsible for protecting your legality and safety 
Your name and contact information will be kept secure by the research team in Newfoundland 
and Labrador. It will not be shared with others without your permission. Your name will not 
appear in any report or article published as a result of this study. 
Information collected for this study will be kept for five years. 
If you decide to withdraw from the study, the information collected up to that time will continue 
to be used by the research team. It may not be removed. This information will only be used for 
the purposes of this study 
Information collected and used by the research team will be stored by the Principal Investigator 
in a locked office. Amanda Hancock is the person responsible for keeping it secure. 
Your access to records 
You may ask the researcher to see the information that has been collected about you. 
9. Questions: 
If you have any questions about taking part in this study, you can meet with the investigator who 
is in charge of the study at this institution. That person is: 
Amanda Hancock 
Email: r63a,jh(a rnun.ca 
Phone: (709)437-6162 
Or you can talk to someone who is not involved '' ith the study at all, but can advise you on your 
rights as a participant in a research study. This person can be reached through: 
V l.! rs iun date: 
Office of the Human Investigation Committee (IIIC) at 709-777-697-4 
Email: hic1a rnull.ca 
r\ ft<'r signing this consent you will be ginn a copy. 
-2- Initials: 
-- - -- - - - --
Signature Page 
Study title: HIV Testing in [small urban centre]: Are Policies and Practices 
Congruent? 
Name of principal investigator: Amanda J. Hancock 
To be filled out and signed by the participant: 
I have read the consent form 
I have had the opportunity to ask questions/to discuss this study. 
I have received satisfactory answers to all of my questions. 
I have received enough information about the study. 
I have spoken to Amanda Hancock and she has answered my questions 
I understand that I am free to withdraw from the study 
• at any time 
• without having to give a reason 
• without affecting my professional status 
Please check as appropriate: 
Yes { } No {} 
Yes { } No { } 
Yes { } No { } 
Yes { } No {} 
Yes {} No {} 
Yes { } No {} 
I understand that it is my choice to be in the study and that I may not benefit. 
I agree to be audio taped 
Yes {} 
Yes {} 
Yes {} 
No {} 
No {} 
No {} I agree to having a professional transcriber listen to this audio tape 
I agree to take part in this study. Yes {} No {} 
Signature of participant Date 
Signature of witness (if applicable) Date 
To be signed by the investigator or person obtaining consent 
I have explained this study to the best of my ability. I invited questions and gave answers. I believe 
that the participant fully understands what is involved in being in the study, any potential risks of 
the study and that he or she has freely chosen to be in the study. 
ignature of investigator 'person obtaining consent Date 
Telephone number: 
Version date: -3- Initials: 
- - - - ---- - ------
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Appendix C - Generic Interview Guide 
Anonymous HIV Testing in [small urban centre], L: Are Policies and Practices 
Congruent? 
Student Name: Amanda Hancock 
Interview Guide 
I) Walk me through a typical HIV testing scenario at (fill in name of organization). 
Probes 
• let the individual describe a typical H IV testing experience 
'rrithout specifying which type of test (nominal, non-
nominal, or anonymous) 
• 'Who, what, where, how often' of testing 
2) !--'rom yuur experience, what are the procedural differences that occur at tS.lU.D. 
name of organization) when the test is anonymous? 
Probes 
• Find out the interviewee's practical application of the 
characteristics that differentiate the three types of tests 
• Determine if he or she knows that PHAC Epi reports state 
that anonymous testing is available in NL 
3) What personal information is collected at the time of an anonymous HIV test? 
(name, fake name, contact information, etc) 
4) Can you describe the contact, follow-up and counseling procedure for an 
anonymous HIV test for which the result is negative? Positive? 
Probes 
• How is news of a positive test delivered? 
• How is someone who has had an anonymous test given pre 
and post-test counseling? 
5) T here are a limited number of places in the city that test for HIV and at each place 
there are a relatively small number of healthcare practitioners - did you ever have 
concerns that the identities of individuals who wanted to remain unidentified 
would become known. If so, how did you handle that? 
Probes 
• Describe the measure that are taken to safeguard the 
identities of the e individuals. 
6) Can you describe a situation when an individual came seeking testing but refused 
to provide any personal information? Or refused to make up a nameless code? 
Probes 
• Would an individual ever leave without bcing tested? 
• What would you do if this person's test came back 
positive? 
Anonymous HIV Tc ting in [small urban centre], L: Are Policies and Pradiccs 
Congruent? 
Student Name: Amanda Hancock 
7) Is there a policy about HIV testing at your organization? 
• 
Probes 
• If yes 
o How do the procedures you've just described fit with 
the policies at (fill in name of organization)? 
• If they don't fit, why did you do it? 
o When/how did you learn about this policy? 
• Formally: Orientation, training, etc. 
• Informally: what did co-workers and managers 
say about this policy, what imprcs ion did they 
gth. 
o When/how is it introduced to new staff'? 
• What are new staff told about anonymous 
testing? 
• Do they get an orientation or training on HIV 
testing policy? 
• Do they get an orientation or training on HIV 
practice? 
o Ilow often do you refer to it? 
o Can you describe a time when you did refer to it? 
• Circumstances 
• Outcomes 
o What format is it in? 
o Were you involved in writing the policy? 
• If not, who was involved? Why? 
o When was it last revised? 
0 
0 
If no 
• Were you involved in the latest policy review? 
Why/why not? 
• Do you have suggestions that could improve the 
policy? 
What is the general attitude towards this policy at (fill 
in name of organization)? 
In your opinion, is it effective? 
o Why isn' t there a policy for HIV testing? 
o Would having a policy help you do your job better? 
8) If you needed anonymous HIV testing, where would you go'? 
Probes 
• Is it possible to get a truly anonymous H IV test in [small urban 
centre]. NL? 
9) What does anonymous testing in [small urban centre] , . L mean to you·.> 
Probes 
• ome say anonymity is lost\\ hen one· · t~tce is exposed. 
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Appendix 0 - Document Trees 
Community-based Organization #I 
15 documents 
I 
I I 
Historical Documents Current Documents 
8 documents 7 documents 
B I - STis and your Relationship A I -Clinic Information 
~ ~ 
H2- When and Where to get fested for A2 -The 5 W's ofSTI Testing 
STis 2005 ~ ___, 
BJ - No Title. STI Research 2002 A3- Poster Advertising HIV Testing 
~ ~ 
84- Poster Advertising HIV Testing A4- Services and Resources (2009) 
1--- --1 
I:JS - Services and Resources (2007) A5 - Intake Sheet 
~ ~ 
B6- lntaJ...c Shcet A6 - Prescription Pad (voided sample) 
~ ~ 
87- Policies for II IV Testing (2004) A 7 - Polic) Manual Centre Operation Clinic 
1---
--
Procedures and Guidelines 
R8- C linic Po licies and Procedures 
(2003) 1---
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I I 
I 
Education, 
Prevention, & 
Awareness 
9 documents 
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Current 
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Current 
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2005 
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Where to Get 
Tested for STls 
:wos 
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STI Research 
2002 
/" 84 - Poster ' 
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(same year) 
" 
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based 
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15 documents 
I 
I 
Clinical 
3 documents 
" 
./ 
I 
I I I 
A4 - Services AS- Intake /" A6-
and Resources Sheet Prescription 
Current Current Pad 1 Voided Sample) 
Current 
I' 85 - Services 86 -Intake 
and Resources Sheets 
2007 
" 
I 
Policy-Related 
3 documents 
r 
A 7 - Policy Manual 
Centre Opcrdtiun 
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Guidel im:s 
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Policies and 
Procedures 
2003 
\ 
I 
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40 documents 
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Current Documents 
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Prevention, & 
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/ C7 and C8 - HIV 
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\.. 
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1 document 
Current 
./ 
' 
I 
/ " Policy-Related 
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I 
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Current 
,current \.. 
-------------------
I 
Regional Health Authority 
8 documents 
I 
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Current Documents 
5 documents 
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~ Transmitted Infections, HfV and 
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\. 
E5 - Canadian Guidelines 
....._ on Sexually Transmitted 
Infections 
I 
Legal 
3 documents 
' I 
I 
E 1 - Communicable ' 
/ 
I 
Regional Health 
Authority 
8 documents 
I 
I 
I 
Policy-Related 
5 documents 
I 
E2 - Health and ' Clinical Procedures 
I 
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/ National Guidelim:s ' 
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' 
/ F I - Venera! Diseases 
Act 
~~--------------_// 
Current 
' 
Act 
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' 
E3 -Draft Testing. Treatment'\ 
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and Bloodbome Infections 
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and Follow-
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-
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I 
/ ES -Canadian Guidelines' 
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Infections 
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./ 
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Appendix E - Interview Guide Revision 
Anonymous HIV Testing inl ,ll.ill11rb.lnl· ·ntrc•J , L: Are Policies and Practices 
Congruent? 
tudent ~ame: Amanda Hancock 
Interview Guide 
1) Walk me through a typical HIV testing scenario at (fill in name of organization). 
Probes 
• let the individual describe a typical HIV testing experience 
without specifying which type of test (nominal, non-
nominal, or anonymous) 
• 'Who, what, where, how often ' of testing 
2) From your experience, what are the procedural di tTercnces that occur at (till in 
name of organization) when the test is anonymous? 
Probes 
• Find out the interviewee's practical application of the 
characteristics that differentiate the three types of tests 
• Determine if he or she knows that PHAC Epi reports state 
that anonymous testing is available in NL 
3) What personal information is collected at the time of an anonymous HIV test? 
(name, fake name, contact information, etc) 
4) Can you describe the contact, follow-up and counseling procedure for an 
anonymous HI V test for which the result is negative? Positive? 
Probes 
• How is news of a positive test delivered? 
• How is someone who has had an anonymous test given pre 
and post-test counseling? 
5) There are a limited number of places in the city that test for HIV and at each place 
there are a relatively small number of healthcare practitioners- did you ever have 
concerns that the identities of individuals who wanted to remain unidentified 
would become known. If so, how did you handle that? 
Probes 
• De cribc the measures that arc taken to safeguard the 
identities of these individuals. 
ti) Can you describe a s ituation when an individual came seeking testing but refused 
to provide any personal information? Or refused to make up a nameless code? 
Probes 
• Would an individual ever leave without being te ted? 
• What would you do if this person's test came back 
po·itivc? 
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Anonymous HIV Testing inJ.. ~tn .tl lt, rh: tn r,·llt t"< 'j, L: Are Policies and Practices 
Congruent? 
. tuJent ame: Amanda Hancock 
7) Is there a policy about HIV testing at your organization? 
Probes 
• Ifyes 
o How do the procedures you've just described fit with 
the policies at (till in name of organization)? 
• If the) don ' t tit, why did you do it? 
o \VhenJhow did you learn about this policy? 
• Formally: Orientation, training, etc. 
• Informally: what did co-workers and managers 
say about this policy, what impression did they 
give 
o When/how is it introduced to new staff? 
• What are new statftold about anonymous 
testing? 
• Do they get an orientation or training on HIV 
testing policy? 
• Do they get an orientation or training on HIV 
practice? 
o How often do you refer to it? 
o Can you describe a time when you did refer to it? 
• Circumstances 
• Outcomes 
o What format is it in? 
o Were you involved in writing the policy? 
• If not, who was involved? Why? 
o When was it last revised? 
• Were you involved in the latest policy review? 
Why/why not? 
• Do you have suggestions that could improve the 
policy? 
o What is the general attitude towards this policy at ill!! 
in name of organization)? 
o In your opinion, is it effective? 
• Ifno 
o Why isn't there a policy for HIV testing? 
o Would having a policy help you do your job better? 
8) If you needed anonymous HIV testing, where would you go? 
Probes 
• Is it possible to gt:t a truly anonymous HIV test inl nul l 11rl,:tn 
..: ·tl_lr,·J, L? 
9) What dot:s anonymous testing inJ.. ,tr1.1l l 111 h: tn ''tllrl.'j . • L mean to you? 
Probt:s 
• Some say anonymity is lost when one's face is exposed .. 
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Appendix F- HIC Ethics Approval 
·, J • I 
.. . . ~. ·. = .. l·t~ r~ 
January 30, 2009 
Refer·ence #08.166 
Ms. A. Hancock 
34 Quarry Road 
Torbay, NL AIK IA3 
Dear 1\ls. Hancock 
RE: Newfoundland and Labrador's anonymous HIV testing policy: Provider knowledge, 
attitudes and practices 
This wil l acknowledge receipt of your correspondence, dated January 29, 2009 
This correspondence has bl!en reviewed by the co-chair under the direction of the Committee Fu ll 
approval of this research study has been granted for one year effective November 6, 2008. 
This is to confirm that the Human Investigation Committee reviewl!d and approved or acknowlc.:dged 
the following documents (as indicated): 
• Revised consent jorm, approved 
• Interview guide, approved 
This approval wi ll lapse on November 6, 2009. It is your responsibility to ensure that the Ethics 
Renewal form is torwarded to the HIC office prior to the renewal date. l111: mjonn,ltion pro1·ided in 
tiJisfonn must bt: current to the time of.\'llhmiss;on and submitted to HIC not less than JO nor mvre 
tlum .Jj tlt1ys ofthe anll ll 'ers,n ")' v(your appro1·al dare. The Ethics Renewal torm can he do\\nloaJcd 
t'rum tile HIC 1\Cbsitc !l!.t~ 1\\\\'.fllcd.mun . ..:a hie dm1n/oad~ .·\J!nt~;ll%~ 1){ pd:tlc.:" .. ~Ofo'nrmJ.h~ 
/'he H11111an fnl 't'stigation Cnmmi1tce .~th-i.l't·s !H:I r IF YOU DO .\'OT rl'tum the ('nmpl( t,·t! Eth(( ·s 
RL'IIl' tt ·ul jorm prior to dale u(rcnctt ul: 
four <'I hit'S <ljlprm·ultt il//.,pse 
• You tn/1 be rct{l tired to ,·top i'<'St '<ll'( /1 tldll 't(l ' llltlllt'tliatt'ly 
• f ou 11/t/l 1101 he P<'l'lllltfe, / tv rnt<lrt t!JL•. ·ru<~l' until you rc,rpplt jin · !I l td ,.,.,·, ·n t' <lflf' I'Ot·a! w 
tllltft·rr, tf,l' the studr tlg,Jin 
Ms. A. H:.~n~ o..: k 
Rdcren..:e # 08.166 
J .tnu.uy JO, 2CG9 
P:tge 2 
for a hospi al-bast!d study, it is your responsibility to seek the necessary approval from Ea tern 
Health and/or other hospital boards as appropriate. 
i\lodilications of the protocol/consent are not permitted without prior appro\'al from the Human 
Inves tigation Committee. Implementing changes in the protocol/consent without HIC approval 
may result in the approval of your research study being revoked, necessitating cessation of all 
related research activity. Request for modification to the protocol/consent must be outlined on an 
amendment form (available on the HIC website) and submitted to lhc HIC for review. 
This research ethics board (the HIC) has reviewed and approved tht: research protocol and 
documentation as noted above for the study which is to be conducted by you as the qualified 
investigator named above at the specified site. This approval and the views of this Research Ethics 
Board have been documented in writing. In addition, please be advised that the Human Investigation 
Committee currently opcrates according to Tri-Cowzcil Policy Statement: Ethical Conduct f or Research 
fnvolving Humans and applicable laws and regulations. The membership of this research ethics board 
is constituted in compliance with the membership n:quirements for research ethics boards as per these 
guidelines. 
Notwithstanding the approval of the HIC. the primary responsibility for the ethical conduct of the 
invt!stigation remains with you. 
We wish you every success with your study. 
Sincerdy, 
John D. Hamett, MD. FRCPC 
Co-Chair 
Human Investigation Committee 
Fern Brunger, PhD 
Co-Chair 
Human Investigation Committee 
C C Dr. C. Loomis, c, o Office of Research, 1 N 
1r. \V. Miller, c. o Patient Research Ct!ntrc, Eastern Health 
HIC meeting date : February 5, 2009 
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Appendix G - RPAC Application and Approval 
Eastern 
Health 
Process for Review and Approval of Clinical Research 
to be conducted within 
Eastern Health (city hospitals) 
In keeping with the commitment to review and to approve research projects in a timely and efficient manner, we have a 
two step research approval process. 
1. All projects to be conducted within this institution are required to have review and full approval of the Human 
Investigations Committee. This is a joint committee of Eastern Health and The Faculty of Medicine, MUN. 
Applications should be completed and forwarded to The Office of Research and Graduate Studies, Faculty of 
Medicine, Level I, HSC. Information on the Human investigations Committee application form and process are 
available from web site http://www.med.mun.ca/hic/default.htm 
2. Once full approval has been granted by HIC, application for research to be conducted within our institution, must be 
made to the Research Proposal Approval Committee (RPAC). The primary mandate of this committee is to review 
resource utilization, impact to the organization and access to confidential information for any project to be 
conducted within the institution. In addition we catalogue all research activities within the institution. 
Review by RPAC requires submission of a short form, which provides a brief explanation of the project, associated 
costs and sources of funding. Applications are available at http://www.med.mun.ca/prc/ 
3. All projects are reviewed and approved by the appropriate Program Clinical Chair or Director before receiving final 
full approval from RPAC. 
• The committee meets monthly. 
• It is the responsibility of the Principal Investigator of research project to insure appropriate 
institutional and departmental approvals are in place prior to undertaking any research project 
****************************************************************************** 
Two copies of this application form are required 
1. Completed and signed RPAC Applications are to be sent to: 
Donna Bruce RN 
Manager Patient Research Centre 
Room 1406, Level I, HSC 
300 Prince Philip Drive 
St.John's , NL, AlB 3V6 
• Or can be faxed 709-777-6995 
An electronic copy forwarded to Donna.Bruce@easternhealth .ca 
Questions can be directed to Patient Research Centre at Phone 709-777-7283 
Eastern 
Health 
RESOURCE ALLOCATION REQUEST 
FOR CLINICAL RESEARCH PROPOSALS 
To complete this application you will need: 
1. A copy of your spending budget 
2. A copy of any applicable Departmental Agreements 
3. An electronic copy of this application is to be sent to Donna. Bruce@easternhealth. ca 
4. HIC approvals are automatically forwarded to the Patient Research Centre 
• HIC Reference Number: #08.166 
• Protocol Title: N/A 
• Title of Study: Anonymous HIV Testing in [small urban centre], NL: Are Policies and Practices 
Congruent? 
Brief Description 
Across Canada, HIV testing policies have evolved differently in each province since testing became available in the 
80's. It is important to engage in regionally-specific research to fine out if NL's HIV testing policies are effective. 
The Public Health Agency of Canada's Epidemiology Report (2007) suggests that in Newfoundland and Labrador, "if 
someone tests positive for HIV through anonymous HIV testing, that individual then becomes part of the 
nominal/name-based system, in which counseling, follow-up care, and HIV data reporting are all done nominally" (p. 
15). fn other words, the names of individuals who test positive for HlV could eventually be disclosed. To date, there 
has been no attempt to detem1ine if and how this anonymous HIV testing policy is followed in practice. Examining 
the policies of three settings that offer HlV testing in [small urban centre 1 and asking the persons involved in 
providing that service will inform academics, policy, and decision-makers for future policy debates on the matter. 
The tindings will not attempt to solve, rather shed light on, issues of public health ethics and privacy. 
Study objec tives 
I. To re'vicw the I IIV testing policies in the three settings (four organizations) that otTer voluntary I II V testing in 
[small urban ct:ntre 1. N L. 
,. -Sc~·l-ti-ng--------------~,-0-r_g_a •-li-za-l-io-n----------------------. 
I) Institutional i. St. Claire's 
2) Public Health ii . Eastern Health Public Health Clinic(s) 
3) Community Ill. NL Sexual Health Centre - Planned 
Parenthood 
iv. AIDS Committee ofNL (ACNL) 
2. To determine policy guidelines by performing a document review. Specifically, how is anonymity maintained 
if anonymous testing is offered? 
3. To examine everyday HIV testing practices by speaking with the healthcare providers who have been or are 
presently involved in administering HIV testing and/or counseling. 
4. To evaluate and interpret the congruence between established policy and everyday practices. 
5. To address the policy challenges associated with offering anonymous testing in [small urban centre], NL. 
I Pharmacy 
1. Does this proposal involve the use of medication (including placebos) other than those normally used for 
patients? Medications (Active or Placebo) will be dispensed by the Hospital Pharmacy? 
YES ( ) NO( x) 
(A) If yes, Please specify 
(B) Has this project been submitted to pharmacy for review YES ( ) NO( x) 
I Tests and Procedures 
2. Does the proposal involve local laboratory tests, x-rays or other imaging techniques other than required 
for normal patient care?(lf yes, attach a copy of your Departmental Agreement) YES ( ) NO ( x ) 
Will samples be sent to Central Laboratory YES ( ) NO ( x ) 
Does this project request use of archived biloglcal samples YES ( ) NO ( x ) 
I Health Records or IMAT? 
3. Does this project require access to Health Records or I MAT? 
If yes .. How many records 
When do you plan to do this review from ______ _ 
I Other Hospital Supports 
Paper 
Electronic 
YES ( ) NO ( x ) 
YES ( ) NO ( x) 
YES ( ) NO ( x ) 
to ______ _ 
4. Does the proposal require assistance of nurses or hospital staff other than the research personnel 
YES ( x) NO ( 
If yes, please describe 
This study will be completed in two stages: a document reivew and key informant interviews. 
The document review of each organization's HIV testing policy must be completed before the 
key informant interviews. I do not anticipate needing the assistance of any staff other than the 
research personnel to complete the first stage (the document review), but I will not rule it out 
because it may be required for clarification depending on how developed the policy documents 
are. The purpose of the second stage is to tind out about eYeryday practice issues of HIV testing; 
therefore, I wi ll need the assistance of healthcare providers who have been or are presently 
involved in administering HIV testing and/or counselling or responding to public inquiries about 
the same. This assistance will be required at a later date at which timer will request key 
informant interviews with a maximum of 12 key informants: three from each of the 
aforementioned organi7ations (see ·stuJy Ohjecti\'cs') . 
5. Does the proposal involve admission of subjects to the hospital or the clinical investigation unit? 
YES ( ) NO ( x) 
Please describe -----------------------------
The approval of this proposal is contingent upon 
• Adequate funding being available to support the project 
• The researcher providing upon request an update on the progress of the research. 
Your signature on this form gives approval to list your project in our annual report. 
For contracts please check any contractuallimitaions related to publishing the title 
SIGNED: ____________ _ 
Principal Investigator Date 
Program Clinical Chief/ Director Date 
Version : June 08/06 
April14, 2009 
Ms. Amanda Hancock 
34 Quarry Rd 
Torbay, Nl 
A1K 1A3 
Dear Ms. Hancock : 
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lluttflr n,;,,u,,. 'J:J p,.,,., 1•1,"• 
1•. 0 . Bo.w / .1/ :J:J 
."it • . Itt/ere·,, .VL ,II II I ,IJ 
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,.., .... , (70!J# 1.J:l-·17.1.1 
Your research proposal HIC # 08.166- "Anonymous HIV testing in a QIL: Are policies 
and practices congruent?" was reviewed by the Research Proposals Approval Committee 
(RPAC) of Eastern Health at its meeting on April14, 2009 and we are pleased to inform you that 
the proposal has been approved. 
The approval of this project is subject to the following conditions: 
• The project is conducted as outlined in the HIC approved protocol; 
• Adequate funding is secured to support the project; 
• In the case of Health Records, efforts will be made to accommodate requests based 
upon available resources. If you require access to records that cannot be 
accommodated, then additional fees may be levied to cover the cost; 
• A progress report being provided upon request. 
If you have any questions or comments, please contact Donna Bruce, Manager of the Patient 
Research Centre at 777-7283. 
Sincerely, 
Mike Doyle, PhD 
Director of Research 
Corporate Strategy & Research 
Chair, RPAC 
cc· 1\ls Donna Bruce. ,!arager Patien t Research Cen tre 
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